Nomad Foods Limited (NOMD) 20-F 3 Mar 22 2021 FY Annual report (foreign) Financial data

Cover

Cover	12 Months Ended
	Dec. 31, 2021shares
Document and Entities Information [Line Items]
Document Type	20-F
Document Registration Statement	false
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Document Shell Company Report	false
Entity File Number	001-37669
Entity Registrant Name	Nomad Foods Limited
Entity Incorporation, State or Country Code	D8
Entity Address, Address Line One	No. 1 New Square
Entity Address, Address Line Two	Bedfont Lakes Business Park
Entity Address, City or Town	Feltham
Entity Address, Postal Zip Code	TW14 8HA
Entity Address, Country	GB
Title of 12(b) Security	Ordinary Shares, no par value
Trading Symbol	NOMD
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding	173,559,173
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Accounting Standard	International Financial Reporting Standards
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Entity Central Index Key	0001651717
Entity Shell Company	false
Business Contact
Document and Entities Information [Line Items]
Entity Address, Address Line One	No. 1 New Square
Entity Address, Address Line Two	Bedfont Lakes Business Park
Entity Address, City or Town	Feltham
Entity Address, Postal Zip Code	TW14 8HA
Contact Personnel Name	Samy Zekhout
City Area Code	+(44)
Local Phone Number	208 918 3200
Contact Personnel Fax Number	+(44) 208 918 3491
Preference shares [member]
Document and Entities Information [Line Items]
Entity Common Stock, Shares Outstanding	1,500,000

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2021
Auditor [Line Items]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	London, United Kingdom
Auditor Firm ID	876

Consolidated Statements of Fina

Consolidated Statements of Financial Position - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Non-current assets
Goodwill	€ 2,099.4	€ 1,902.5
Intangibles	2,455.7	2,155.7
Property, plant and equipment	549.4	422.2
Other non-current assets	8.9	1.1
Derivative financial instruments	0	17.2
Deferred tax assets	128.3	113.5
Total non-current assets	5,241.7	4,612.2
Current assets
Cash and cash equivalents	254.2	393.2
Inventories	410.6	344.3
Trade and other receivables	234.6	185
Indemnification assets	9.5	15.4
Short-term deposits, not classified as cash equivalents	0	25
Derivative financial instruments	20.2	5.5
Total current assets	929.1	968.4
Assets	6,170.8	5,580.6
Current liabilities
Trade and other payables	692	647.2
Current tax payable	198.5	166.2
Provisions	39.3	45.7
Loans and borrowings	29.1	22.5
Derivative financial instruments	7.3	35.5
Total current liabilities	966.2	917.1
Non-current liabilities
Loans and borrowings	2,198.3	1,736.3
Employee benefits	244.2	276.2
Other non-current liabilities	1.8	2.2
Provisions	2.9	6.1
Derivative financial instruments	20.8	89.5
Deferred tax liabilities	437.6	427.1
Total non-current liabilities	2,905.6	2,537.4
Total liabilities	3,871.8	3,454.5
Net assets	2,299	2,126.1
Equity
Share capital and capital reserve	1,623.1	1,620.5
Share-based compensation reserve	6.9	8.3
Founder Preferred Shares Dividend Reserve	166	245.5
Translation reserve	105.1	84.7
Other reserves	10.5	(24.5)
Retained earnings	387.4	191.6
Equity	€ 2,299	€ 2,126.1

Consolidated Statements of Prof

Consolidated Statements of Profit or Loss - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Profit or loss [abstract]
Revenue	€ 2,606.6	€ 2,515.9	€ 2,324.3
Cost of sales	(1,862.3)	(1,753.4)	(1,626.4)
Gross profit	744.3	762.5	697.9
Other operating expenses	(356.3)	(382.7)	(359.9)
Exceptional items	(45.3)	(20.6)	(54.5)
Operating profit	342.7	359.2	283.5
Finance income	0.1	4.7	2.5
Finance costs	(106.1)	(68.4)	(75.7)
Net finance costs	(106)	(63.7)	(73.2)
Profit before tax	236.7	295.5	210.3
Taxation	(55.7)	(70.4)	(56.7)
Profit for the period	181	225.2	154
Profit (loss), attributable to non-controlling interests	0	(0.1)	(0.4)
Profit (loss)	€ 181	€ 225.1	€ 153.6
Earnings per share:
Basic earnings per share (in euros per share)	€ 1.02	€ 1.16	€ 0.80
Diluted earnings per share (in euros per share)	€ 1.02	€ 1.14	€ 0.78

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of comprehensive income [abstract]
Profit (loss)	€ 181	€ 225.1	€ 153.6
Other comprehensive income/(loss):
Actuarial gains/(losses) on defined benefit pension plans	36.1	(27.8)	(35.9)
Taxation (charge)/credit on remeasurement of defined benefit pension plans	(10.2)	8.3	6.7
Items not reclassified to the Consolidated Statement of Profit or Loss	25.9	(19.5)	(29.2)
Gain/(loss) on investment in foreign subsidiary, net of hedge		(10.1)	6
Effective portion of changes in fair value of cash flow hedges	22.6	(17.3)	(27.3)
Taxation (charge)/credit relating to components of other comprehensive income	(13.6)	6	5.6
Items that may be subsequently reclassified to the Consolidated Statement of Profit or Loss	27.8	(21.4)	(15.7)
Other comprehensive income/(loss) for the period, net of tax	53.7	(40.9)	(44.9)
Comprehensive income	234.7	184.2	108.7
Total comprehensive income for the period	234.7	184.3	109.1
Comprehensive income, attributable to non-controlling interests	€ 0	€ (0.1)	€ (0.4)

Consolidated Statements of Chan

Consolidated Statements of Changes in Equity - EUR (€) € in Millions	Total	Share capital and capital reserve	Share based compensation reserve	Founder preferred shares dividend reserve	Translation reserve	Other reserves*	Accumulated deficit reserve	Equity attributable to owners of parent [member]	Non-controlling interests [member]
Equity | Increase (decrease) due to changes in accounting policy required by IFRSs	€ 31.3				€ 0		€ 31.3	€ 31.3
Equity	2,059.1	€ 1,748.5	€ 9.4	€ 372.6	88.8	€ 8.5	(167.9)	2,059.9	€ (0.8)
Equity (restated)	2,090.4	1,748.5	9.4	372.6	88.8	8.5	(136.6)	2,091.2	(0.8)
Profit (loss)	153.6						154	154	(0.4)
Other comprehensive income/(loss) for the year	(44.9)				6	(21.7)	(29.2)	(44.9)
Comprehensive income	108.7				6	(21.7)	124.8	109.1	(0.4)
Dividends recognised as distributions to owners		2.5		(2.5)
Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity	(0.8)	0	(0.8)					(0.8)
Issue of equity	354.2	355.5	(1.3)					354.2
Increase (decrease) from listing and share transaction costs, equity	(11.1)	(11.1)						(11.1)
Share based payment charge	14.9		14.9					14.9
Reclassification of awards for settlement of tax liabilities	0.4		0.4					0.4
Increase (decrease) through transactions with owners, equity	357.6	346.9	13.2	(2.5)				357.6	0
Equity | Increase (decrease) due to changes in accounting policy required by IFRSs					0
Equity	2,556.7	2,095.4	22.6	370.1	94.8	(13.2)	(11.8)	2,557.9	(1.2)
Equity (restated)					94.8
Profit (loss)	225.1						225.2	225.2	(0.1)
Other comprehensive income/(loss) for the year	(40.9)				(10.1)	(11.3)	(19.5)	(40.9)
Comprehensive income	184.2				(10.1)	(11.3)	205.7	184.3	(0.1)
Dividends recognised as distributions to owners		124.6		(124.6)
Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity	0	0.7	(0.7)					0
Issue of equity	0.5	8.4	(7.9)					0.5
Repurchase of ordinary shares (in shares)	(608.6)	(608.6)						(608.6)
Share based payment charge	9		9					9
Reclassification of awards for settlement of tax liabilities	(14.7)		(14.7)					(14.7)
Increase/(decrease) through non-controlling interests extinguished on acquisition of subsidiary	(1)						(2.3)	(2.3)	1.3
Increase (decrease) through transactions with owners, equity	(614.8)	(474.9)	(14.3)	(124.6)			(2.3)	(616.1)	1.3
Equity | Increase (decrease) due to changes in accounting policy required by IFRSs					1.6	(1.6)
Equity	2,126.1	1,620.5	8.3	245.5	84.7	(24.5)	191.6	€ 2,126.1	€ 0
Equity (restated)	2,126.1	1,620.5	8.3	245.5	86.3	(26.1)	191.6
Profit (loss)	181						181
Other comprehensive income/(loss) for the year	53.7				18.8	9	25.9
Comprehensive income	234.7				18.8	9	206.9
Deferred hedging gains transferred to the carrying value of inventory	27.6					27.6
Dividends recognised as distributions to owners		79.5		(79.5)
Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity		0.6	(0.6)
Issue of equity	0	0.1	(0.1)
Repurchase of ordinary shares (in shares)	(77.6)	(77.6)
Share based payment charge	5.1		5.1
Reclassification of awards for settlement of tax liabilities	(16.9)		(5.8)				(11.1)
Increase (decrease) through transactions with owners, equity	(89.4)	2.6	(1.4)	(79.5)			(11.1)
Equity	€ 2,299	€ 1,623.1	€ 6.9	€ 166	€ 105.1	€ 10.5	€ 387.4

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of cash flows [abstract]
Cash generated from operations before tax and exceptional items	€ 450.3	€ 552	€ 376.9
Cash flows relating to exceptional items	(48.8)	(12.1)	(15.9)
Tax paid	(95.2)	(82.9)	(45.6)
Net cash flows from operating activities	306.3	457	315.4
Cash flows from investing activities
Business combinations, net of cash acquired	(597.3)	(112.9)	(1.5)
Purchase of property, plant and equipment and intangibles	(79.2)	(58.7)	(47.3)
Purchase of investments	0	(25)	(25)
Redemption of investments	16.5	25.2	0
Net cash used in investing activities	(660)	(171.4)	(73.8)
Cash flows from financing activities
Proceeds from issuance of Ordinary Shares	0	0.6	354.1
Share issuance costs	0	0	(11.1)
Repurchase of ordinary shares	(77.6)	(608.6)	0
Income taxes paid (refund), classified as financing activities	(22.6)	(19.2)	0
Proceeds from new loans and notes	800	0	2
Repayment of loan principal	(408.7)	(11.7)	(22.2)
Payments of lease liabilities, classified as financing activities	(19.4)	(20.3)	(21.8)
Payment of financing fees	(18.7)	0	0
Interest paid	(36.7)	(50.2)	(48.4)
Interest received	0.1	0.7	2.4
Other financing cash flows	(2)	(6.1)	(3.6)
Net cash provided by/(used in) financing activities	214.4	(714.8)	251.4
Net (decrease)/increase in cash and cash equivalents	(139.3)	(429.2)	493
Cash and cash equivalents at beginning of period	393.2	824.8	327.6
Effect of exchange rate fluctuations	11	(13.1)	4.2
Cash and cash equivalents at end of period	254.2	393.2	824.8
Cash and cash equivalents if different from statement of financial position	€ 254.2	€ 382.5	€ 824.8

General information

General information	12 Months Ended
	Dec. 31, 2021
General Information About Financial Statements [Abstract]
General information	General information Nomad Foods Limited (the “Company” or “Nomad”) was incorporated in the British Virgin Islands on April 1, 2014. The address of Nomad’s registered office is Ritter House, Wickhams Cay II, Road Town, Tortola, VG1110 British Virgin. The Company is domiciled for tax in the United Kingdom. Nomad Foods Limited (NYSE: NOMD) is Europe's leading frozen foods company. Nomad Foods Limited's (the “Company” or “Nomad”) portfolio of iconic brands, which includes Birds Eye , Findus , iglo , Ledo and Frikom , have been a part of consumers’ meals for generations, standing for great tasting food that is convenient, high quality and nutritious. Nomad Foods is headquartered in the United Kingdom. Additional information may be found at www.nomadfoods.com.

Basis of preparation

Basis of preparation	12 Months Ended
	Dec. 31, 2021
Basis Of Presentation [Abstract]
Basis of preparation	Basis of preparation The consolidated financial statements of Nomad and its subsidiaries (the “Company” or “Nomad”) have been prepared in accordance with International Financial Reporting Standards issued by the International Accounting Standards Board. These consolidated financial statements are also in accordance with International Financial Reporting Standards as adopted by the European Union. The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis using our historical experience, as well as other factors we believe appropriate under the circumstances, such as current economic conditions in light of the COVID-19 pandemic. Actual results could differ from these estimates. In preparing cash flow forecasts, management consider severe but plausible downside scenarios taking into consideration the Company's key risks, including the impacts of the COVID-19 pandemic. Having considered these risks in their assessment, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis in preparing these financial statements. Adoption of new accounting standards - IFRS 9 'Financial Instruments' IFRS 9 ‘Financial Instruments’ was issued in July 2014 and replaced IAS 39 ‘Financial Instruments: Recognition and Measurement.’ The Company had previously elected to continue hedge accounting under IAS 39 as was allowed by the standard. On January 1, 2021, the Company adopted hedge accounting under IFRS 9, as the hedge accounting requirements have been simplified and are more closely aligned to the Company's risk management strategy. Under IFRS 9 all existing hedging relationships qualified as continuing hedging relationships. The Company applied IFRS 9 hedge accounting prospectively, "except for application of the cost of hedging approach". The Company has elected the cost of hedging approach for the fair value movement of all hedging instruments, whereby the movements will be recognized within equity, to the extent that they relate to the hedged item. As permitted by the standard, adjustments required as a result of adopting the cost of hedging approach, have been made to the opening Consolidated Statement of Changes in Equity. As such, prior year comparatives have not been restated. A summary of adjustments arising from application of IFRS 9 for hedge accounting as of January 1, 2021 are as follows: Opening Balance Impact of change in policy Opening Balance January 1, 2021 Cash flow hedge reserve (24.5) 2.8 (21.7) Cost of hedging reserve — (4.4) (4.4) Other reserves (24.5) (1.6) (26.1) Translation reserve 84.7 1.6 86.3 The Company's policy is to reduce its risk of foreign exchange movements on forecasted transactions (such as purchases of raw materials) in currencies other than the operating entity's functional currency using forward foreign exchange contracts designated as cash flow hedges. Under IFRS 9, in cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition. The Company has elected to apply this accounting policy prospectively and therefore as at January 1, 2021 any existing hedges of non-financial items (such as inventory) that were already recognized in the Consolidated Statement of Financial Position, did not result in an opening balance transfer out of equity to the non-financial item as a result of the transition to IFRS 9. For the year ended December 31, 2021, €27.6 million was recognized as deferred hedging gains transferred to the carrying value of inventory. This is not a reclassification adjustment and will not be recognized in the Consolidated Statement of Other Comprehensive Income for the period. Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 – Interest Rate Benchmark Reform (Phase 2) In August 2020, the IASB issued Interest Rate Benchmark Reform (Phase 2), which amends other IFRS standards. The amendments provide temporary reliefs which address the financial reporting effects when an interbank offered rate (IBOR) is replaced with an alternative nearly risk-free interest rate (RFR). The amendments in this final phase relate to practical expedient for particular changes in contractual cash flows, relief from specific hedge accounting requirements and certain disclosure requirement. On June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing revolving credit facility of €80.0 million and replace it with a new €175.0 million facility, paying interest rate applicable to the respective drawn down currency. Per the restated Senior Facilities Agreement, the Sterling Overnight Index Average (“SONIA”) has replaced GBP LIBOR and is effective immediately if there is a drawdown on the facility. The Secured Overnight Financing Rate (“SOFR”) will replace USD LIBOR and Swiss Average Rate Overnight (“SARON”) will replace CHF LIBOR, when existing benchmark rates are replaced and borrowings are requested under the Facility. Equally, on June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. There is currently no indication of the timing of the phase-out of EURIBOR. The Company continues to assess changes in underlying markets and expects to be able to refinance its Senior EUR Loan once replacement reference rates become confirmed. The existing senior USD loan of $916.4 million (the "Senior USD Loan") paying interest at a rate per annum equal to LIBOR (subject to a zero floor) plus 2.25% per annum has not been refinanced during 2021. The Company uses cross currency interest rate swaps to convert cash flows payable under the Senior USD Loan into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge. The USD LIBOR phase out is expected to be completed by June 2023, and therefore in due course the Company will need to renegotiate the terms of our Senior Facilities Agreement with our lenders and amend the terms of linked interest rate hedging arrangements. Such an amendment is expected to be able to be achieved without material financial impact on the Company. The Amendments are effective for annual periods beginning on or after January 1, 2021. Phase 2 amendments will require the Company to account for a change in the basis for determining the cash flows of a financial asset or a financial liability measured at amortized cost, by updating the effective interest rates as required by IBOR reform. Management continues to assess implications as a result of these amendments on the wider business. These amendments had no impact on the financial statements of the Company for the year ended December 31, 2021. The Company intends to use the practical expedients in future periods as they become applicable. Recently Issued and Not Yet Adopted Accounting Pronouncements under IFRS Amendments to IAS 12 - Deferred Tax related to Assets and Liabilities arising from a Single Transaction In May 2021, the International Accounting Standards Board issued targeted amendments to IAS 12, Income Taxes. The amendments are effective for annual periods beginning on or after January 1, 2023, although earlier application is permitted. With a view to reducing diversity in reporting, the amendments will clarify that companies are required to recognize deferred taxes on transactions where both assets and liabilities are recognized, such as with leases and asset retirement (decommissioning) obligations. Based upon our current facts and circumstances, we do not expect our financial performance or disclosure to be materially affected by the application of the amended standard. Other The consolidated financial statements and notes are presented in the reporting currency of millions of Euros. All financial information has been rounded to the nearest €0.1 million, except where otherwise indicated.

Accounting policies

Accounting policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies, Changes in Accounting Estimates and Errors [Abstract]
Accounting policies	Accounting policies The accounting policies set out below have, unless otherwise stated, been applied consistently. Judgments made by the Directors in the application of these accounting policies that have a significant effect on the financial statements and key sources of estimation uncertainty are discussed in Note 4. 3.1 Measurement convention The financial statements are prepared on the historical cost basis with the exception of derivative financial instruments, business combinations, share based payments, and founder preferred shares which are stated at fair value. 3.2 Business combination The Company uses the acquisition method to account for business combinations. The consideration transferred for the acquisition of a subsidiary is the fair value of the assets transferred, the liabilities incurred and the equity interest issued by the Company. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. Acquisition-related costs are expensed as incurred. Non-controlling interests arise from business combinations in which the Company acquires less than a 100 per cent interest. Non-controlling interests are initially measured at either fair value or at the non-controlling interest’s proportionate share of the fair value of the acquiree’s identifiable net assets. Nomad determines on a transaction by transaction basis which measurement method is used. The excess of the consideration transferred, the amount of any non-controlling interests in the acquiree and the acquisition-date fair value of any previous equity interest in the acquiree over the fair value of the identifiable net assets is recorded as goodwill. Where selling shareholders have contractually agreed to indemnify Nomad Foods Limited for contingent liabilities, an indemnification asset is recognized equivalent to the fair value of the liability recognized by Nomad. The indemnification asset is deducted from consideration transferred for the business combination. The indemnification asset value will subsequently be revised where revisions are made to the value of the liability or where there are doubts over the ability to recover losses from the selling shareholders. 3.3 Basis of consolidation The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions, and any unrealized income and expenses arising from intra-group transactions are eliminated. Accounting policies are applied consistently across the Company. Subsidiaries are all entities (including structured entities) over which Nomad has control; directly or indirectly. The Company controls an entity when the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. Where the Company owns less than a 100 per cent interest in a subsidiary, a non-controlling interest is recognized. The carrying amount of non-controlling interests is increased or decreased by the non-controlling interest’s share of subsequent changes in equity and payments to the non-controlling interest. Total comprehensive income is attributed to the non-controlling interests even if this results in the non-controlling interests having a negative balance. 3.4 Foreign currency i) Foreign currency transactions Transactions in foreign currencies (currencies other than the functional currency of the transacting entity) are translated into the functional currency at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the functional currency at the foreign exchange rate ruling the financial year end. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates are generally recognized in profit or loss. They are deferred in equity if they relate to qualifying cash flow hedges, qualifying net investment hedges or are attributable to part of a net investment in a foreign operation. Non-monetary assets and liabilities in a foreign currency are translated into the functional currency to establish historical cost, using the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies that are stated at fair value are translated at foreign exchange rates ruling at the date the fair value was determined. Translation differences on assets and liabilities carried at fair value are reported as part of the fair value gain or loss. The revenues and expenses of foreign operations are translated at an average rate for the period (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated at the dates of the transaction). ii) Assets and liabilities of foreign operations For the purposes of presenting consolidated financial statements, the assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on consolidation, are translated at foreign exchange rates ruling at the financial year ended December 31, 2021 of £1:€1.19 (December 31, 2020: £1:€1.11). The revenues and expenses of foreign operations are translated at an average rate for the period where this rate approximates to the foreign exchange rates ruling at the dates of the transactions. The average rate used for year ended December 31, 2021 is £1:€1.16 (year ended December 31, 2020: £1:€1.13, year ended December 31, 2019: £1:€1.14). Foreign exchange gains and losses that relate to these assets and liabilities are presented in the Consolidated Statement of Profit or Loss within ‘finance income or costs’, except where hedge accounting applies. iii) Net investment in foreign operations Exchange differences arising from the translation of foreign operations and of any related qualifying hedges are taken directly to the translation reserve within equity. They are realized through the Consolidated Statement of Profit or Loss upon disposal of the related foreign operation. 3.5 Goodwill Goodwill represents amounts arising on acquisition of subsidiaries. Goodwill is the difference between the cost of the acquisition and the fair value of the net identifiable assets acquired. Goodwill is stated at cost less any accumulated impairment losses. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold. Goodwill is not monitored below the operating segment. Goodwill is not amortized but is tested annually for impairment. 3.6 Other intangible assets Intangible assets acquired separately are recorded at cost and those acquired as part of a business combination are recorded at fair value as at the date of acquisition. i) Computer software Capitalized software costs include the cost of acquired computer software licenses and costs that are directly associated with the design, construction and testing of such software where this relates to a major business system. Costs associated with identifying, sourcing, evaluating or maintaining computer software are recognized as an expense within other operating expenses as incurred. The assets are stated at cost less accumulated amortization and impairment losses. Software costs are amortized by equal monthly installments over their estimated useful economic life of five ii) Brands Our largest brands, including Birds Eye , Iglo, Findus, Ledo and Frikom are considered to have indefinite lives. This is based on the market position of the brands, the significant levels of investment in advertising and promoting the brands, and the fact that they have been established for at least 20 years. Therefore these brands are not amortized, but instead held at historical cost less provision for any impairment. Brands that are deemed to not have an indefinite life are being amortized by equal monthly installments within other operating expenses over the course of their remaining useful economic life. iii) Customer relationships Long standing Food Service customer relationships have been identified as intangible assets as part of business combinations. These are deemed to not have an indefinite life and are being amortized by equal monthly installments within other operating expenses over their expected lives. The most significant of these assets were acquired as part of the Findus Acquisition in 2015 and are being amortized over 14 years. 3.7 Impairment of non-current assets The carrying amounts of the Company’s non-current assets are reviewed annually to determine whether there is any indication of impairment. If any such indication exists, the asset’s recoverable amount is estimated. Impairment losses are recognized in the Consolidated Statement of Profit or Loss in the period in which they arise. For goodwill and assets that have an indefinite useful life an impairment review is performed at least annually. Assets that are subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the net carrying amount may not be recoverable. An impairment loss is recognized whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount. i) Calculation of recoverable amount Recoverable amount is the greater of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows of the business are discounted to their present value using a discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit to which the asset belongs. ii) Allocation of impairment losses Impairment losses recognized in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash-generating units, then to reduce the carrying amount of the other assets in the unit on a pro rata basis. A cash-generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets. iii) Reversals of impairment An impairment loss in respect of goodwill is not reversed. In respect of other assets, an impairment loss is reversed when there is an indication that the impairment loss may no longer exist and there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized. 3.8 Property, plant and equipment i) Owned assets Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses. Cost includes the original purchase price of the asset and the costs attributable to bringing the asset to its working condition for its intended use. Where parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment. ii) Leased assets The Company leases various properties, equipment and cars. The Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Where a contract contains both lease and non-lease components, the Group has elected to account for the contract as a single lease. Leases are recognized as a right-of-use asset and a corresponding liability at the date at which the leased asset is available for use by the group. Each lease payment is allocated between the liability and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. The right-of-use asset is classified within property, plant and equipment and is depreciated over the shorter of the asset's useful life or the lease term on a straight-line basis. Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities are presented within loans and borrowings and include the net present value of expected lease payments, including those from extension options if the Company reasonably expects to exercise them. The lease payments are discounted using the interest rate implicit in the lease, if that rate can be determined, otherwise the Company’s incremental borrowing rate is used. Right-of-use assets are measured at cost comprising the amount of the lease liability, adjusted for payments made or received before the commencement date, initial direct costs and restoration costs. Payments associated with short-term leases and leases of low-value assets are recognized on a straight-line basis as an expense in profit or loss. Short-term leases are leases with a lease term of 12 months or less. Low-value assets primarily comprise IT equipment and small items of office furniture. iii) Depreciation Depreciation is charged to the Consolidated Statement of Profit or Loss on a straight line basis over the shorter of the lease term and the estimated useful lives of each part of an item of property, plant and equipment once the item is brought into use. Land is not depreciated. The estimated useful lives are as follows: • Buildings 40 years • Plant and equipment 5 to 14 years • Computer equipment 3 to 5 years The assets’ residual values and useful lives are reviewed on a frequent basis. 3.9 Inventories Inventories are stated at the lower of cost and net realizable value. Cost is based on the weighted average principle and includes expenditure incurred in acquiring the inventories and bringing them to their existing location and condition. Inventories that are acquired through business combinations are fair valued at the time of acquisition. In the case of manufactured inventories and work in progress, cost includes an appropriate share of direct costs and overheads based on normal operating capacity. Provision is made for slow moving, obsolete and defective inventories. 3.10 Employee benefits i) Defined contribution plans Obligations for contributions to defined contribution pension plans are recognized as an expense in the Consolidated Statement of Profit or Loss as incurred. Prepaid contributions are recognized as an asset to the extent that a cash refund or reduction in the future payments is available. ii) Defined benefit plans The Company’s net obligation in respect of defined benefit pension plans and other post-employment benefits is calculated separately for each plan by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. That net obligation is discounted to determine its present value. The calculation is performed by a qualified actuary using the projected unit credit method. The current service cost of the defined benefit plan, recognized in the Consolidated Statement of Profit or Loss in staff costs included within Operating profit/(loss), except where included in the cost of an asset, reflects the increase in the defined benefit obligation resulting from employee service in the current year, benefit changes, curtailments and settlements. Actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions are charged or credited to equity in Other Comprehensive Income in the period in which they arise. The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the Consolidated Statement of Profit or Loss. Past service cost is recognized immediately. iii) Share-based payment schemes Employee benefits given through share-based payment schemes are discussed further in section 3.15 of this note. 3.11 Founder Preferred Shares Nomad Foods issued Founder Preferred Shares to both TOMS Acquisition I LLC and Mariposa Acquisition II, LLC (collectively the “Founder Entities”) in connection with its initial public offering in April 2014. Holders of the Founder Preferred Shares are entitled to receive annual dividend amounts subject to certain performance conditions (the “Founder Preferred Shares Dividend Amount”). The instrument and its component parts were analyzed under IFRS 2. The Company intends that any future Founder Preferred Shares Annual Dividend Amount will be equity settled. Accordingly, the Founder Preferred Shares Annual Dividend Amount as of June 1, 2015, of €531.5 million (the “Founder Preferred Shares Dividend reserve”) was classified as equity and no further revaluations will be required or recorded. Should a Founder Preferred Share Annual Dividend Amount become due and payable, the market value of any dividend paid will be deducted from the Founder Preferred Shares Dividend reserve, with any excess deducted from the accumulated profit/(deficit) reserve within equity. 3.12 Provisions Provisions are recognized when the Company has a legal or constructive present obligation as a result of a past event and it is probable that the Company will be required to settle that obligation. Provisions are measured at the Directors’ best estimate of the expenditure required to settle the obligation at the financial year end date and are discounted to present value where the effect is material. Where it is not possible to make a reliable estimate of the estimated financial effect of a provision, appropriate disclosure of the resulting contingent liability is made, but no provision is recognized. 3.13 Financial instruments Financial assets and liabilities are recognized in the Company’s Statement of Financial Position when the Company becomes a party to the contractual provisions of the instrument. i) Trade receivables Trade receivables are amounts due from customers for goods sold when control of the products has transferred, being when the products are delivered in accordance with the contractual arrangements. At this point, there is no unfulfilled performance obligation that could affect the customer’s acceptance of the product, except for returns due to quality. The Company holds the trade receivables with the objective of collecting the contractual cash flows and so they are subsequently measured at amortized cost using the effective interest method, less any loss allowance. Since trade receivables are due within one year, this equates to initial carrying value less any loss allowance. To assist in managing operating cash flow, we may enter into non-recourse factoring arrangements with certain receivables whereby we sell specific account receivables to one or more external financial institutions. The risks and rewards of ownership are considered to have been transferred at the point of sale. Up to the point of sale, these receivables are treated as held for sale and measured at fair value through Profit or Loss. Under the terms of the contractual arrangements, the Company may continue to collect the cash from the customer receivables sold, albeit acting solely as a collecting agent on behalf of the purchaser of receivables. Any cash received from customers which is due to be paid to the agent is presented as a financial liability in the Statement of Financial Position and as a financing activity within the Statement of Cash Flows. Factoring fees associated with the sale of factored receivables were minimal for all periods presented. See Note 18. The Company applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables. Trade receivables are grouped by days past due. Expected loss rates are based on historical credit losses experienced in each market as well as forward looking information where this is significant. Trade receivables are written off when there is no reasonable expectation of recovery. Appropriate allowances for expected credit losses and estimated irrecoverable amounts are recognized in the Consolidated Statement of Profit or Loss. Trade receivables are presented net of associated contract liabilities, referred to as 'trade terms' as discussed further in Note 3.14 and Note 4. ii) Cash and cash equivalents Cash and cash equivalents comprise of cash balances and deposits that are readily convertible to a known amount of cash and are measured at amortized cost. Deposits held in money market funds are measured at fair value through Profit or Loss as the cash flows do not only represent principal and interest. iii) Loans and borrowings a. Valuation Interest bearing borrowings are recognized initially at fair value less attributable transaction costs. Subsequent to initial recognition, interest bearing loans and borrowings are stated at amortized cost with any difference between cost and redemption value being recognized in the Consolidated Statement of Profit or Loss over the expected period of the borrowings. b. Capitalization of transaction costs Fees paid on the establishment of loan facilities are recognized as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs. iv) Trade payables Trade payables are measured at initial recognition at fair value and are subsequently measured at amortized cost using the effective interest method. Since trade payables are largely due within one year, this equates to initial carrying value. v) Derivative financial instruments and hedge accounting Derivative financial instruments are recognized at fair value. When a derivative financial instrument is not designated in a hedge accounting relationship, all changes in its fair value are recognized immediately in the Consolidated Statement of Profit or Loss. However, where derivatives qualify for hedge accounting, recognition of any resultant gain or loss depends on the nature of the item being hedged. Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the Company has elected the cost of hedging approach for the fair value movement on currency basis spreads of all hedging relationships, whereby the movements will be recognized within equity, if material, to the extent that they relate to the hedged item. In cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition. The fair value of all financial derivative instruments (including but not limited to forward foreign exchange contracts, currency swaps and cross currency interest rates swaps), is determined per market standard using forward foreign exchange and interest rates at the balance sheet date, with the resulting value discounted back to present value. Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the Company applies the hedge accounting requirements of IFRS 9 to all hedging relationships. IAS 39 was beforehand with the impact of the changes disclosed in Note 2 Basis of preparation. a. Cash flow hedges Where a derivative financial instrument is designated as a hedge of the cash flow of a recognized asset or liability, (including a highly probable forecast transaction) the effective part of any gain or loss on the derivative financial instrument is recognized directly in the cash flow hedging reserve, within other reserves. Any ineffective portion of the hedge is recognized immediately in the Consolidated Statement of Profit or Loss. Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, if the result of a forecasted transaction is recognition of a non-financial asset (for example inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve (presented together as 'Other reserves') are included in the initial cost of the non-financial item upon its recognition. For all other hedged forecasted transactions, the amounts accumulated in the hedging reserve and cost of hedging reserve are reclassified to the Consolidated Statement of Profit or Loss in the same period, or periods, in which the hedged forecasted future cash flows affect the Consolidated Statement of Profit or Loss. When a hedging instrument expires or is sold, exercised or otherwise terminated, or the entity revokes designation of the hedge relationship but the hedged forecast transaction is still expected to occur, the cumulative gain or loss at that point remains in equity and is recognized when the transaction occurs. If the hedged transaction is no longer expected to take place, the cumulative unrealized gain or loss recognized in equity is recognized in the Consolidated Statement of Profit or Loss immediately. When a hedging instrument is substantially modified, any fair value gain or loss is recognized immediately in the Consolidated Statement of Profit or Loss. b. Net investment hedges Foreign currency differences arising on the retranslation of the spot rate component of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income to the extent that the hedge is effective, and are presented in the translation reserve within equity. Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the change in fair value of the future price element of the hedging instrument (‘forward element’) is not included as part of the hedging relationships and is recognized in the Consolidated Statement of Profit or Loss immediately. To the extent that any net investment hedge is entered into and the hedge is deemed effective, any foreign currency differences arising on the retranslation of the spot rate component of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income, and are presented in the translation reserve within equity. To the extent that the hedge is ineffective, such differences are recognized in the Consolidated Statement of Profit or Loss. When the hedged net investment is disposed of, the relevant amount in the translation reserve is transferred to the Consolidated Statement of Profit or Loss as part of the gain or loss on disposal. vi) Short-term investments The Company may invest surplus cash positions in short-term investments to manage liquidity and credit risk. Short‐term investments are held within managed investment funds and are measured at fair value with all changes in fair value are recognized immediately in the Consolidated Statement of Profit or Loss. Short-term investments are valued using inputs that are derived principally from or corroborated by observable market data. 3.14 Revenue from contracts with customers The Company manufactures and sells a range of frozen foods to retail, wholesale and Food Service markets. Revenue is recognized when control of the products has transferred, being when the products are delivered to the customer in accordance with the contractual arrangements. At this point, there is no unfulfilled performance obligation that could affect the customer’s acceptance of the product, except for returns due to quality. A provision for product return allowances, which is estimated based upon the Company’s historical performance and management’s experience, is recorded as a reduction of sales in the same period that the revenue is recognized. Revenue excludes sales taxes and intra-company sales. Products are often sold with variable pricing arrangements, including payment discounts, trade promotions and slotting fees. Discounts given by the Company include rebates, price reductions and incentives to customers, promotional couponing and trade communication costs. Trade promotions consist of pricing allowances, merchandising funds and customer coupons, which are offered through various programs to customers and consumers. Certain retailers require the payment of slotting fees to obtain space for the Company’s products on the retailers’ store shelves. Where variable pricing arrangements are in place, revenue is only recognized to the extent that it is highly probable that the amount recognized is unlikely to be reversed. Accumulated experience is used to estimate and provide for the discounts. Revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. Accruals for expected pay-outs under these programs are collectively known as ‘trade terms’ and are included within trade and other receivables or within trade and other payables in the Consolidated Statement of Financial Position. No element of financing is deemed present as the sales are made in line with market practice and accruals are typically settled within twelve months of the sale. 3.15 Share based payments The Nomad Foods Long-term Incentive Plan known as the (the "Management Share Awards"), which incorporates an annual Non-Executive Directors Restricted Stock Scheme, falls within the provisions of IFRS 2 “Share-based Payment” and awards under the Management Share Awards represent equity settled share based payments. A charge is taken to the Consolidated Statement of Profit or Loss for the difference between the fair value of the shares at grant date and the amount subscribed, spread over the vesting period. Share based payment arrangements in which Nomad receives goods or services as consideration for its own equity instruments are accounted for as equity-settled share based payment transactions, regardless of how the equity instruments are obtained by Nomad. The grant date fair value of share-based payment awards granted to any Director or employee is recognized as an expense, with a corresponding increase in equity, over the period that any Director or employee becomes unconditionally entitled to the awards. The fair value of the awards granted is measured using a valuation model, taking into account the terms and conditions upon which the awards were granted. The amount recognized as an expense is adjusted to reflect the actual number of awards for which the related service and non-market vesting conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the number of awards that do meet the related service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcomes. See Note 8(b) for further information on the Company’s share-based payment arrangements and details of the valuation model used. 3.16 Interest income Interest income is recognized in the Consolidated Statement of Profit or Loss on an accruals basis using the effective interest method. 3.17 Expenses & Exceptional items i) Borrowing costs Unless capitalized as part of the cost of borrowing (see Note 3.13(iii)), borrowing costs are recognized in the Consolidated Statement of Profit or Loss in the period in which they are incurred. ii) Exceptional items The separate reporting of exceptional items which are presented as exceptional within the relevant Consolidated Statement of Profit or Loss category, helps provide an indication of the Company’s underlying business performance. Exceptional items have been identified and presented by virtue of their size, nature or incidence. In determining whether an event or transaction is exceptional, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence. Exceptional items comprise restructuring costs, impairments or reversal of impai

Critical accounting estimates a

Critical accounting estimates and judgments	12 Months Ended
	Dec. 31, 2021
Accounting Policies, Changes in Accounting Estimates and Errors [Abstract]
Critical accounting estimates and judgments	Critical accounting estimates and judgments The preparation of financial statements in accordance with IFRS requires the use of judgment in applying the accounting policies and estimation that affect the reported amounts of assets and liabilities and results. Actual results could differ from those estimates and the financial statements will be impacted by key judgments taken. Key Judgments Judgments are made in the process of applying accounting policies. Those judgments which are considered key are listed below. a) Business Combinations For business combinations that have a significant effect on the amounts reported in the consolidated financial statements. The Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves judgment over whether intangible assets can be separately identified, the useful economic life of assets and in selecting an appropriate valuation methodology. Furthermore, judgment is applied in allocating business combinations to operating segments, as well as allocating Goodwill to cash generating units. Please refer to Note 14 for details of business combinations in the period. b) Discounts and trade promotions Management use judgment when considering when accruals for discounts and trade promotions can be released. Management makes the judgment based on the principle that accruals are reversed only to the extent that it is highly probable that a significant reversal will not occur. c) Uncertain tax positions Management use judgment when determining whether it is appropriate to accrue for uncertain tax positions and for how long accruals for uncertain tax positions are retained. Management considers tax laws which are in place in making that assessment determining whether it is appropriate to release. d) Cash generating units When performing goodwill impairment testing, management apply judgment to the allocation of goodwill to cash generating units. Management has determined goodwill is monitored at the operating segment level of “Frozen”. Please refer to Note 13 for further information. e) Operating segments Management apply judgment in determining the Chief Operating Decision Maker (“CODM”), and the nature and extent of the financial information which is reviewed by the CODM. Management have considered how resources are allocated in determining the single reporting and operating segment of “Frozen”. Please refer to Note 5 for further information. Significant estimates Information about estimates and assumptions that have significant effects on the amounts reported in the consolidated financial statements are listed below. Management have taken into account the impact and potential future impact of COVID-19 on these estimates. We will continue to assess the impact of future developments in relation to COVID-19 as it relates to estimates, especially around the carrying value of goodwill, brands and other intangibles, as well as on property, plant and equipment. In particular, we will focus on the long-term impact on the food service customer relationship intangible assets. a) Discounts and trade promotions Discounts given by the Company include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. Each customer has bespoke agreements that are governed by a combination of observable and unobservable performance conditions. Trade promotions comprise of amounts paid to retailers for programs designed to promote Company products and include pricing allowances, merchandising funds and customer coupons, which are offered through various programs to customers and consumers. The ultimate costs of these programs can depend upon retailer performance and is the subject of significant management estimates. The estimated ultimate cost of the program is based upon the programs offered, timing of those offers, estimated retailer performance based on history, management’s experience and current economic trends. At each financial year end date, any discount or trade promotion incurred but not yet invoiced is estimated and accrued for. In certain cases, the estimate for discounts and trade promotions requires the use of forecast information for future trading periods and therefore a degree of estimation uncertainty exists. These estimates are sensitive to variances between actual results and forecasts. The estimate is based on accumulated experience. The accruals are presented as ‘trade terms’ and offset against trade receivables due to the same customer, or as trade term payables where there is no receivable to be offset. The balance of the reduction in trade receivables for trade terms as of December 31, 2021 is disclosed in Note 18 and the balance classified as a trade term payable is disclosed in Note 22. b) Business combinations The Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves an estimate of fair value of all assets and liabilities acquired. Such estimates are based on valuation techniques, which require considerable estimation in forecasting future cash flows and developing other assumptions. These estimates are based on information available on the acquisition date and assumptions that have been deemed reasonable by management. The following estimates and assumptions can materially affect our financial position and profit: • The fair value and expected useful economic life of acquired intangible and tangible assets that are subject to depreciation or amortization in future periods. • Future changes to the assumptions over forecast future profitability used in estimating the value of intangible assets and goodwill may result in additional expenses or income. • Future changes to the assumptions used in estimating the value of uncertain tax positions may result in additional expenses or income. Please refer to Note 14 for details of business combinations in the period. c) Carrying value of goodwill and brands Determining whether goodwill and brands are impaired requires an estimation of the value in use of the cash generating unit to which goodwill and brands have been allocated. The value in use calculation requires the entity to estimate the future cash flows expected to arise from the cash generating unit and a suitable discount rate in order to calculate present value. Future cash flows for the purposes of the value in use calculation are taken from approved budgets. Details of impairment reviews including disclosures covering sensitivities are provided in Note 13. d) Employee benefit obligation The Group operates a number of defined benefit pension schemes and post-employment benefit schemes which are valued by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. Each scheme has an actuarial valuation performed by a specialist third party and is dependent on a series of assumptions which are estimated by management. See Note 23 for details of these assumptions and a sensitivity analysis on material assumptions. e) Uncertain tax positions Where tax exposures can be quantified, an accrual for uncertain tax positions is based on the Group's judgment of the most likely amount of the liability expected to be paid to the relevant tax authority; or, when there is a wide range of possible outcomes, a probability weighted average approach. Given the inherent uncertainties in assessing the outcomes of these exposures, the Company could in future periods experience adjustments to these accruals. The factors considered in estimating the accrual include the progress of discussions with the tax authorities, the complexity of respective tax legislation, valuations of assets for tax purposes and the level of documentary support for historical positions taken by previous owners. The accruals are made on the basis of a weighted average of potential outcomes. f) Fair value of derivative financial instruments. Note 34 includes details of the fair value of the derivative instruments that the Company holds at each balance sheet period. Management has estimated the fair value of these instruments by using valuations based on discounted cash flow calculations. These inputs may be readily observable, market corroborated, or generally unobservable inputs and are further discussed in Note 34.

Segment reporting

Segment reporting	12 Months Ended
	Dec. 31, 2021
Operating Segments [Abstract]
Segment reporting	Segment reporting Nomad has one reporting and operating segment, "Frozen", reflected in the segment presentation below for the periods presented. The CODM primarily uses “Adjusted EBITDA”, disclosed in Note 3.19, as the key measure of the segment’s results, which is considered non-IFRS financial information. Segment Adjusted EBITDA Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Note €m €m €m Profit for the period 181.0 225.1 153.6 Taxation 55.7 70.4 56.7 Net financing costs 106.0 63.7 73.2 Depreciation and amortization 71.6 67.6 68.3 Acquisition purchase price adjustments 8.4 — — Exceptional items 7 45.3 20.6 54.5 Other add-backs 18.7 19.4 25.7 Adjusted EBITDA 486.7 466.8 432.0 Acquisition purchase price adjustments relate to the reversal of the non-cash increase applied to inventory acquired in business combinations to value it at fair value as opposed to cost. Other add-backs include the elimination of share-based payment expense and related employer payroll expense of €5.8 million (2020: €12.1 million, 2019: €22.4 million) and elimination of non-operating M&A related costs, professional fees and transaction costs of €12.9 million (2020: €7.3 million, 2019: €3.3 million). We exclude these costs because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. No information on segment assets or liabilities is presented to the CODM. Product information Management considers the products it sells belong to one category, being "Frozen". Geographical information External revenue by geography Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 €m €m €m United Kingdom 758.3 747.3 712.5 Italy 417.9 426.3 394.1 Germany 396.3 393.2 329.6 France 188.6 203.8 176.6 Sweden 148.1 158.7 175.7 Austria 129.3 127.9 108.2 Norway 121.7 115.6 120.4 Spain 75.1 82.6 79.5 Rest of Europe 371.3 260.5 227.7 Total external revenue by geography 2,606.6 2,515.9 2,324.3 Non-current assets by geography December 31, 2021 December 31, 2020 €m €m Germany 140.0 135.5 United Kingdom 139.6 132.1 Italy 64.8 68.5 Serbia 48.5 — Croatia 38.5 — Ireland 34.3 31.9 Norway 31.0 30.0 Sweden 29.8 28.5 Rest of Europe 72.3 52.7 Total non-current assets by geography 598.8 479.2

Operating profit_(loss)

Operating profit/(loss)	12 Months Ended
	Dec. 31, 2021
Analysis of income and expense [abstract]
Operating profit/(loss)	Operating profit Operating profit is stated after charging: Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Note €m €m €m Staff costs 8 340.6 340.2 308.6 Depreciation of property, plant and equipment 12 63.4 59.8 59.7 Impairment of property, plant and equipment 12 — — 0.1 Impairment of software and brands 13 1.7 — — Amortization of software and brands 13 8.2 7.8 8.6 Operating lease charges 6.1 3.0 4.5 Exchange losses/(gains) 27.0 (2.8) (14.6) Research & development expenditure 19.2 17.6 18.9 Inventories recognized as an expense within cost of goods sold 1,694.3 1,627.9 1,536.0

Exceptional items

Exceptional items	12 Months Ended
	Dec. 31, 2021
Analysis of income and expense [abstract]
Exceptional items	Exceptional items Exceptional items are made up as follows: Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 €m €m €m Supply chain reconfiguration (1) — (12.5) (3.6) Findus Group integration costs (2) — — 3.5 Fortenova Acquisition integration costs (3) 3.5 — — Findus Switzerland integration costs (4) 6.2 0.3 — Brexit (5) 5.3 1.6 1.6 Business Transformation program (6) 18.8 2.3 — Information Technology Transformation program (7) 4.2 — — Goodfella's Pizza & Aunt Bessie's integration costs (8) — 4.0 12.5 Factory optimization (9) 4.9 10.0 5.7 Settlement of legacy matters (10) (2.6) (2.9) (9.2) Release of indemnification assets (11) 5.0 17.8 44.0 Total exceptional items 45.3 20.6 54.5 We do not consider these items to be indicative of our ongoing operating performance. (1) Supply chain reconfiguration Supply chain reconfiguration relates to activities associated with the closure of the Bjuv manufacturing facility in Sweden which ceased production in 2017. No income has been recognized in the year ended December 31, 2021 (2020: €12.5 million, 2019: €3.6 million). In 2020, the Company signed an agreement to end its leasehold of a cold store in Sweden in 2021, which was originally due to expire in 2040. The cold store will continue to be used by the Company under a service contract once the lease has come to an end. The agreement resulted in a significant modification of a right-of-use asset and reduction in lease liabilities. The carrying value of the right-of-use asset had previously been impaired such that its value was significantly lower than that of the liabilities extinguished. Consequently, the Company recognized a gain from the transaction. As part of the transaction, the Company has become liable to fulfill certain severance arrangements in 2021 which have been provided for, the cost of which offsets a portion of the income from the modification of the lease. In 2019, the income related to the sale of the agricultural land and the finalization of consideration received for the sale of the industrial property, which had completed in 2018. (2) Findus Group integration costs Following the acquisition of the Findus Group on November 2, 2015, the Company initiated a substantial integration project. Expenses presented primarily relate to the roll-out of the Nomad ERP system which completed in 2019. (3) Fortenova Acquisition integration costs As disclosed in Note 14, the Company completed the acquisition of the Fortenova Group’s Frozen Food Business Group on September 30, 2021, following which the Company is undertaking an integration project over the next three years. Integration expenses incurred relate to external consultancy costs, organizational structure alignment to Nomad design, systems configuration and roll-out of our controls environment to the acquired business. (4) Findus Switzerland integration costs As disclosed in Note 14, the Company completed the acquisition of Findus Switzerland on December 31, 2020, following which the Company commenced an integration project which is expected to complete in 2022. Integration expenses incurred and to be incurred in the future relate to external consultancy costs, organizational structure alignment to Nomad design and roll-out of the Nomad ERP system. (5) Brexit As part of the process of the United Kingdom exiting the European Union, commonly referred to as Brexit, the Company has incurred expenses to prepare for, and respond to, changes impacting our supply chain. Whilst an agreement with the EU was reached on December 24, 2020, border control processes remain in a period of transition. Expenses in 2021 relate to project costs and the write-off of system development costs no longer required due to changes in regulations and the Company's approach to handling Brexit-related logistic issues. (6) Business transformation program In 2020, the Company launched the first phase of a multi-year, enterprise-wide transformation and optimization program. Over the next few years, additional transformation phases will be implemented. The program aims to standardize, simplify and automate end-to-end business processes. This will enable key decision making and analytical capability, building a platform and organization to support future growth and provide better value for shareholders. Execution of the business transformation program will include the evaluation and implementation of a new ERP system. Expenses in the year consist of restructuring and transformational project costs, including business technology transformation initiative costs and related professional fees. (7) Information Technology Transformation program In 2021, the Company launched a program to transform the Information Technology (“IT”) operating model, specifically to modernize the end-to-end technology estate to support current and future complex and evolving business needs driven by acquisitions and organic growth. Among the many changes being made, the program moves our operating model to a cloud-hosted solution, which better deploys new services to the business and end user, including application management, supporting a diverse workforce across multiple locations and languages, as well as deploying artificial Intelligence assisted tools. Other key components of the program include the Company’s cyber security services to adapt to rapidly changing threats and a change of IT service partners to enable one-off renovation and uplift of capabilities across the business. (8) Goodfella's Pizza & Aunt Bessie's integration costs Following the acquisition of the Goodfella’s pizza business in April 2018 and the Aunt Bessie's business in July 2018, the Company completed an integration project which finished in 2020. (9) Factory optimization In 2018, the Company initiated a three-year factory optimization program. The focus of the program is to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. The program is expected to provide a number of benefits, including an optimized supply chain infrastructure, benefits derived from the implementation of a standardized global manufacturing and planning processes, and an increased level of sustainable performance improvement. Due to delays in delivering the program across the Nomad manufacturing portfolio due to various government lockdowns and travel bans, the project has been extended for an additional year. (10) Settlement of legacy matters A net income of €2.6 million has been recognized associated with the release of acquired provisions relating to periods prior to acquisition by the Company. Net income of €2.9 million was recognized in the year ended December 31, 2020 associated with the release of acquired tax liabilities relating to periods prior to acquisition by the Company. Net income of €9.2 million was recognized in the year ended December 31, 2019. This includes an income of €2.7 million recognized on settlement of contingent consideration for the La Cocinera acquisition and net income of €0.7 million associated with settlements of tax audits. (11) Release of indemnification assets The charges for the release of indemnification assets relates to the partial release of shares held in escrow associated with the acquisition of the Findus Group in 2015, as discussed in Note 19. Tax impact of exceptional items The tax impact of the exceptional items amounts to a credit of €8.4 million in the year ended December 31, 2021 (year ended December 31, 2020: €3.5 million, year ended December 31, 2019: €3.1 million). Cash flow impact of exceptional items Included in the Consolidated Statements of Cash Flows for the year ended December 31, 2021 is €48.8 million (year ended December 31, 2020: €12.1 million, year ended December 31, 2019: €15.9 million) of cash outflows relating to exceptional items. This includes cash flows related to the above items as well as the cash impact of the settlement of provisions brought forward from previous accounting periods.

Payroll costs, share based paym

Payroll costs, share based payments and management incentive schemes	12 Months Ended
	Dec. 31, 2021
Employee Benefits And Share-Based Payments [Abstract]
Payroll costs, share based payments and management incentive schemes	Payroll costs, share based payments and management incentive schemes (a) Payroll costs The average number of persons employed by the Company (excluding non-Executive Directors) is analyzed and set out below: Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Production 3,310 3,043 3,308 Administration, distribution & sales 2,193 1,647 1,448 Total number of employees 5,503 4,690 4,756 The increase in the average number of employees in the table above for the year ended December 31, 2021 compared with the year ended December 31, 2020 is primarily due to the Fortenova Acquisition and Findus Switzerland acquisition as described in Note 14. The table below discloses the Company’s aggregate payroll costs of these persons. Payroll costs exclude long term management incentive scheme and share based payment costs, but includes bonus costs. Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 €m €m €m Wages and salaries 266.4 276.4 250.4 Social security costs 56.1 49.2 45.2 Other pension costs 18.1 14.6 13.0 Total payroll costs 340.6 340.2 308.6 (b) Share based payments The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors. All Awards are to be settled by physical delivery of shares. Non-Executive Director Restricted Share Awards In accordance with the Board approved independent Non-Executive Director compensation guidelines, each independent Non-Executive Director is entitled to a grant of $100,000 of restricted shares annually on the date of the annual general meeting, valued at the closing market price for such shares on this date. The restricted shares vest on the earlier of twelve months from the date of grant or the date of the Company’s next annual meeting of shareholders. The Non-Executive Directors restricted share awards granted on June 19, 2018, which consisted of 32,172 shares at a share price of $18.07, vested on June 14, 2019 and were issued at a share price of $20.74, resulting in a €0.1 million increase in the share based compensation reserve. Of the total 44,272 number of shares vesting, 12,100 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares. The Non-Executive Directors restricted share awards granted on June 14, 2019, which consisted of 39,370 shares at a share price of $20.32. In July 2019, in conjunction with the resignation of one of our Non-Executive Directors, 2,460 shares from this grant were vested and issued. The remaining awards vested on June 17, 2020 and were issued at a share price of $21.78. Of the total 34,447 number of shares vesting, 8,656 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares. The Non-Executive Directors restricted share awards granted on June 17, 2020, which consisted of 32,140 shares at a share price of $21.78, vested on June 30, 2021 and were issued at a share price of $30.14, resulting in a €0.2 million increase in the share based compensation reserve. Of the total 32,140 number of shares vesting, 7,734 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares. On June 30, 2021, after the Company's annual general meeting of shareholders, the current Non-Executive Directors were granted 24,759 restricted share award at a share price of $28.27. The total charge for Non-Executive Director grants within the Statement of Consolidated Profit or Loss for the year ended December 31, 2021 for stock compensation awards was €0.8 million (year ended December 31, 2020: €0.7 million; year ended December 31, 2019: €0.9 million). Director and Senior Management Share Awards As part of its long term incentive initiatives, the Company has outstanding awards over 2,016,855 ordinary shares granted to certain members of its management team (the “Management Share Awards”) as of the following four award dates: January 1, 2016 Award January 1, 2017 Award January 1, 2018 Award January 1, 2019 Award January 1, 2020 Award January 1, 2021 Award Total Number of awards outstanding at January 1, 2021 1,041,953 819,873 446,575 159,561 710,438 — 3,178,400 New awards granted in the period — — — — — 820,202 820,202 Awards vested and issued in the period (1,041,953) (819,873) — — — — (1,861,826) Forfeitures in the period — — (14,785) (6,866) (65,345) (32,925) (119,921) Number of awards outstanding at December 31, 2021 — — 431,790 152,695 645,093 787,277 2,016,855 The 2018 award has vesting conditions based on cumulative EBITDA performance over four years and Company share price performance over two years to five years. During 2021, the Compensation Committee of the Board of Directors amended the non-market condition targets for this award due to recent acquisitions, which did not increase its incremental fair value. The share price and EBITDA performance conditions for the 2018 award are weighted 50% each per performance target. • For the 2018 award, for the share price target, the initial two-year period was through to January 1, 2020 and the subsequent three-year period is through to January 1, 2023. For the four-year cumulative EBITDA Performance Condition, if satisfied, will vest on January 1, 2022. For the 2019, 2020 and 2021 awards, those grants have vesting conditions based on cumulative EBITDA performance, cumulative Net Sales and Company share price performance over three years. During 2021, the Compensation Committee of the Board of Directors amended the non-market condition targets for these awards due to recent acquisitions, which did not increase their incremental fair value. In addition, the 2020 award had a holding period of one-year that has been removed from the vesting period. The 2021 award was issued late in 2021 with a performance period starting January 1, 2021. In September 2019, 166,427 restricted share awards were granted as part of the 2019 Management Share Award. The performance period associated with the award began as of January 1, 2019. The 2019 awards have vesting conditions based on three-year cumulative EBITDA and net sales, and Company share price performance measures. One third of the total share award is assigned to each type of performance measure. All shares are subject to a holding period of an additional year and require that the participants to the scheme are still actively employed during the entire four year period, through January 1, 2023. In January 2020, 761,979 restricted share awards were granted as part of the 2020 Management Share Award. The performance period associated with the award began on January 1, 2020. The Share awards will vest on the Company achieving a range of performance conditions including cumulative EBITDA, cumulative net sales, and share price performance measures over a three-year period. The cumulative EBITDA and Cumulative Net Sales tranches of shares are equally weighted, being worth 37.5% of the total award each. The Company Share Price Tranche is worth 25% of the total award. All shares vest, subject to satisfaction of the award conditions, on January 1, 2023. In late 2021, 820,202 restricted share awards were granted as part of the 2021 Management Share Award. The performance period associated with the award began on January 1, 2021. The Share awards will vest on the Company achieving a range of performance conditions including cumulative EBITDA, cumulative net sales, and Company share price performance measures over a three-year period. The cumulative EBITDA and Cumulative Net Sales tranches of shares are equally weighted, being worth 37.5% of the total award each. The Share Price Tranche is worth 25% of the total award. All shares vest, subject to satisfaction of the award conditions, on January 1, 2024. In January 2019, 85,315 restricted shares granted as part of the 2017 Management Share Awards vested based on share price performance, resulting in the issuance of 51,932 ordinary shares (net of 33,383 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares). In January 2020, 284,555 restricted shares granted as part of the 2016 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $22.37), resulting in the issuance of 163,816 ordinary shares to participants in the LTIP (net of 120,739 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares). In February 2020, 1,626,006 restricted shares granted as part of the 2016 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $19.53), resulting in the issuance of 928,042 ordinary shares to participants in the LTIP (net of 697,964 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares). In September 2020, 42,825 restricted shares granted as part of the 2018 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $25.30). Due to the timing of the vesting, the resulting issuance of 25,655 ordinary shares to participants in the LTIP (net of 17,170 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares) occurred in October 2020. In January 2021, 1,041,953 restricted shares granted as part of the 2016 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $25.42), resulting in the issuance of 587,633 ordinary shares to participants in the LTIP (net of 454,320 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares). In January 2021, 368,154 restricted shares granted as part of the 2017 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $25.42), resulting in the issuance of 217,228 ordinary shares to participants in the LTIP (net of 150,926 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares). In February 2021, 451,719 restricted shares granted as part of the 2017 Management Share Awards vested as a result of the satisfaction of the applicable EBITDA Performance Condition (based on a share price of $25.89 at time of vesting), resulting in the issuance of 271,451 ordinary shares to participants in the LTIP (net of 180,268 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares). The stock compensation charge reported within the Consolidated Statement of Profit or Loss for the year ended December 31, 2021 related to the director and senior management share awards is €4.3 million (year ended December 31, 2020: €8.3 million: year ended December 31, 2019: €14.0 million). The Company calculates the cost of the Management Share Awards based upon their fair value using the Monte Carlo Model, which is considered to be the most appropriate methodology considering the restricted shares only vest once the market performance conditions have been satisfied. The inputs and assumptions underlying the Monte Carlo models for all awards outstanding as of the valuation date are now as follows: January 1, 2018 award January 1, 2019 award January 1, 2020 award January 1, 2021 award Grant date price $ 16.72 $ 20.15 $ 22.37 $ 25.42 Exercise price $ — $ — $ — $ — Expected life of restricted share 1.50 - 4.00 years 4.00 years 3.00 years 3.00 years Expected volatility of the share price 22.7 % 24.0 % 24.4 % 30.0 % Dividend yield expected — % — % — % — % Risk free rate 2.55 % 1.33 % 1.70 % 0.24 % Employee exit rate 14.0 % 14.0 % 27.3 % 14.0 % EBITDA Performance Target Condition 35.0 % 35.0 % 35.0 % 35.0 % The expected volatility of the share price inputs above were estimated by referencing selected quoted companies which are considered to exhibit some degree of comparability with the Company, as the Company has only been listed for approximately six years. Based on the latest assessments of fair value and the number of shares expected to vest, the total fair values in respect of the Restricted Shares are: • 2018 award - $1.6 million (€1.3 million) • 2019 award - $1.4 million (€1.2 million) • 2020 award - $4.8 million (€4.3 million) • 2021 award - $7.0 million (€5.8 million) Initial Director Options In 2014, certain Non-Executive Directors were granted options (“Initial Options”) to purchase a maximum of 125,000 Ordinary Shares at an exercise price of $11.50 per ordinary share. The awards were valued at issuance and expensed during the two years ended April 1, 2016. Throughout 2019, former Non-Executive Directors exercised 56,250 of the 125,000 initial options granted to them for €0.6 million.

Directors and Key Management co

Directors and Key Management compensation	12 Months Ended
	Dec. 31, 2021
Related Party [Abstract]
Disclosure of information about key management personnel [text block]	Directors and Key Management compensation Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 €m €m €m Short-term employee benefits 2.2 3.9 2.8 Share-based payment expense 2.4 3.5 7.6 Non-Executive Director fees 0.3 0.3 0.4 Total Directors' and executive officers' compensation 4.9 7.7 10.8 All significant management decision making authority is vested within the Board of Directors and the executive team, therefore key management are considered to be the Directors and executive Officers. Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Benefits are accruing to the following number of key management personnel under: Defined contribution plans 2 2 2 Share based payment schemes 2 2 2

Finance income and costs

Finance income and costs	12 Months Ended
	Dec. 31, 2021
Analysis of income and expense [abstract]
Finance income and costs	Finance income and costs Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 €m €m €m Interest income 0.1 0.7 2.5 Net foreign exchange gains on translation of financial assets and liabilities — 4.0 — Finance income 0.1 4.7 2.5 Interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss (a) (59.8) (64.0) (79.0) Cross-currency interest rate swaps: cash flow hedges, transfer from equity 1.6 5.9 21.8 Net impairment loss on short-term investments (8.6) — — Net pension interest costs (1.7) (2.7) (3.8) Amortization of borrowing costs (2.0) (2.0) (2.0) Net foreign exchange losses on translation of financial assets and liabilities (4.0) — (3.9) Net fair value losses on derivatives held at fair value through profit or loss (b) (13.7) (5.6) (8.8) Financing costs incurred in amendment of terms of debt (c) (17.9) — — Finance costs (106.1) (68.4) (75.7) Net finance costs (106.0) (63.7) (73.2) (a) Includes the unwinding of discounting on lease liabilities. (b) Net fair value losses on derivatives held at fair value through profit or loss includes a one-off non-cash charge of €7.8 million for changes to cross currency interest rate swaps as disclosed in Note 34. (c) Charges of €17.9 million have been recognized as a consequence of the refinancing in June 2021, as disclosed in Note 34. Of this, €10.1 million relates to the extinguishment of the previous debts, including the write-off of deferred transaction costs.

Taxation

Taxation	12 Months Ended
	Dec. 31, 2021
Income Taxes [Abstract]
Taxation	Taxation Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, Note €m €m €m Current tax expense Current tax on profits for the period (117.5) (44.8) (66.4) Adjustments in respect of prior periods 0.6 (7.6) — (116.9) (52.4) (66.4) Deferred tax benefit/(expense) Origination and reversal of temporary differences 116.3 (1.2) 9.7 Impact of change in tax rates (55.1) (16.8) — 16 61.2 (18.0) 9.7 Total tax expense (55.7) (70.4) (56.7) Reconciliation of effective tax rate: Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, €m €m €m Profit before tax 236.7 295.5 210.3 Tax charge at the standard UK corporation tax rate 19% (2020: 19%; 2019: 19%) (45.0) (56.1) (39.9) Difference in tax rates 22.7 (18.2) (11.9) Non tax deductible interest 0.1 (0.1) 0.6 Other income and expenses not taxable or deductible 2.5 (0.8) (1.2) Unrecognized tax assets (1.5) (6.3) (0.9) Provisions for uncertainties (52.5) 35.5 (3.4) Impact of change in tax rates (55.1) (16.8) — Change in tax base of assets due to step-up 72.5 — — Prior period adjustment 0.6 (7.6) — Total tax expense (55.7) (70.4) (56.7) Effective tax rates The Company is resident in the United Kingdom for tax purposes. The effective tax rate for the year ended December 31, 2021 was 23.5% (year ended December 31, 2020: 23.8%). The change is principally caused by the release of uncertain tax positions in relation to exposures that are now time barred, offset in part by the impact of a change in tax rates on deferred tax assets and liabilities. The Company operates in many different jurisdictions and in some of these, certain matters are under discussion with local tax authorities. These discussions are often complex and can take many years to resolve, and are in different stages with respect to assessments appeals and refunds. The Company actively seeks to manage the associated risks by proactively engaging with tax authorities and applying for Advanced Pricing Agreements where appropriate. Accruals for tax contingencies require management to make estimates and judgments with respect to the ultimate outcome of a tax audit, and actual results could vary from these estimates. Where tax exposures can be quantified, a provision is made based on best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could, in future years, experience adjustments to this provision, including releases of provisions when those exposures become time-barred. Notwithstanding this, management believes that the Company’s position on all open matters including those in current discussion with local tax authorities is robust and that the Company is appropriately provided. As of December 31, 2021, the current tax payable of €198.5m and deferred tax assets of €128.3m includes provisions for tax uncertainties of €163.4m. As of December 31, 2020, the current tax payable of €166.2m and deferred tax assets of €113.5m included provisions for tax uncertainties of €103.9m. The UK government announced an increase in the standard rate of corporation tax from 19% for 2021 (2020: 19%) to 25% effective from April 1, 2023, substantively enacted on May 24, 2021. The increase gave rise to a substantial one-off deferred tax expense, which is offset in part by a deferred tax benefit from the implementation of certain arrangements benefiting from one-off government incentives and other tax incentives. The financial statements for the year ended December 31, 2020 were prepared using the substantively enacted rate of corporation tax of 19%. The tax (benefit)/expense relating to components of other comprehensive income is as follows: Before Tax After tax Year ended December 31, 2021 Note €m €m €m Remeasurement of post-employment benefit liabilities (36.1) 10.2 (25.9) Net investment hedge (18.8) — (18.8) Cash flow hedges (22.6) 13.6 (9.0) Other comprehensive (income)/loss (77.5) 23.8 (53.7) Current tax — Deferred tax 16 23.8 23.8 Before Tax benefit After tax Year ended December 31, 2020 Note €m €m €m Remeasurement of post-employment benefit liabilities 27.8 (8.3) 19.5 Net investment hedge 10.1 — 10.1 Cash flow hedges 17.3 (6.0) 11.3 Other comprehensive loss/(income) 55.2 (14.3) 40.9 Current tax — Deferred tax 16 (14.3) (14.3) Before Tax After tax Year ended December 31, 2019 €m €m €m Remeasurement of post-employment benefit liabilities 35.9 (6.7) 29.2 Net investment hedge (6.0) — (6.0) Cash flow hedges 27.3 (5.6) 21.7 Other comprehensive loss/(income) 57.2 (12.3) 44.9 Current tax — Deferred tax (12.3) (12.3) Recognized deferred tax assets and liabilities Deferred tax assets and liabilities are attributable to the following: December 31, 2021 December 31, 2020 (restated) Assets Liabilities Total Assets Liabilities Total €m €m €m €m €m €m Property, plant and equipment 8.9 (34.4) (25.5) 20.6 (27.3) (6.7) Intangible assets 33.8 (382.9) (349.1) 0.9 (384.4) (383.5) Employee benefits 36.4 — 36.4 48.3 (0.3) 48.0 Tax value of loss carry forwards 40.4 — 40.4 24.6 — 24.6 Derivative financial instruments 1.7 (7.0) (5.3) 9.3 (0.1) 9.2 Other 7.1 (13.3) (6.2) 9.8 (15.0) (5.2) Tax assets/(liabilities) 128.3 (437.6) (309.3) 113.5 (427.1) (313.6) As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition. Deferred income tax assets are recognized for tax loss carry-forwards to the extent that the realization of the related tax benefit through future taxable profits is probable. Deferred tax assets that the Company has not recognized in the financial statements amount to €70.4 million (December 31, 2020: €72.7 million). These deferred tax assets had not been recognized as the likelihood of recovery is not probable. The aggregate deferred tax relating to items that have been credited directly to equity is €23.8 million (December 31, 2020: debit of €14.3 million). Movement in deferred tax during the year: Opening balance Jan 1, 2021 (restated) Acquired in Recognized Recognized Movement Closing balance Dec 31, 2021 €m €m €m €m €m €m Property, plant and equipment (6.7) (2.2) (17.2) — 0.6 (25.5) Intangible assets (383.5) (30.1) 64.5 — — (349.1) Employee benefits 48.0 — (1.2) (10.2) (0.2) 36.4 Tax value of loss carry forwards 24.6 — 15.8 — — 40.4 Derivative financial instruments 9.2 — (0.3) (13.6) (0.6) (5.3) Other (5.2) (0.6) (0.4) — — (6.2) Total deferred tax (313.6) (32.9) 61.2 (23.8) (0.2) (309.3) Opening balance Jan 1, 2020 Acquired in business combinations (restated) Recognized Recognized Movement Closing balance Dec 31, 2020 (restated) €m €m €m €m €m €m Property, plant and equipment (6.3) (1.3) 1.0 — (0.1) (6.7) Intangible assets (356.6) (6.3) (20.6) — — (383.5) Employee benefits 39.8 — — 8.3 (0.1) 48.0 Tax value of loss carry forwards 20.7 — 3.9 — — 24.6 Derivative financial instruments 2.9 — 0.3 6.0 — 9.2 Other (2.3) (0.4) (2.6) — 0.1 (5.2) Total deferred tax (301.8) (8.0) (18.0) 14.3 (0.1) (313.6)

Goodwill and Intangibles

Goodwill and Intangibles	12 Months Ended
	Dec. 31, 2021
Intangible assets and goodwill [abstract]
Goodwill and Intangibles	Goodwill and Intangibles Goodwill Brands Computer Customer Total €m €m €m €m €m Cost Balance at December 31, 2019 1,862.9 2,051.1 29.8 31.0 3,974.8 Acquisitions through business combinations (restated) 40.1 66.0 0.1 — 106.2 Additions — — 8.8 — 8.8 Effect of movements in foreign exchange (0.5) 5.3 0.3 — 5.1 Balance at December 31, 2020 (restated) 1,902.5 2,122.4 39.0 31.0 4,094.9 Acquisitions through business combinations 192.6 296.5 1.1 4.3 494.5 Additions — — 5.8 — 5.8 Disposals — — (2.5) — (2.5) Effect of movements in foreign exchange 4.3 3.2 (0.5) — 7.0 Balance at December 31, 2021 2,099.4 2,422.1 42.9 35.3 4,599.7 Goodwill Brands Computer Customer Total €m €m €m €m €m Accumulated amortization and impairment Balance at December 31, 2019 — 4.4 15.2 9.2 28.8 Amortization — 1.2 4.4 2.2 7.8 Effect of movements in foreign exchange — — 0.1 — 0.1 Balance at December 31, 2020 — 5.6 19.7 11.4 36.7 Amortization — 1.2 4.6 2.4 8.2 Impairment — — 1.7 — 1.7 Disposals — — (1.7) — (1.7) Effect of movements in foreign exchange — — (0.3) — (0.3) Balance at December 31, 2021 — 6.8 24.0 13.8 44.6 Net book value December 31, 2019 1,862.9 2,046.7 14.6 21.8 3,946.0 Net book value December 31, 2020 (restated) 1,902.5 2,116.8 19.3 19.6 4,058.2 Net book value December 31, 2021 2,099.4 2,415.3 18.9 21.5 4,555.1 As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition. Amortization and impairment of €9.9 million (December 31, 2020: €7.8 million; December 31, 2019: €8.6 million) is included in ‘other operating expenses’ in the Consolidated Statement of Profit or Loss. Goodwill is initially recognized based on the accounting policy for goodwill (see note 3.5) and is subsequently measured at cost less amounts provided for impairment. The Company’s goodwill, brand and customer relationships values have been allocated to a level no larger than the identified operating segment. This represents the lowest level within the Group at which the goodwill is monitored for internal management purposes. As required by IAS 36 'Impairment of Assets', an annual review of the carrying amount of the goodwill and the indefinite life brands is carried out to identify whether there is any impairment to these carrying values. This is done by means of comparison of the carrying values to the value in use of the CGU. Value in use is calculated as the net present value of the projected risk-adjusted cash flows of each CGU. Key assumptions The values for the key assumptions relating to the annual review of the carrying amount of goodwill and indefinite life brands were arrived at by taking into consideration detailed historical information and comparison to external sources where appropriate, such as market rates for discount factors. • Budgeted cash flows: the calculation of value in use has been based on the cash flow forecasts by management for 2022 to 2025. The trends in these forecasts have been extrapolated to produce a forecast cash flow for 2026. Beyond 2026 the same assumptions have been applied for future periods in the absence of longer term detailed forecasts. These plans have been prepared and approved by management, and incorporate past performance of the entities acquired in the period, historical growth rates and projections of developments in key markets. • Revenue: projected revenues are built up with reference to markets and product platforms. They incorporate past performance, historical growth rates and projections of developments in key markets. • Profit margins: projected margins reflect historical performance, adjusted to account for volatility, such as the impact of COVID-19. • Capital expenditure forecast reflects expected expenditure requirements and includes an allowance for the replacement of leased right-of-use assets. • Discount rate: a pre-tax discount rate of 6.4% (2020: 5.8%) was applied to the cash flows. This discount rate has been calculated using a capital asset pricing model using observable market data, including the share price of Nomad Foods Limited. • Long-term growth rates: the growth rate used in the testing after the detailed forecasting period was 1.0% (2020: 1.0%). These rates do not reflect the long-term assumptions used by the Company for investment planning. Sensitivity to changes in assumptions Impairment was not required at either December 31, 2021, or December 31, 2020. In each case the valuations derived from the discounted cash flow model indicate a sufficient amount of headroom for which any reasonably possible change to key assumptions is unlikely to result in an impairment of the related goodwill.

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2021
Business Combinations1 [Abstract]
Acquisitions	Indemnification assets Year ended December 31, 2021 Year ended December 31, 2020 €m €m Balance at January 1 15.4 35.4 Release of indemnified provision (5.9) (20.0) Balance at December 31 9.5 15.4 As at December 31, 2021, €7.0 million (December 31, 2020: €12.0 million) of the indemnification assets relate to the acquisition of the Findus Group in 2015 for which 342,190 shares are held in escrow and are valued at $25.39 (€22.40) (December 31, 2020: 618,099 shares valued at $25.42 (€20.69)) each. The shares placed in escrow were released in stages over a four-year period beginning January 2019 with the final release in January 2022. During 2021, 275,909 shares were released from escrow. As a consequence the indemnification asset was reduced by €5.0 million with a corresponding charge of to the Statement of Profit or Loss within the financial statements for the year ended December 31, 2021. In January 2022, the remaining 342,190 shares were released from escrow. As a consequence the indemnification asset will be reduced by €7.0 million with a corresponding charge of to the Statement of Profit or Loss within the financial statements for the year ended December 31, 2022. As at December 31, 2021, €2.5 million (2020: €3.4 million) of the indemnification asset relates to the Goodfella’s Pizza acquisition for several contingent liabilities that arose prior to acquisition and were recognized in the balance sheet to the same extent as the asset. During 2021, €0.9 million was released against the liabilities.

Investments

Investments	12 Months Ended
	Dec. 31, 2021
Interests in Other Entities [Abstract]
Investments	Investments The following are the Company's significant investments as of December 31, 2021. Activity Country of Class of Ownership Nomad Foods Europe Holdings Limited Holding England Ordinary 100% Nomad Foods Europe Holdco Limited Holding England Ordinary 100% Nomad Foods Europe Finco Limited Holding England Ordinary 100% Nomad Foods Europe Midco Limited Holding/ England Ordinary 100% Nomad Foods Bondco Plc Finance England Ordinary 100% Nomad Foods Lux S.à.r.l. Finance Luxembourg Ordinary 100% Nomad Foods Europe Limited Management England Ordinary 100% Birds Eye Limited Trading England Ordinary 100% Nomad Foods Europe Finance Limited Finance England Ordinary 100% Birds Eye Ireland Limited Trading Republic of Ordinary 100% Iglo Holding GmbH Holding Germany Ordinary 100% Iglo Nederland B.V. Trading Netherlands Ordinary 100% Iglo Belgium S.A. Trading Belgium Ordinary 100% Iglo Portugal Trading Portugal Ordinary 100% Iglo Austria Holdings GmbH Holding Austria Ordinary 100% C.S.I. Compagnia Surgelati Italiana S.R.L Trading Italy Ordinary 100% Findus Sverige Holdings AB Holding Sweden Ordinary 100% Iglo GmbH Trading Germany Ordinary 100% Frozen Fish International GmbH Trading Germany Ordinary 100% Liberator Germany Newco GmbH Property Germany Ordinary 100% Iglo Austria GmbH Trading Austria Ordinary 100% Findus Sverige AB Trading Sweden Ordinary 100% Frionor Sverige AB Holding Sweden Ordinary 100% Findus Holdings France SAS Holding France Ordinary 100% Findus France SAS Trading France Ordinary 100% Findus Espana SLU Trading Spain Ordinary 100% Findus Danmark A/S Trading Denmark Ordinary 100% Findus Finland Oy Trading Finland Ordinary 100% Findus Norge AS Trading Norway Ordinary 100% Findus Norge Holding AS Holding Norway Ordinary 100% Toppfrys AB Trading Sweden Ordinary 100% Findus Switzerland AG Trading Switzerland Ordinary 100% LEDO plus d.o.o. Trading Croatia Ordinary 100% INDUSTRIJA SMRZNUTE HRANE FRIKOM DOO BEOGRAD Trading Serbia Ordinary 100% LEDO d.o.o. Čitluk Trading Bosnia & Herzegovina Ordinary 100% IRIDA d.o.o. Trading Croatia Ordinary 100% LEDO Jégkrém és Fagyasztott Élelmiszer Gyártó és Forgalmazó Korlátolt Felelősségű Társaság Trading Hungary Ordinary 100% Ledo d.o.o. (LEDO, podjetje za trgovino s sladoledom, zmrznjeno hrano in storitve, d.o.o.) Trading Slovenia Ordinary 100% Ledo d.o.o. Podgorica (Društvo Za Proizvodnju, promet roba i usluga “Ledo” d.o.o. Podgorica) Trading Montenegro Ordinary 100% Ledo Sh.p.k. Trading Kosovo Ordinary 100% FRIKOM BEOGRAD DOOEL Cucer Sandevo Trading North Macedonia Ordinary 100%

Deferred tax assets and liabili

Deferred tax assets and liabilities	12 Months Ended
	Dec. 31, 2021
Disclosure of income tax [Abstract]
Deferred tax assets and liabilities	Taxation Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, Note €m €m €m Current tax expense Current tax on profits for the period (117.5) (44.8) (66.4) Adjustments in respect of prior periods 0.6 (7.6) — (116.9) (52.4) (66.4) Deferred tax benefit/(expense) Origination and reversal of temporary differences 116.3 (1.2) 9.7 Impact of change in tax rates (55.1) (16.8) — 16 61.2 (18.0) 9.7 Total tax expense (55.7) (70.4) (56.7) Reconciliation of effective tax rate: Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, €m €m €m Profit before tax 236.7 295.5 210.3 Tax charge at the standard UK corporation tax rate 19% (2020: 19%; 2019: 19%) (45.0) (56.1) (39.9) Difference in tax rates 22.7 (18.2) (11.9) Non tax deductible interest 0.1 (0.1) 0.6 Other income and expenses not taxable or deductible 2.5 (0.8) (1.2) Unrecognized tax assets (1.5) (6.3) (0.9) Provisions for uncertainties (52.5) 35.5 (3.4) Impact of change in tax rates (55.1) (16.8) — Change in tax base of assets due to step-up 72.5 — — Prior period adjustment 0.6 (7.6) — Total tax expense (55.7) (70.4) (56.7) Effective tax rates The Company is resident in the United Kingdom for tax purposes. The effective tax rate for the year ended December 31, 2021 was 23.5% (year ended December 31, 2020: 23.8%). The change is principally caused by the release of uncertain tax positions in relation to exposures that are now time barred, offset in part by the impact of a change in tax rates on deferred tax assets and liabilities. The Company operates in many different jurisdictions and in some of these, certain matters are under discussion with local tax authorities. These discussions are often complex and can take many years to resolve, and are in different stages with respect to assessments appeals and refunds. The Company actively seeks to manage the associated risks by proactively engaging with tax authorities and applying for Advanced Pricing Agreements where appropriate. Accruals for tax contingencies require management to make estimates and judgments with respect to the ultimate outcome of a tax audit, and actual results could vary from these estimates. Where tax exposures can be quantified, a provision is made based on best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could, in future years, experience adjustments to this provision, including releases of provisions when those exposures become time-barred. Notwithstanding this, management believes that the Company’s position on all open matters including those in current discussion with local tax authorities is robust and that the Company is appropriately provided. As of December 31, 2021, the current tax payable of €198.5m and deferred tax assets of €128.3m includes provisions for tax uncertainties of €163.4m. As of December 31, 2020, the current tax payable of €166.2m and deferred tax assets of €113.5m included provisions for tax uncertainties of €103.9m. The UK government announced an increase in the standard rate of corporation tax from 19% for 2021 (2020: 19%) to 25% effective from April 1, 2023, substantively enacted on May 24, 2021. The increase gave rise to a substantial one-off deferred tax expense, which is offset in part by a deferred tax benefit from the implementation of certain arrangements benefiting from one-off government incentives and other tax incentives. The financial statements for the year ended December 31, 2020 were prepared using the substantively enacted rate of corporation tax of 19%. The tax (benefit)/expense relating to components of other comprehensive income is as follows: Before Tax After tax Year ended December 31, 2021 Note €m €m €m Remeasurement of post-employment benefit liabilities (36.1) 10.2 (25.9) Net investment hedge (18.8) — (18.8) Cash flow hedges (22.6) 13.6 (9.0) Other comprehensive (income)/loss (77.5) 23.8 (53.7) Current tax — Deferred tax 16 23.8 23.8 Before Tax benefit After tax Year ended December 31, 2020 Note €m €m €m Remeasurement of post-employment benefit liabilities 27.8 (8.3) 19.5 Net investment hedge 10.1 — 10.1 Cash flow hedges 17.3 (6.0) 11.3 Other comprehensive loss/(income) 55.2 (14.3) 40.9 Current tax — Deferred tax 16 (14.3) (14.3) Before Tax After tax Year ended December 31, 2019 €m €m €m Remeasurement of post-employment benefit liabilities 35.9 (6.7) 29.2 Net investment hedge (6.0) — (6.0) Cash flow hedges 27.3 (5.6) 21.7 Other comprehensive loss/(income) 57.2 (12.3) 44.9 Current tax — Deferred tax (12.3) (12.3) Recognized deferred tax assets and liabilities Deferred tax assets and liabilities are attributable to the following: December 31, 2021 December 31, 2020 (restated) Assets Liabilities Total Assets Liabilities Total €m €m €m €m €m €m Property, plant and equipment 8.9 (34.4) (25.5) 20.6 (27.3) (6.7) Intangible assets 33.8 (382.9) (349.1) 0.9 (384.4) (383.5) Employee benefits 36.4 — 36.4 48.3 (0.3) 48.0 Tax value of loss carry forwards 40.4 — 40.4 24.6 — 24.6 Derivative financial instruments 1.7 (7.0) (5.3) 9.3 (0.1) 9.2 Other 7.1 (13.3) (6.2) 9.8 (15.0) (5.2) Tax assets/(liabilities) 128.3 (437.6) (309.3) 113.5 (427.1) (313.6) As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition. Deferred income tax assets are recognized for tax loss carry-forwards to the extent that the realization of the related tax benefit through future taxable profits is probable. Deferred tax assets that the Company has not recognized in the financial statements amount to €70.4 million (December 31, 2020: €72.7 million). These deferred tax assets had not been recognized as the likelihood of recovery is not probable. The aggregate deferred tax relating to items that have been credited directly to equity is €23.8 million (December 31, 2020: debit of €14.3 million). Movement in deferred tax during the year: Opening balance Jan 1, 2021 (restated) Acquired in Recognized Recognized Movement Closing balance Dec 31, 2021 €m €m €m €m €m €m Property, plant and equipment (6.7) (2.2) (17.2) — 0.6 (25.5) Intangible assets (383.5) (30.1) 64.5 — — (349.1) Employee benefits 48.0 — (1.2) (10.2) (0.2) 36.4 Tax value of loss carry forwards 24.6 — 15.8 — — 40.4 Derivative financial instruments 9.2 — (0.3) (13.6) (0.6) (5.3) Other (5.2) (0.6) (0.4) — — (6.2) Total deferred tax (313.6) (32.9) 61.2 (23.8) (0.2) (309.3) Opening balance Jan 1, 2020 Acquired in business combinations (restated) Recognized Recognized Movement Closing balance Dec 31, 2020 (restated) €m €m €m €m €m €m Property, plant and equipment (6.3) (1.3) 1.0 — (0.1) (6.7) Intangible assets (356.6) (6.3) (20.6) — — (383.5) Employee benefits 39.8 — — 8.3 (0.1) 48.0 Tax value of loss carry forwards 20.7 — 3.9 — — 24.6 Derivative financial instruments 2.9 — 0.3 6.0 — 9.2 Other (2.3) (0.4) (2.6) — 0.1 (5.2) Total deferred tax (301.8) (8.0) (18.0) 14.3 (0.1) (313.6)

Inventories

Inventories	12 Months Ended
	Dec. 31, 2021
Inventories [Abstract]
Inventories	17) Inventories December 31, 2021 December 31, 2020 (restated) €m €m Raw materials and consumables 95.8 80.5 Work in progress 64.9 46.5 Finished goods and goods for resale 249.9 217.3 Total inventories 410.6 344.3 As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition. As at December 31, 2021, €2.1 million was recognized as a basis adjustment transferred to the carrying value of inventory. This has been applied to the three inventory categories above. During the year ended December 31, 2021, €8.3 million (year ended December 31, 2020: €8.5 million, year ended December 31, 2019: €9.0 million) was charged to the Consolidated Statement of Profit or Loss for the write down of inventories.

Trade and other receivables

Trade and other receivables	12 Months Ended
	Dec. 31, 2021
Subclassifications of assets, liabilities and equities [abstract]
Trade and other receivables	Trade and other receivables December 31, 2021 December 31, 2020 Current assets €m €m Trade receivables 182.8 141.2 Prepayments and accrued income 15.4 9.2 Other receivables 32.3 31.2 Tax receivable 4.1 3.4 Total current trade and other receivables 234.6 185.0 Non-current assets Other receivables 8.9 1.1 Total non-current trade and other receivables 8.9 1.1 Total trade and other receivables 243.5 186.1 Trade receivables, prepayments and other receivables, except for those defined as non-current, are expected to be recovered in less than 12 months. Other receivables includes VAT receivable. The aging of trade receivables is detailed below: Gross Impaired Net December 31, 2021 €m €m €m Not past due 343.8 (0.1) 343.7 Past due less than 1 month 19.9 (0.1) 19.8 Past due 1 to 3 months 5.2 (0.6) 4.6 Past due 3 to 6 months 2.4 (0.1) 2.3 Past due more than 6 months 5.0 (2.7) 2.3 Sub-total 376.3 (3.6) 372.7 Reduction in trade-terms (189.9) Total trade receivables 182.8 Gross Impaired Net December 31, 2020 €m €m €m Not past due 308.6 (0.3) 308.3 Past due less than 1 month 20.5 (0.2) 20.3 Past due 1 to 3 months 4.0 (0.1) 3.9 Past due 3 to 6 months 1.1 (0.1) 1.0 Past due more than 6 months 11.9 (3.7) 8.2 Sub-total 346.1 (4.4) 341.7 Reduction in trade-terms (200.5) Total trade receivables 141.2 Reduction in trade-terms are described in Note 4(a). Trade receivables have been provided against based on expected credit losses on positions net of trade-terms, which fall into all aging categories. The maximum exposure to credit risk at the reporting date is the fair value of each class of receivable. The Company does not hold any collateral as security. Debts past due are not impaired where there are eligible trade terms deductions which can be offset against them. For the periods covered in these financial statements, the Company has entered into facilities with third-party banks/credit providers in which the Company has sold qualifying trade debtors on a non-recourse basis. Under the terms of these agreements, the Company transferred substantially all the credit risks and control of the receivables. All factoring facilities have been cancelled during 2021. No trade receivables have been derecognized at the period end (December 31, 2020:€ nil). Liabilities related to contracts with customers The Company has recognized the following liabilities related to contracts with customers: December 31, 2021 December 31, 2020 €m €m Trade terms liabilities reported within trade receivables (189.9) (200.5) Trade terms liabilities reported within trade and other payables (Note 22) (93.8) (89.7) Total trade terms liabilities (283.7) (290.2) Significant changes to trade terms No significant changes to trade terms occurred in the year ended December 31, 2021. Revenue recognized in relation to trade terms

Indemnification assets

Indemnification assets	12 Months Ended
	Dec. 31, 2021
Business Combinations1 [Abstract]
Indemnification assets	Indemnification assets Year ended December 31, 2021 Year ended December 31, 2020 €m €m Balance at January 1 15.4 35.4 Release of indemnified provision (5.9) (20.0) Balance at December 31 9.5 15.4 As at December 31, 2021, €7.0 million (December 31, 2020: €12.0 million) of the indemnification assets relate to the acquisition of the Findus Group in 2015 for which 342,190 shares are held in escrow and are valued at $25.39 (€22.40) (December 31, 2020: 618,099 shares valued at $25.42 (€20.69)) each. The shares placed in escrow were released in stages over a four-year period beginning January 2019 with the final release in January 2022. During 2021, 275,909 shares were released from escrow. As a consequence the indemnification asset was reduced by €5.0 million with a corresponding charge of to the Statement of Profit or Loss within the financial statements for the year ended December 31, 2021. In January 2022, the remaining 342,190 shares were released from escrow. As a consequence the indemnification asset will be reduced by €7.0 million with a corresponding charge of to the Statement of Profit or Loss within the financial statements for the year ended December 31, 2022. As at December 31, 2021, €2.5 million (2020: €3.4 million) of the indemnification asset relates to the Goodfella’s Pizza acquisition for several contingent liabilities that arose prior to acquisition and were recognized in the balance sheet to the same extent as the asset. During 2021, €0.9 million was released against the liabilities.

Cash and cash equivalents

Cash and cash equivalents	12 Months Ended
	Dec. 31, 2021
Subclassifications of assets, liabilities and equities [abstract]
Cash and cash equivalents	Cash and cash equivalents December 31, 2021 December 31, 2020 Note €m €m Cash and cash equivalents 254.0 393.1 Restricted cash 0.2 0.1 Cash and cash equivalents 254.2 393.2 Bank overdraft 22 — (10.7) Cash and cash equivalents per Statement of Cash Flows 254.2 382.5

Loans and borrowings

Loans and borrowings	12 Months Ended
	Dec. 31, 2021
Financial Instruments [Abstract]
Loans and borrowings	Loans and borrowings The repayment profile of the syndicated and other loans held by the Company is as follows: December 31, 2021 December 31, 2020 €m €m Current liabilities Syndicated loans 8.5 7.8 Lease liabilities 22.6 16.7 Less deferred borrowing costs to be amortized within 1 year (2.0) (2.0) Total due in less than one year 29.1 22.5 Non-current liabilities Syndicated loans 1,347.4 1,287.5 2024 fixed rate senior secured notes — 400.0 2028 fixed rate senior secured notes 800.0 — Lease liabilities 58.3 53.7 Less deferred borrowing costs to be amortized in 2-5 years (5.7) (4.9) Less deferred borrowing costs to be amortized in more than 5 years (1.7) — Total due after more than one year 2,198.3 1,736.3 Total borrowings 2,227.4 1,758.8 Syndicated loans includes the Senior U.S. Dollar debt of $916.4 million (€808.6 million) (the “Senior USD Loan”) and the Senior EUR debt of €553.2 million (the "Senior EUR Loan"), repayable in May 2024 and May 2028 respectively. The Senior USD Loan includes an annual amortization repayment, equivalent to 1.0% of the original issuance value or $9.6 million (€8.5 million) in May each year until maturity. The Senior EUR Loan is repayable only upon maturity. As required under the Senior Facilities Agreement, the Company is also required to undertake an annual excess cash flow calculation whereby additional principal could be repaid. On June 24, 2021, the Company through its indirect, wholly-owned subsidiary, Nomad Foods Bondco Plc, repaid the €400.0 million 3.25% senior secured notes due 2024 and completed a private offering of €750.0 million aggregate principal amount of 2.5% senior secured notes due June 24, 2028. In addition, on July 9, 2021 the Company announced that Nomad Foods Bondco Plc completed a further private offering of €50.0 million aggregate principal amount of additional 2.5% senior secured notes due 2028, representing a tack-on to the €750.0 million aggregate principal amount of senior secured notes due 2028 issued on June 24, 2021, and issued at a price of €100.75 (together the “Notes”). Interest on the Notes accrue from June 24, 2021 (being the original date of issuance) and are payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2022. The Notes are guaranteed on a senior basis by the Company and certain subsidiaries thereof. This transaction was accounted for as an extinguishment of the existing Notes and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. Eligible transaction costs on the new Notes of €4.0 million were capitalized and will be amortized over the life of the debt. On June 24, 2021, the Company amended and restated the Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility originally due in May 2024, through a new 7-year term facility due June 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. This transaction was accounted for as an extinguishment of the existing debt and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Senior EUR Loan, eligible transaction costs of €3.8 million were capitalized and will be amortized over the life of the debt. Under the refinancing, the existing revolving credit facility of €80.0 million due 2023, was also replaced with a new €175.0 million facility (the "Revolving Credit Facility") available until June 2026 with an applicable margin of 2.25% per annum that may be adjusted subject to a leverage ratchet. The Revolving Credit Facility may be utilized to support working capital requirements, including letters of credit and bank guarantees. The structure of the Revolving Credit Facility now also includes a pricing structure linked to environmental impact metrics during the life of the facility, and by doing so demonstrates further commitment to the Company’s sustainability strategy by incorporating ESG target KPIs covering areas of sourcing, packaging and carbon emissions. Charges of €17.9 million have been recognized as a consequence of the refinancing activities in 2021. Of this, €10.1 million relates to the extinguishment of the previous debts, including the write-off of deferred transaction costs. As at December 31, 2021 €2.8 million (December 31, 2020: €16.1 million) has been utilized for issuance of letters of credit and bank guarantees. Guarantees and secured assets The Senior Facility Agreement that governs the Company’s Senior debt, establishes security over the assets of the “Guarantor Group”. The Guarantor Group consists of those companies that individually have more than 5% of consolidated total assets or EBITDA (subject to the terms of the Senior Facilities Agreement) of the Company and in total comprise more than 80% of consolidated total assets or EBITDA at any testing date. The Senior Facilities Agreement includes an excess cash flow calculation whereupon an amount of principal shall be repaid based upon terms including cash generated during the year and leverage. In 2021 the amount repaid was nil relating to the calculation performed at the end of 2020. Based on the calculation performed for December 31, 2021, there will be no excess cash flow repayment in 2022.

Trade and other payables

Trade and other payables	12 Months Ended
	Dec. 31, 2021
Subclassifications of assets, liabilities and equities [abstract]
Trade and other payables	Trade and other payables December 31, 2021 December 31, 2020 (restated) Current liabilities €m €m Trade payables 413.2 363.7 Accruals and deferred income 120.4 134.5 Trade terms payable 93.8 89.7 Social security and other taxes 24.6 24.1 Other payables 20.3 21.2 Financial payables 19.7 3.3 Bank overdrafts — 10.7 Total current trade and other payables 692.0 647.2 Non-current liabilities Accruals and deferred income 1.8 2.2 Total non-current trade and other payables 1.8 2.2 Total trade and other payables 693.8 649.4 As disclosed in Note 14 "Acquisitions", values for the year ended December 31, 2020 have been restated for fair value adjustments related to the Findus Switzerland acquisition. The Company has implemented a Supply Chain Financing (“SCF”) program for its suppliers. The principal purpose of these arrangements is to provide the supplier with the option to access liquidity earlier through the sale of its receivables due from the Company to a bank or other financial institution prior to their due date. Management has determined that the Company’s payables to these suppliers have neither been extinguished nor have the liabilities been significantly modified by these arrangements. The value of amounts payable, invoice due dates and other terms and conditions applicable, from the Company’s perspective, remain unaltered, with only the ultimate payee being changed. At December 31, 2021, there was no material usage of the programs (December 31, 2020: nil). The cash outflows in respect of these arrangements will be recognized within operating cash flows.

Employee benefits

Employee benefits	12 Months Ended
	Dec. 31, 2021
Employee Benefits [Abstract]
Employee benefits	Employee benefits The Company operates defined benefit plans as well as defined contribution plans. i. Defined contribution plans The total expense relating to defined contribution plans for the year ended December 31, 2021 was €10.2 million (year ended December 31, 2020: €8.3 million, year ended December 31, 2019: €9.0 million) ii. Defined benefit plans The Company operates partially funded defined benefit pension plans in Germany and Austria, an unfunded defined benefit pension plan in Sweden and defined benefit indemnity arrangements in Italy and Austria. In addition, pension benefits in Switzerland are met via a contract with a collective foundation that offers a fully insured solution to provide a contribution-based cash balance retirement plan, which is classified as a defined benefit plan. In addition, an unfunded post-retirement medical plan is operated in Austria. In Germany and Italy, long term service awards are in operation and various other countries provide other employee benefits. December 31, 2021 December 31, 2020 €m €m Net employee benefit obligations-Germany 149.3 181.2 Net employee benefit obligations-Sweden 70.3 74.1 Net employee benefit obligations-Austria 5.5 5.6 Net employee benefit obligations-Switzerland 5.8 6.6 Net employee benefit obligations-Italy 4.6 4.7 Net employee benefit obligations-total of other countries 8.7 4.0 Total net employee benefit obligations 244.2 276.2 The net obligation of €8.7 million (December 31, 2020: €4.0 million) in respect of other countries is the aggregate of a number of different types of minor schemes, each one not being considered individually material. The amount included in the Statement of Financial Position arising from the Company’s obligations in respect of its defined benefit retirement plans and other post-employment benefits is as follows: Defined benefit Post-employment Total December 31, 2021 €m €m €m Present value of unfunded employee benefit obligations 77.5 11.1 88.6 Present value of funded employee benefit obligations 264.0 — 264.0 Subtotal present value of employee benefit obligations 341.5 11.1 352.6 Fair value of plan assets (108.4) — (108.4) Recognized liability for net employee benefit obligations 233.1 11.1 244.2 Defined benefit Post-employment Total December 31, 2020 €m €m €m Present value of unfunded employee benefit obligations 79.6 9.0 88.6 Present value of funded employee benefit obligations 285.5 — 285.5 Subtotal present value of employee benefit obligations 365.1 9.0 374.1 Fair value of plan assets (97.9) — (97.9) Recognized liability for net employee benefit obligations 267.2 9.0 276.2 Reconciliation from the opening balances to the closing balances for the net employee benefit obligation and its components, including the amounts recognized in the Consolidated Statement of Profit or Loss and the Consolidated Statement of Comprehensive Income: Present value of defined benefit obligation Fair value of plan assets Net defined benefit obligation 2021 2020 2021 2020 2021 2020 €m €m €m €m €m €m Balance at January 1 374.1 323.9 (97.9) (86.4) 276.2 237.5 Included in the Consolidated Statement of Profit or Loss Current service cost 7.9 6.6 — — 7.9 6.6 Interest cost (income) 2.2 3.7 (0.5) (1.0) 1.7 2.7 10.1 10.3 (0.5) (1.0) 9.6 9.3 Included in the Consolidated Statement of Comprehensive Income Actuarial (gain) loss arising from: – demographic assumptions (1.5) — — — (1.5) — – financial assumptions (26.8) 29.1 — — (26.8) 29.1 – experience adjustment 1.8 (0.8) — — 1.8 (0.8) Return on plan assets, excluding interest income — — (9.6) (0.4) (9.6) (0.4) Exchange adjustments (0.3) 2.8 (0.6) — (0.9) 2.8 (26.8) 31.1 (10.2) (0.4) (37.0) 30.7 Other Acquired through business combinations 3.5 18.4 — (11.8) 3.5 6.6 Contributions by employer — — (1.2) (0.5) (1.2) (0.5) Contributions by members 0.8 0.4 (0.8) (0.5) — (0.1) Benefits paid (9.1) (10.0) 2.2 2.7 (6.9) (7.3) (4.8) 8.8 0.2 (10.1) (4.6) (1.3) Balance at December 31 352.6 374.1 (108.4) (97.9) 244.2 276.2 Current service cost is allocated between cost of sales and other operating expenses. Interest on net employee benefit obligation is disclosed in net financing costs. The cumulative amount of actuarial losses recognized is as follows: Year ended December 31, 2021 Year ended December 31, 2020 €m €m Cumulative amount of actuarial losses recognized in Consolidated Statement of Comprehensive Income 40.5 77.5 The fair value of plan assets, all at quoted prices are as follows: December 31, 2021 December 31, 2020 €m €m Equities 32.7 24.5 Debt instruments 42.7 44.1 Property 20.3 17.1 Other 12.7 12.2 Total 108.4 97.9 The following are the principal actuarial assumptions at the reporting date for the defined benefit retirement plans in Germany, Sweden, Austria, Switzerland and Italy. The remaining employee benefit plans are not considered to be material, individually and in aggregate, and therefore we do not provide disclosure of the individual actuarial assumptions for those plans: Defined benefit December 31, 2021 Germany Sweden Austria Switzerland Italy Discount rate 1.10 % 1.80 % 0.90 % 0.10 % 0.35 % Inflation rate 2.00 % 2.20 % 2.00 % 1.00 % 1.50 % Rate of increase in salaries 2.80 % 3.20 % 2.00 % 1.50 % 2.63 % Rate of increase for pensions in payment 1%-2% 2.20 % — — — Defined benefit December 31, 2020 Germany Sweden Austria Switzerland Italy Discount rate 0.55 % 1.05 % 1.00 % 0.15 % 0.33 % Inflation rate 2.00 % 1.50 % 2.00 % 0.20 % 1.00 % Rate of increase in salaries 2.80 % 2.50 % 2.00 % 0%-2.50% 2.63 % Rate of increase for pensions in payment 1%-2% 1.50 % — — — In valuing the liabilities of the pension fund at December 31, 2021 and December 31, 2020, mortality assumptions have been made as indicated below. The assumptions relating to longevity underlying the pension liabilities at the financial year end date are based on standard actuarial mortality tables and include an allowance for future improvements in longevity. The assumptions are based on the following mortality tables: • Germany: Richttafeln 2018 G • Sweden: DUS 14 • Austria: AVÖ 2018 - P • Switzerland: BVG 2020 GT (2020: BVG 2015 GT) • Italy: RG48 These references are to the specific standard rates of mortality that are published and widely used in each country for the use of actuarial assessment of pension liabilities and take account of local current and future average life expectancy. December 31, 2021 (years) Germany Sweden Austria Switzerland Italy Retiring at the end of the year: Male 21 22 23 22 21 Female 24 24 26 24 22 December 31, 2020 (years) Germany Sweden Austria Switzerland Italy Retiring at the end of the year: Male 21 22 23 21 21 Female 24 24 26 24 22 The history of experience adjustments from inception of the Company for the employee benefit plans is as follows: December 31, 2021 December 31, 2020 December 31, 2019 €m €m €m Present value of defined benefit obligations 341.5 365.1 314.9 Fair value of plan assets (108.4) (97.9) (86.4) Recognized liability in the scheme 233.1 267.2 228.5 Experience losses/(gains) on plan liabilities 1.8 (0.8) 0.2 Experience gains on plan assets (9.6) (0.4) (5.1) Net defined benefit obligation - sensitivity analysis The effect of a 1 percentage point movement in the most significant assumptions for the year ended December 31, 2021 is as follows: Increase Decrease €m €m Discount rate (54.6) 71.9 Inflation rate 47.4 (38.7) Rate of increase in salaries 15.2 (11.5) Rate of increase for pensions in payment 47.6 (37.0) There are no deficit elimination plans for any of the defined benefit plans. Expected contributions and payments to post-employment benefit plans for the period ending December 31, 2021 are €6.7 million. The weighted average duration of the defined benefit obligations is 18.9 years.

Provisions

Provisions	12 Months Ended
	Dec. 31, 2021
Other Provisions, Contingent Liabilities and Contingent Assets [Abstract]
Provisions	Provisions Restructuring Onerous/ Provisions Other Total €m €m €m €m €m Balance at December 31, 2019 7.4 1.2 6.9 31.3 46.8 Additional provision in the period 15.6 — 0.1 13.4 29.1 Release of provision — (0.7) (0.4) (6.0) (7.1) Utilization of provision (10.4) (0.5) — (5.9) (16.8) Foreign exchange 0.3 — — (0.5) (0.2) Balance at December 31, 2020 12.9 — 6.6 32.3 51.8 Acquired through business combinations — — 0.3 3.8 4.1 Additional provision in the period 2.6 — 1.0 2.5 6.1 Release of provision (0.1) — — (4.0) (4.1) Utilization of provision (9.8) — — (6.9) (16.7) Foreign exchange — — — 1.0 1.0 Balance at December 31, 2021 5.6 — 7.9 28.7 42.2 Analysis of total provisions: December 31, 2021 December 31, 2020 Current 39.3 45.7 Non-current 2.9 6.1 Total 42.2 51.8 Restructuring The €5.6 million (2020: €12.9 million) provision relates to committed plans for certain restructuring activities of exceptional nature which are due to be completed within the next 12 months. The amounts have been provided based on the latest information available on the likely remaining expenditure required to complete the committed plans. An additional provision of €2.6 million has been made and €9.8 million has been utilized in the year ended December 31, 2021. Provisions relating to other taxes The €7.9 million (2020: €6.6 million) provision relates to other, non-income taxes due to tax authorities after tax investigations within certain operating subsidiaries within the Nomad Group. Other Other provisions include €3.9 million (December 31, 2020: €4.4 million) of contingent liabilities acquired as part of the Goodfella’s Pizza acquisition that are indemnified by the Seller’s insurance policies, €4.3 million (December 31, 2020: €4.7 million) of obligations in Italy, €4.6 million (December 31, 2020: €6.1 million) for asset retirement obligations, €1.3 million (December 31, 2020: €1.9 million) of pre-acquisition related liabilities related to the acquisition date liabilities of Aunt Bessie's Limited, €2.4 million (December 31, 2020: €6.6 million) of provisions in the period relate to employer taxes on the Long-term Incentive Plan (see Note 8) which would become payable on the issuance of shares, and other obligations from previous accounting periods.

Share capital and reserves

Share capital and reserves	12 Months Ended
	Dec. 31, 2021
Share Capital, Reserves and Other Equity Interest [Abstract]
Share capital and reserves	Share capital, Capital reserve and Founder Preferred Shares Dividend reserve Share capital and capital reserve As at December 31, 2021 As at December 31, 2020 €m €m Authorized: Unlimited number of Ordinary Shares with nil nominal value issued at $10.00 per share n/a n/a Unlimited number of Founder Preferred Shares with nil nominal value issued at $10.00 per share n/a n/a Issued and fully paid: 173,559,173 (December 31, 2020: 172,180,897) Ordinary Shares with nil nominal value 1,639.6 1,636.9 1,500,000 (December 31, 2020: 1,500,000) Founder Preferred Shares with nil nominal value 10.6 10.6 Total share capital and capital reserve 1,650.2 1,647.5 Listing and share transaction costs (27.1) (27.0) Total net share capital and capital reserve 1,623.1 1,620.5 Ordinary Shares Issued and Repurchased Ordinary shares Balance at December 31, 2019 194.5 Shares issued in the year 7.6 Shares repurchased in the year (29.9) Balance at December 31, 2020 172.2 Shares issued in the year 5.0 Shares repurchased in the year (3.6) Balance at December 31, 2021 173.6 Note 8(b) sets out the Non-Executive Director, Initial Director Options and Director and Senior Management Restricted share awards. Note 27 sets out the Founder Preferred Share Dividends issued as ordinary shares in all years presented. On March 13, 2020, the Company announced a share repurchase program to purchase up to an aggregate of $300.0 million of the Company’s ordinary shares. Acquisitions pursuant to the stock repurchase program may be made from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. After the announcement, the Company entered into a series of open-market repurchases. During 2020, 11,913,682 ordinary shares at an average price of $21.04, for aggregate gross costs of $250.9 million (€217.4 million) had been repurchased and canceled. Directly attributed transaction costs of €0.2 million were incurred. During 2021, a further 507,396 ordinary shares were repurchased and cancelled at an average price of $25.29 for aggregate gross costs of $12.8 million (€10.5 million) under this authorization. In August 2020, the Company announced the repurchase of up to $500.0 million of shares, to be executed by way of a Dutch auction. On September 15, 2020, a total of 18,061,952 shares at a clearing price of $25.50 per share amounting to the purchase price of $460.6 million (€389.3 million) was paid to the prevailing shareholders with all shares canceled as of the same date. Directly attributed transaction costs of €1.9 million were incurred. On August 5, 2021, the Company announced a new share repurchase program to purchase up to an aggregate of $500.0 million of the Company’s ordinary shares, to be executed in the period to August 2024. Acquisitions pursuant to the stock repurchase program may be made from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions, at the Company's discretion, as permitted by securities laws and other legal requirements. Pursuant to the program, as at December 31, 2021, 3,090,082 ordinary shares had been repurchased and canceled at an average price of $24.50, for aggregate gross costs of $75.8 million (€67.1 million). Directly attributed transaction costs of €0.1 million were incurred. Listing and share transaction costs As at December 31, 2021, cumulative listing and share transaction costs, which includes the total cost of admission and share issuance expenses, as well as costs associated with share repurchases were €27.1 million and are disclosed as a deduction directly against the capital reserve. €m At December 31, 2019 24.9 Share transaction costs 2.1 At December 31, 2020 27.0 Share transaction costs 0.1 At December 31, 2021 27.1 Obligation to purchase shares As part of the August 5, 2021 authorized share repurchase program, the Company entered into share purchases at agreed prices, totaling 135,621 shares in late 2021 which had not been settled and were therefore not owned by Nomad until early 2022. As a result, the Company recorded €3.0 million within accounts payable to recognize the liability for those shares, with a corresponding other receivable to reflect the value of the shares to be received upon settlement. Founder Preferred Shares Annual Dividend Amount Each of the Founder Entities holds 750,000 shares for a total of 1,500,000 Founder Preferred Shares which were issued at $10.00 per share. The Founder Preferred Shares are intended to incentivize the Founders to achieve Nomad’s objectives. In addition to providing long term capital, the Founder Preferred Shares are structured to provide a dividend based on the future appreciation of the market value of the ordinary shares thus aligning the interests of the Founders with those of the holders of ordinary shares on a long term basis. The Founder Preferred Shares are also intended to encourage the Founders to grow Nomad to maximize value for holders of ordinary shares. There are no Founder Preferred Shares held in Treasury. Founder Preferred Shares confer upon the holder the following: 1. the right to one vote per Founder Preferred Share on all matters to be voted on by shareholders generally and to vote together with the holders of ordinary shares; 2. commencing on January 1, 2015 and for each financial year thereafter: a. once the average price per ordinary share for the Dividend Determination Period, i.e. the last ten b. the right to receive dividends and other distributions as may be declared from time to time by the Company’s board of directors with respect to the Ordinary Shares (such dividends to be distributed among the holders of Founder Preferred Shares, as if for such purpose the Founder Preferred Shares had been converted into Ordinary Shares immediately prior to such distribution) plus an amount equal to 20% of the dividend which would be distributable on such number of Ordinary Shares equal to the Preferred Share Dividend Equivalent (as defined below); and 3. in addition to amounts payable pursuant to clause 2 above, the right, together with the holders of Ordinary Shares, to receive such portion of all amounts available for distribution and from time to time distributed by way of dividend or otherwise at such time as determined by the Directors; and 4. the right to an equal share (with the holders of Ordinary Shares on a share for share basis) in the distribution of the surplus assets of Nomad on its liquidation as are attributable to the Founder Preferred Shares; and 5. the ability to convert into Ordinary Shares on a 1-for-1 basis (mandatorily upon a Change of Control or the seventh full financial year after an acquisition) See Note 27 for further information on the Founder Preferred Shares Dividends issued.

Share-based compensation reserv

Share-based compensation reserve	12 Months Ended
	Dec. 31, 2021
Share Capital, Reserves and Other Equity Interest [Abstract]
Share-based compensation reserve	Share-based compensation reserve The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors. All Awards are to be settled by physical delivery of shares. Note 8(b) sets out the Non-Executive Director and Director and Senior Management Restricted share awards. Share based €m Balance as of January 1, 2021 8.3 Non-Executive Director restricted share awards charge 0.8 Directors and Senior Management share awards charge 4.3 Shares issued upon vesting of awards (0.7) Reclassification of awards for settlement of tax liabilities (5.8) Balance as of December 31, 2021 6.9 Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25. The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year. The Preferred Shares Annual Dividend amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts (currently $25.2127) multiplied by 140,220,619 Preferred Share Dividend Equivalent (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding. The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association. Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred. On December 31, 2019, the Company’s Board of Directors approved a share dividend of an aggregate of 6,421,074 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2018 dividend price of $16.7538 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $21.7289 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2019) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2020. On December 31, 2020, the Company’s Board of Directors approved a share dividend of an aggregate of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by the Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2020) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 4, 2021. As of December 31, 2021, no Founder Preferred Shares Annual Dividend Amount was due, as the average price per ordinary share for the last ten consecutive trading days of the year did not reach the previously achieved 2020 Dividend Price of $25.2127. Founder €m Balance as of January 1, 2021 245.5 Settlement of dividend through share issue (79.5) Balance as of December 31, 2021 166.0 The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary. Year ended December 31, 2021 2020 2019 €m €m €m Balance as of January 1 84.7 94.8 88.8 Adjustment on adoption of hedge accounting under IFRS 9 1.6 — — Restated balance as of January 1 86.3 94.8 88.8 Foreign currency translation adjustments 31.7 (23.6) 19.2 Net deferred (losses)/gains on net investment hedges (1) (12.9) 13.5 (13.2) Total presented in Other Comprehensive Income 18.8 (10.1) 6.0 Balance as of December 31 105.1 84.7 94.8 (1) (Losses)/gains on net investment hedges are offset by €24.6 million of gains (2020: losses of €25.7 million, 2019: gains of €19.0 million) on GBP net investments included within the foreign currency translation adjustments. The translation reserve as at December 31, 2021 does not include any balances relating to continuing hedging relationships. As at December 31, 2020, the translation reserve included €17.3 million relating to continuing hedging relationships in respect of GBP net investments. The translation reserve as at December 31, 2021 included €50.8 million (2020: €46.4 million) relating to a discontinued hedging relationship in respect of GBP net investments. Under IFRS, cost of hedging allows firms to separately account for the fair value movement attributable to foreign currency basis under other comprehensive income (OCI) thereby excluding its impact from the hedge designation itself. Details of the Company's cash flow hedge accounting is detailed in Note 33. The table below shows the movement in the cash flow hedging reserve and cost of hedging reserve during the year, including the gains or losses arising on the revaluation of hedging instruments during the year and the amount reclassified from Other Comprehensive Income ("OCI") to the Consolidated Statement of Profit or Loss in the year. Cross currency interest rate swaps Forward currency contracts Total Cash flow hedge reserve Cost of Hedging reserve Total Other reserves €m €m €m €m €m Balance as of January 1, 2019 0.9 7.6 8.5 — 8.5 Change in fair value of hedging instrument recognized in OCI for the year 28.1 3.8 31.9 — 31.9 Reclassified to cost of goods sold — (21.8) (21.8) — (21.8) Reclassified from OCI to finance costs (37.4) — (37.4) — (37.4) Deferred tax 1.6 4.0 5.6 — 5.6 Balance as of December 31, 2019 (6.8) (6.4) (13.2) — (13.2) Change in fair value of hedging instrument recognized in OCI for the year (63.7) (20.0) (83.7) — (83.7) Reclassified to cost of goods sold — 0.2 0.2 — 0.2 Reclassified from OCI to finance costs 66.2 — 66.2 — 66.2 Deferred tax (0.2) 6.2 6.0 — 6.0 Balance as of December 31, 2020 (4.5) (20.0) (24.5) — (24.5) Reallocation for IFRS 9 changes to policy (start of the year) 2.8 — 2.8 (4.4) (1.6) Transferred to the carrying value of inventory — 27.6 27.6 — 27.6 Change in fair value of hedging instrument recognized in OCI for the year 73.3 9.3 82.6 2.4 85.0 Reclassified from OCI to finance costs (64.1) — (64.1) 1.7 (62.4) Deferred tax (2.4) (11.1) (13.5) (0.1) (13.6) Balance as of December 31, 2021 5.1 5.8 10.9 (0.4) 10.5

Founder Preferred Shares Divide

Founder Preferred Shares Dividend Reserve	12 Months Ended
	Dec. 31, 2021
Share Capital, Reserves and Other Equity Interest [Abstract]
Founder Preferred Shares Dividend reserve	Share-based compensation reserve The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors. All Awards are to be settled by physical delivery of shares. Note 8(b) sets out the Non-Executive Director and Director and Senior Management Restricted share awards. Share based €m Balance as of January 1, 2021 8.3 Non-Executive Director restricted share awards charge 0.8 Directors and Senior Management share awards charge 4.3 Shares issued upon vesting of awards (0.7) Reclassification of awards for settlement of tax liabilities (5.8) Balance as of December 31, 2021 6.9 Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25. The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year. The Preferred Shares Annual Dividend amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts (currently $25.2127) multiplied by 140,220,619 Preferred Share Dividend Equivalent (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding. The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association. Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred. On December 31, 2019, the Company’s Board of Directors approved a share dividend of an aggregate of 6,421,074 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2018 dividend price of $16.7538 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $21.7289 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2019) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2020. On December 31, 2020, the Company’s Board of Directors approved a share dividend of an aggregate of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by the Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2020) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 4, 2021. As of December 31, 2021, no Founder Preferred Shares Annual Dividend Amount was due, as the average price per ordinary share for the last ten consecutive trading days of the year did not reach the previously achieved 2020 Dividend Price of $25.2127. Founder €m Balance as of January 1, 2021 245.5 Settlement of dividend through share issue (79.5) Balance as of December 31, 2021 166.0 The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary. Year ended December 31, 2021 2020 2019 €m €m €m Balance as of January 1 84.7 94.8 88.8 Adjustment on adoption of hedge accounting under IFRS 9 1.6 — — Restated balance as of January 1 86.3 94.8 88.8 Foreign currency translation adjustments 31.7 (23.6) 19.2 Net deferred (losses)/gains on net investment hedges (1) (12.9) 13.5 (13.2) Total presented in Other Comprehensive Income 18.8 (10.1) 6.0 Balance as of December 31 105.1 84.7 94.8 (1) (Losses)/gains on net investment hedges are offset by €24.6 million of gains (2020: losses of €25.7 million, 2019: gains of €19.0 million) on GBP net investments included within the foreign currency translation adjustments. The translation reserve as at December 31, 2021 does not include any balances relating to continuing hedging relationships. As at December 31, 2020, the translation reserve included €17.3 million relating to continuing hedging relationships in respect of GBP net investments. The translation reserve as at December 31, 2021 included €50.8 million (2020: €46.4 million) relating to a discontinued hedging relationship in respect of GBP net investments. Under IFRS, cost of hedging allows firms to separately account for the fair value movement attributable to foreign currency basis under other comprehensive income (OCI) thereby excluding its impact from the hedge designation itself. Details of the Company's cash flow hedge accounting is detailed in Note 33. The table below shows the movement in the cash flow hedging reserve and cost of hedging reserve during the year, including the gains or losses arising on the revaluation of hedging instruments during the year and the amount reclassified from Other Comprehensive Income ("OCI") to the Consolidated Statement of Profit or Loss in the year. Cross currency interest rate swaps Forward currency contracts Total Cash flow hedge reserve Cost of Hedging reserve Total Other reserves €m €m €m €m €m Balance as of January 1, 2019 0.9 7.6 8.5 — 8.5 Change in fair value of hedging instrument recognized in OCI for the year 28.1 3.8 31.9 — 31.9 Reclassified to cost of goods sold — (21.8) (21.8) — (21.8) Reclassified from OCI to finance costs (37.4) — (37.4) — (37.4) Deferred tax 1.6 4.0 5.6 — 5.6 Balance as of December 31, 2019 (6.8) (6.4) (13.2) — (13.2) Change in fair value of hedging instrument recognized in OCI for the year (63.7) (20.0) (83.7) — (83.7) Reclassified to cost of goods sold — 0.2 0.2 — 0.2 Reclassified from OCI to finance costs 66.2 — 66.2 — 66.2 Deferred tax (0.2) 6.2 6.0 — 6.0 Balance as of December 31, 2020 (4.5) (20.0) (24.5) — (24.5) Reallocation for IFRS 9 changes to policy (start of the year) 2.8 — 2.8 (4.4) (1.6) Transferred to the carrying value of inventory — 27.6 27.6 — 27.6 Change in fair value of hedging instrument recognized in OCI for the year 73.3 9.3 82.6 2.4 85.0 Reclassified from OCI to finance costs (64.1) — (64.1) 1.7 (62.4) Deferred tax (2.4) (11.1) (13.5) (0.1) (13.6) Balance as of December 31, 2021 5.1 5.8 10.9 (0.4) 10.5

Translation reserve Translation

Translation reserve Translation reserve (Notes)	12 Months Ended
	Dec. 31, 2021
Disclosure of share capital, reserves and other equity interest [Abstract]
Share-based compensation reserve	Share-based compensation reserve The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors. All Awards are to be settled by physical delivery of shares. Note 8(b) sets out the Non-Executive Director and Director and Senior Management Restricted share awards. Share based €m Balance as of January 1, 2021 8.3 Non-Executive Director restricted share awards charge 0.8 Directors and Senior Management share awards charge 4.3 Shares issued upon vesting of awards (0.7) Reclassification of awards for settlement of tax liabilities (5.8) Balance as of December 31, 2021 6.9 Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25. The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year. The Preferred Shares Annual Dividend amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts (currently $25.2127) multiplied by 140,220,619 Preferred Share Dividend Equivalent (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding. The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association. Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred. On December 31, 2019, the Company’s Board of Directors approved a share dividend of an aggregate of 6,421,074 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2018 dividend price of $16.7538 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $21.7289 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2019) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2020. On December 31, 2020, the Company’s Board of Directors approved a share dividend of an aggregate of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by the Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2020) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 4, 2021. As of December 31, 2021, no Founder Preferred Shares Annual Dividend Amount was due, as the average price per ordinary share for the last ten consecutive trading days of the year did not reach the previously achieved 2020 Dividend Price of $25.2127. Founder €m Balance as of January 1, 2021 245.5 Settlement of dividend through share issue (79.5) Balance as of December 31, 2021 166.0 The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary. Year ended December 31, 2021 2020 2019 €m €m €m Balance as of January 1 84.7 94.8 88.8 Adjustment on adoption of hedge accounting under IFRS 9 1.6 — — Restated balance as of January 1 86.3 94.8 88.8 Foreign currency translation adjustments 31.7 (23.6) 19.2 Net deferred (losses)/gains on net investment hedges (1) (12.9) 13.5 (13.2) Total presented in Other Comprehensive Income 18.8 (10.1) 6.0 Balance as of December 31 105.1 84.7 94.8 (1) (Losses)/gains on net investment hedges are offset by €24.6 million of gains (2020: losses of €25.7 million, 2019: gains of €19.0 million) on GBP net investments included within the foreign currency translation adjustments. The translation reserve as at December 31, 2021 does not include any balances relating to continuing hedging relationships. As at December 31, 2020, the translation reserve included €17.3 million relating to continuing hedging relationships in respect of GBP net investments. The translation reserve as at December 31, 2021 included €50.8 million (2020: €46.4 million) relating to a discontinued hedging relationship in respect of GBP net investments. Under IFRS, cost of hedging allows firms to separately account for the fair value movement attributable to foreign currency basis under other comprehensive income (OCI) thereby excluding its impact from the hedge designation itself. Details of the Company's cash flow hedge accounting is detailed in Note 33. The table below shows the movement in the cash flow hedging reserve and cost of hedging reserve during the year, including the gains or losses arising on the revaluation of hedging instruments during the year and the amount reclassified from Other Comprehensive Income ("OCI") to the Consolidated Statement of Profit or Loss in the year. Cross currency interest rate swaps Forward currency contracts Total Cash flow hedge reserve Cost of Hedging reserve Total Other reserves €m €m €m €m €m Balance as of January 1, 2019 0.9 7.6 8.5 — 8.5 Change in fair value of hedging instrument recognized in OCI for the year 28.1 3.8 31.9 — 31.9 Reclassified to cost of goods sold — (21.8) (21.8) — (21.8) Reclassified from OCI to finance costs (37.4) — (37.4) — (37.4) Deferred tax 1.6 4.0 5.6 — 5.6 Balance as of December 31, 2019 (6.8) (6.4) (13.2) — (13.2) Change in fair value of hedging instrument recognized in OCI for the year (63.7) (20.0) (83.7) — (83.7) Reclassified to cost of goods sold — 0.2 0.2 — 0.2 Reclassified from OCI to finance costs 66.2 — 66.2 — 66.2 Deferred tax (0.2) 6.2 6.0 — 6.0 Balance as of December 31, 2020 (4.5) (20.0) (24.5) — (24.5) Reallocation for IFRS 9 changes to policy (start of the year) 2.8 — 2.8 (4.4) (1.6) Transferred to the carrying value of inventory — 27.6 27.6 — 27.6 Change in fair value of hedging instrument recognized in OCI for the year 73.3 9.3 82.6 2.4 85.0 Reclassified from OCI to finance costs (64.1) — (64.1) 1.7 (62.4) Deferred tax (2.4) (11.1) (13.5) (0.1) (13.6) Balance as of December 31, 2021 5.1 5.8 10.9 (0.4) 10.5

Cash flow hedging reserve

Cash flow hedging reserve	12 Months Ended
	Dec. 31, 2021
Share Capital, Reserves and Other Equity Interest [Abstract]
Cash flow hedging reserve	Share-based compensation reserve The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors. All Awards are to be settled by physical delivery of shares. Note 8(b) sets out the Non-Executive Director and Director and Senior Management Restricted share awards. Share based €m Balance as of January 1, 2021 8.3 Non-Executive Director restricted share awards charge 0.8 Directors and Senior Management share awards charge 4.3 Shares issued upon vesting of awards (0.7) Reclassification of awards for settlement of tax liabilities (5.8) Balance as of December 31, 2021 6.9 Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25. The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year. The Preferred Shares Annual Dividend amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts (currently $25.2127) multiplied by 140,220,619 Preferred Share Dividend Equivalent (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding. The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association. Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred. On December 31, 2019, the Company’s Board of Directors approved a share dividend of an aggregate of 6,421,074 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2018 dividend price of $16.7538 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $21.7289 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2019) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2020. On December 31, 2020, the Company’s Board of Directors approved a share dividend of an aggregate of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by the Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2020) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 4, 2021. As of December 31, 2021, no Founder Preferred Shares Annual Dividend Amount was due, as the average price per ordinary share for the last ten consecutive trading days of the year did not reach the previously achieved 2020 Dividend Price of $25.2127. Founder €m Balance as of January 1, 2021 245.5 Settlement of dividend through share issue (79.5) Balance as of December 31, 2021 166.0 The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary. Year ended December 31, 2021 2020 2019 €m €m €m Balance as of January 1 84.7 94.8 88.8 Adjustment on adoption of hedge accounting under IFRS 9 1.6 — — Restated balance as of January 1 86.3 94.8 88.8 Foreign currency translation adjustments 31.7 (23.6) 19.2 Net deferred (losses)/gains on net investment hedges (1) (12.9) 13.5 (13.2) Total presented in Other Comprehensive Income 18.8 (10.1) 6.0 Balance as of December 31 105.1 84.7 94.8 (1) (Losses)/gains on net investment hedges are offset by €24.6 million of gains (2020: losses of €25.7 million, 2019: gains of €19.0 million) on GBP net investments included within the foreign currency translation adjustments. The translation reserve as at December 31, 2021 does not include any balances relating to continuing hedging relationships. As at December 31, 2020, the translation reserve included €17.3 million relating to continuing hedging relationships in respect of GBP net investments. The translation reserve as at December 31, 2021 included €50.8 million (2020: €46.4 million) relating to a discontinued hedging relationship in respect of GBP net investments. Under IFRS, cost of hedging allows firms to separately account for the fair value movement attributable to foreign currency basis under other comprehensive income (OCI) thereby excluding its impact from the hedge designation itself. Details of the Company's cash flow hedge accounting is detailed in Note 33. The table below shows the movement in the cash flow hedging reserve and cost of hedging reserve during the year, including the gains or losses arising on the revaluation of hedging instruments during the year and the amount reclassified from Other Comprehensive Income ("OCI") to the Consolidated Statement of Profit or Loss in the year. Cross currency interest rate swaps Forward currency contracts Total Cash flow hedge reserve Cost of Hedging reserve Total Other reserves €m €m €m €m €m Balance as of January 1, 2019 0.9 7.6 8.5 — 8.5 Change in fair value of hedging instrument recognized in OCI for the year 28.1 3.8 31.9 — 31.9 Reclassified to cost of goods sold — (21.8) (21.8) — (21.8) Reclassified from OCI to finance costs (37.4) — (37.4) — (37.4) Deferred tax 1.6 4.0 5.6 — 5.6 Balance as of December 31, 2019 (6.8) (6.4) (13.2) — (13.2) Change in fair value of hedging instrument recognized in OCI for the year (63.7) (20.0) (83.7) — (83.7) Reclassified to cost of goods sold — 0.2 0.2 — 0.2 Reclassified from OCI to finance costs 66.2 — 66.2 — 66.2 Deferred tax (0.2) 6.2 6.0 — 6.0 Balance as of December 31, 2020 (4.5) (20.0) (24.5) — (24.5) Reallocation for IFRS 9 changes to policy (start of the year) 2.8 — 2.8 (4.4) (1.6) Transferred to the carrying value of inventory — 27.6 27.6 — 27.6 Change in fair value of hedging instrument recognized in OCI for the year 73.3 9.3 82.6 2.4 85.0 Reclassified from OCI to finance costs (64.1) — (64.1) 1.7 (62.4) Deferred tax (2.4) (11.1) (13.5) (0.1) (13.6) Balance as of December 31, 2021 5.1 5.8 10.9 (0.4) 10.5

Earnings_(loss) per share

Earnings/(loss) per share	12 Months Ended
	Dec. 31, 2021
Earnings per share [abstract]
Earnings/(loss) per share	Earnings per share Basic earnings per share Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Profit for the period attributable to equity owners of the parent (€m) 181.0 225.2 154.0 Weighted average Ordinary Shares and Founder Preferred Shares 178,070,770 194,019,070 192,004,803 Basic earnings per share (€’s) 1.02 1.16 0.80 For the year ended December 31, 2021, basic earnings per share is calculated by dividing the profit attributable to the shareholders of the Company of €181.0 million (year ended December 31, 2020: €225.2 million, year ended December 31, 2019: €154.0 million) by the weighted average number of Ordinary Shares of 176,570,770 (December 31, 2020: 192,519,070, year ended December 31, 2019: 190,504,803) and Founder Preferred Shares of 1,500,000 (December 31, 2020: 1,500,000, year ended December 31, 2019: 1,500,000). Diluted earnings per share Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Profit for the period attributable to equity owners of the parent (€m) 181.0 225.2 154.0 Weighted average Ordinary Shares and Founder Preferred Shares 178,070,770 197,894,106 198,425,877 Diluted earnings per share (€’s) 1.02 1.14 0.78

Reconciliation of liabilities a

Reconciliation of liabilities arising from financing activities	12 Months Ended
	Dec. 31, 2021
Disclosure of reconciliation of liabilities arising from financing activities [abstract]
Reconciliation of liabilities arising from financing activities	Reconciliation of liabilities arising from financing activities The table below details changes in the Company's liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flows were, or future cash flows will be classified in the Company's consolidated statements of cash flows from financing activities. Cash / non-cash Total loans and borrowings (Note 21) Financial payables (Note 22) Derivatives: (Net) Fair value of forward foreign exchange and currency swap contracts FVPTL Derivatives: (Net) Fair value of cross currency interest rate swaps €m €m €m €m Opening balance January 1, 2021 1,758.8 3.3 0.2 72.3 Cash inflow (1) Cash 800.0 — 0.3 1.4 Cash outflow (2) Cash (436.0) (38.1) — (2.3) Interest accretion (3) Cash 2.2 57.6 — — Acquired through business combinations Non-cash 19.6 — — — Exchange movement Non-cash 64.1 (0.2) — — Fair value changes Non-cash — — (0.1) (44.0) Other non-cash adjustments Non-cash 18.7 (2.9) — (6.8) Closing balance December 31, 2021 2,227.4 19.7 0.4 20.6 Cash / non-cash Total loans and borrowings (Note 21) Financial payables (Note 22) Derivatives: (Net) Fair value of forward foreign exchange and currency swap contracts FVPTL Derivatives: (Net) Fair value of cross currency interest rate swaps €m €m €m €m Opening balance January 1, 2020 1,875.3 4.1 (0.2) 15.3 Cash inflow (1) Cash — — — 6.8 Cash outflow (2) Cash (32.0) (57.0) (2.2) (3.9) Interest accretion (3) Cash 5.2 58.8 — — Acquired through business combinations Non-cash 0.4 — — — Exchange movement Non-cash (71.7) 0.9 — — Fair value changes Non-cash — — 2.6 54.1 Other non-cash adjustments Non-cash (18.4) (3.5) — — Closing balance December 31, 2020 1,758.8 3.3 0.2 72.3 (1) Cash inflows from cross currency interest rate swaps are part of effective cash flow hedging relationships and are presented within interest paid within the Consolidated Statements of Cash Flows. (2) Cash outflows from cross currency interest rate swaps are not part of a cash flow hedge and are presented within proceeds on settlement of derivatives within the Consolidated Statements of Cash Flows.

Cash flows from operating activ

Cash flows from operating activities	12 Months Ended
	Dec. 31, 2021
Cash Flow Statement [Abstract]
Cash flows from operating activities	Cash flows from operating activities Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Note €m €m €m Cash flows from operating activities Profit for the period 181.0 225.1 153.6 Adjustments for: Exceptional items 7 45.3 20.6 54.5 Non-cash fair value purchase price adjustment of inventory 5 8.4 — — Share based payments expense 5.1 9.0 14.9 Depreciation and amortization 71.6 67.6 68.3 Loss on disposal and impairment of property, plant and equipment 0.7 0.9 0.6 Net finance costs 10 106.0 63.7 73.2 Taxation 11 55.7 70.4 56.7 Operating cash flow before changes in working capital, provisions and exceptional items 473.8 457.3 421.8 (Increase)/decrease in inventories (23.8) (12.7) 23.5 Decrease/(increase) in trade and other receivables 24.1 (1.8) (34.4) (Decrease)/increase in trade and other payables (25.0) 107.2 (40.6) Increase in employee benefit and other provisions 1.2 2.0 6.6 Cash generated from operations before tax and exceptional items 450.3 552.0 376.9

Financial instruments

Financial instruments	12 Months Ended
	Dec. 31, 2021
Financial Instruments [Abstract]
Financial instruments	The effects of the cash flow hedging instruments on the Company's financial position and performance are as follows: All amounts stated in €m, unless otherwise stated December 31, 2021 December 31, 2020 USD - cross currency interest rate swaps Carrying amount of liability (20.6) (89.5) Notional amount (USD) $916.4 $926.0 Maturity date 5/15/2024 5/15/2022 Change in fair value of outstanding hedging instruments since January 1 68.9 (71.0) (Gain)/loss in value of hedged item used to determine effectiveness (69.6) 71.0 Weighted average hedged rate for the year 1.11 1.11 The effects of the net investment hedging instruments on the Company's financial position and performance are as follows: All amounts stated in €m, unless otherwise stated December 31, 2021 December 31, 2020 UK cross-currency interest rate swaps hedge Carrying amount of cross-currency interest rate swaps — 14.3 Notional amount (GBP) — £220.2 Maturity date 7/29/2021 5/15/2022 Change in fair value of cross-currency interest rate swaps as a result of foreign currency movements since January 1 (12.9) 13.5 Loss/(gain) in value of hedged item used to determine hedge effectiveness 12.9 (13.5) Weighted average hedged rate for the year 1.19 1.19 As at December 31, 2021 EUR/USD GBP/USD GBP/EUR SEK/EUR SEK/USD Other Currencies €m €m €m €m €m €m Derivative financial instruments - forward currency contracts Carrying amount of (liability)/asset 17.5 1.2 (6.7) 0.5 0.1 0.3 Notional amount 343.6 58.4 244.7 70.4 4.5 96.4 Fair value (gains)/losses of outstanding hedging instruments since January 1 (26.3) (0.5) 12.0 (0.9) 13.5 0.6 Weighted average hedge rate for the year 1.20 1.38 1.15 0.10 0.11 — As at December 31, 2020 EUR/USD GBP/USD GBP/EUR SEK/EUR SEK/USD Other Currencies €m €m €m €m €m €m Derivative financial instruments - forward currency contracts Carrying amount of asset/(liability) (21.9) (3.7) 1.4 (4.0) (2.6) (0.5) Notional amount 249.0 53.5 159.0 77.3 14.1 16.8 Fair value (gains)/losses of outstanding hedging instruments since January 1 (20.6) (2.0) 8.5 (4.2) (2.2) 0.8 Weighted average hedge rate for the year 1.13 1.28 1.12 0.09 0.10 0.21 Categories of financial instruments The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 'Financial Instruments'. Financial assets at amortized cost Financial Assets at Fair Value through profit or loss Derivatives at Derivatives designated in hedge relationships Financial Total 2021 €m €m €m €m €m €m Assets Trade and other receivables 201.6 — — — — 201.6 Derivative financial instruments — — 0.5 19.7 — 20.2 Cash and cash equivalents 254.2 — — — — 254.2 Liabilities Trade and other payables excluding non-financial liabilities — — — — (647.1) (647.1) Derivative financial instruments — — (0.1) (28.0) — (28.1) Loans and borrowings (1) — — — — (2,236.8) (2,236.8) Total 455.8 — 0.4 (8.3) (2,883.9) (2,436.0) (1) Loans and borrowings excludes €9.4 million of deferred borrowing costs which are included within €2,227.4 million of total loans and borrowings in Note 21. Financial assets at amortized cost Financial Assets at Fair Value through profit or loss Derivatives at Derivatives designated in hedge relationships Financial Total 2020 €m €m €m €m €m €m Assets Trade and other receivables 141.2 — — — — 141.2 Derivative financial instruments — — 2.9 19.8 — 22.7 Cash and cash equivalents 393.2 — — — — 393.2 Short - term investments — 25.0 — — — 25.0 Liabilities Trade and other payables excluding non-financial liabilities — — — — (601.1) (601.1) Derivative financial instruments — — (0.2) (124.8) — (125.0) Loans and borrowings (2) — — — — (1,765.7) (1,765.7) Total 534.4 25.0 2.7 (105.0) (2,366.8) (1,909.7) (2) Loans and borrowings excludes €6.9 million of deferred borrowing costs which are included within €1,758.8 million of total non-current loans and borrowings in Note 21. Fair values Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, Nomad uses various methods including market, income and cost approaches. Based on these approaches, Nomad utilizes certain assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs may be readily observable, market corroborated, or generally unobservable inputs. The fair value hierarchy ranks the quality and reliability of the information used to determine fair values. Financial assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories: Level 1—Quoted prices for identical assets and liabilities traded in active exchange markets, such as the New York Stock Exchange. Level 2—Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data. Level 3—Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation; also includes observable inputs for non binding single dealer quotes not corroborated by observable market data. Where market information is not available to support internal valuations, reviews of third party valuations are performed. While Nomad believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The following is a description of the valuation methodologies and assumptions used for estimating the fair values of financial instruments held by the Company. (i) Derivative financial instruments Derivative financial instruments are held at fair value. There is no difference between carrying value and fair value. The valuation technique utilized by the Company maximizes the use of observable market data where it is available. All significant inputs required to fair value the instrument are observable. The Company has classified its derivative financial instruments as level 2 instruments as defined in IFRS 13 ‘Fair value measurement’. (ii) Trade and other payables/receivables The notional amount of trade and other payables/receivables are deemed to be carried at fair value, short term and settled in cash. (iii) Cash and cash equivalents The carrying value of cash and cash equivalents is deemed to equal fair value. (iv) Short-term investments Short-term investments are valued using inputs that are derived principally from or corroborated by observable market data. The Company has classified these as level 2 instruments as defined in IFRS 13 “Fair value measurement”. (v) Interest bearing loans and liabilities The fair value of secured notes is determined by reference to price quotations in the active market in which they are traded. They are classified as level 1 instruments. The fair value of the senior loans is calculated by discounting the expected future cash flows at the year end’s prevailing interest rates. They are classified as level 2 instruments. There is no requirement to determine or disclose the fair value of lease liabilities. On June 24, 2021, the Company through its indirect, wholly-owned subsidiary, Nomad Foods Bondco Plc, repaid the €400.0 million 3.25% senior secured notes due 2024 and completed a private offering of €750.0 million aggregate principal amount of 2.5% senior secured notes due June 24, 2028 (the “Notes”). Interest on the Notes accrues from the date of issue and is payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2022. The Notes are guaranteed on a senior basis by the Company and certain subsidiaries thereof. This transaction was accounted for as an extinguishment of the existing Notes and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Notes, eligible transaction costs of approximately €4.0 million were capitalized and will be amortized over the life of the debt. On July 9, 2021 the Company announced that Nomad Foods Bondco Plc, an indirect, wholly-owned subsidiary of the Company, completed its private offering of €50.0 million aggregate principal amount of additional 2.5% senior secured notes due 2028, representing a tack-on to the €750.0 million aggregate principal amount of senior secured notes due 2028 issued on June 24, 2021, and issued at a price of €100.75. On June 24, 2021, the Company amended and restated the Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility originally due in May 2024, through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. This transaction was accounted for as an extinguishment of the existing debt and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Senior EUR Loan, eligible transaction costs of approximately €3.8 million were capitalized and will be amortized over the life of the debt. Under the refinancing, the existing revolving credit facility of €80.0 million due 2023, was replaced with a new €175.0 million facility (the "Revolving Credit Facility") available until June 2026 with an applicable margin of 2.25% per annum and that includes a leverage ratchet. The Revolving Credit Facility may be utilized to support working capital requirements, including letters of credit and bank guarantees. The structure of the Revolving Credit Facility now also includes a pricing structure linked to environmental impact metrics during the life of the facility, and by doing so demonstrates further commitment to the Company’s sustainability strategy by incorporating ESG target KPIs covering areas of sourcing, packaging and carbon emissions. The Company continues to have outstanding senior USD loans as at December 31, 2021 of $916.4 million (€808.6 million) (the “Senior USD Loan”). The Senior USD Loan is repayable in May 2024. The Senior USD Loan requires a repayment of $9.6 million (€8.5 million) in May each year until maturity equivalent to 1.0% of the original issued notional. Furthermore as part of the senior loan structure, the Company is additionally required to undertake an annual excess cash flow calculation whereby additional principal could be paid. The Company uses cross currency interest rate swaps (“CCIRS”) to convert its $916.4 million of floating rate Senior USD Loans into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge. On July 29, 2021 the Company extended its CCIRS used to hedge the foreign currency and interest rate risk on the current Senior Secured USD Term Loan from May 2022 to May 2024 to align with the maturity date of the USD Term Loan. As part of the transaction, the EUR fixed rate paid by the Company has been amended and reflected in the underlying interest cost. The transaction is considered to be a substantial modification of the hedging instruments, so is considered to be a new hedging relationship which will give rise to some ineffectiveness in future periods. CCIRS contracts that have previously been used as a net investment hedge of the Company’s investments in Pound Sterling have also been extinguished. A change in fair value of the CCIRS arose as a consequence of the transaction, which the Company has elected to write-off immediately as a cost of extinguishment. This non-cash loss, as well as the write-off of the cost of hedging reserves associated with the discontinued net investment hedge, are presented as a one-off charge for the transaction as disclosed in Note 10. The cash flow hedge reserve related to the previous hedge relationship will be released on a straight line basis until May 2022. The senior loans, Senior Secured Notes and any drawn balances of the Revolving Credit Facility are secured with equal ranking against assets of the Company and specified subsidiaries. Fair value Carrying value December 31, 2021 December 31, 2020 December 31, 2021 December 31, 2020 €m €m €m €m Senior EUR/USD loans 1,360.8 1,300.4 1,355.8 1,295.1 Other external debt 0.1 0.2 0.1 0.2 2024 fixed rate senior secured notes — 405.8 — 400.0 2028 fixed rate senior secured notes 802.6 — 800.0 — Less deferred borrowing costs — — (9.4) (6.9) 2,163.5 1,706.4 2,146.5 1,688.4 Derivatives As at December 31, 2021 As at December 31, 2020 €m €m Cross Currency Interest Rate Swaps — 17.2 Forward foreign exchange contracts 20.2 5.5 Total assets 20.2 22.7 Cross Currency Interest Rate Swaps (20.6) (89.5) Forward foreign exchange contracts (7.3) (35.5) Total liabilities (27.9) (125.0) Total (7.7) (102.3) Offsetting of derivatives Derivative contracts are held under International Swaps and Derivatives Association (ISDA) agreements with financial institutions. An ISDA is an enforceable master netting agreement that permits the Company to settle net in the event of default. The following table sets out the carrying amounts of recognized financial instruments that are subject to the above agreements. Gross amount Related Net amount As at Dec 31, 2021 €m €m €m Derivatives - assets 20.2 (10.8) 9.4 Derivatives - liabilities (27.9) 10.8 (17.1) Gross amount Related Net amount As at Dec 31, 2020 €m €m €m Derivatives - assets 22.7 (22.7) — Derivatives - liabilities (125.0) 22.7 (102.3)

Commitments

Commitments	12 Months Ended
	Dec. 31, 2021
Leases1 [Abstract]
Commitments	Commitments Future aggregate minimum contractual payments under non-cancellable service agreements and lease rentals for short-lived and low-value assets are payable as follows: As at December 31, 2021 As at December 31, 2020 €m €m Less than one year 2.2 1.9 Between one and three years 4.1 3.5 Between three and five years 2.2 2.0 More than five years 0.2 0.1 Total 8.7 7.5 These agreements may be subject to contractual annual increases linked to inflation indices. The payments shown above exclude the impact of these contractual increases which cannot be reliably estimated.

Capital commitments

Capital commitments	12 Months Ended
	Dec. 31, 2021
Additional information [abstract]
Capital commitments	Capital commitments Capital expenditure contracted for at the end of the reporting period but not yet incurred is as follows: As at December 31, 2021 As at December 31, 2020 €m €m Property, plant and equipment 21.3 13.6 Intangible assets 1.7 3.4 Total 23.0 17.0

Related parties

Related parties	12 Months Ended
	Dec. 31, 2021
Related Party [Abstract]
Related parties	Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 €m €m €m Short-term employee benefits 2.2 3.9 2.8 Share-based payment expense 2.4 3.5 7.6 Non-Executive Director fees 0.3 0.3 0.4 Total Directors' and executive officers' compensation 4.9 7.7 10.8

Significant events after the St

Significant events after the Statement of Financial Position date	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2015
Events After Reporting Period [Abstract]
Preference shares, dividend payment terms, weighted average share price, minimum term required		10 days
Significant events after the Statement of Financial Position date	Significant events after the Statement of Financial Position date

Basis of preparation Summary of

Basis of preparation Summary of adjustments arising form application of IFRS 9 (Policies)	12 Months Ended
	Dec. 31, 2021
Disclosure of notes and other explanatory information [Abstract]
IFRS 9 'Financial Instruments'	Recently Issued and Not Yet Adopted Accounting Pronouncements under IFRS Amendments to IAS 12 - Deferred Tax related to Assets and Liabilities arising from a Single Transaction In May 2021, the International Accounting Standards Board issued targeted amendments to IAS 12, Income Taxes. The amendments are effective for annual periods beginning on or after January 1, 2023, although earlier application is permitted. With a view to reducing diversity in reporting, the amendments will clarify that companies are required to recognize deferred taxes on transactions where both assets and liabilities are recognized, such as with leases and asset retirement (decommissioning) obligations. Based upon our current facts and circumstances, we do not expect our financial performance or disclosure to be materially affected by the application of the amended standard.
Amended standards early adopted	Adoption of new accounting standards - IFRS 9 'Financial Instruments' IFRS 9 ‘Financial Instruments’ was issued in July 2014 and replaced IAS 39 ‘Financial Instruments: Recognition and Measurement.’ The Company had previously elected to continue hedge accounting under IAS 39 as was allowed by the standard. On January 1, 2021, the Company adopted hedge accounting under IFRS 9, as the hedge accounting requirements have been simplified and are more closely aligned to the Company's risk management strategy. Under IFRS 9 all existing hedging relationships qualified as continuing hedging relationships. The Company applied IFRS 9 hedge accounting prospectively, "except for application of the cost of hedging approach". The Company has elected the cost of hedging approach for the fair value movement of all hedging instruments, whereby the movements will be recognized within equity, to the extent that they relate to the hedged item. As permitted by the standard, adjustments required as a result of adopting the cost of hedging approach, have been made to the opening Consolidated Statement of Changes in Equity. As such, prior year comparatives have not been restated. A summary of adjustments arising from application of IFRS 9 for hedge accounting as of January 1, 2021 are as follows: Opening Balance Impact of change in policy Opening Balance January 1, 2021 Cash flow hedge reserve (24.5) 2.8 (21.7) Cost of hedging reserve — (4.4) (4.4) Other reserves (24.5) (1.6) (26.1) Translation reserve 84.7 1.6 86.3 The Company's policy is to reduce its risk of foreign exchange movements on forecasted transactions (such as purchases of raw materials) in currencies other than the operating entity's functional currency using forward foreign exchange contracts designated as cash flow hedges. Under IFRS 9, in cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition. The Company has elected to apply this accounting policy prospectively and therefore as at January 1, 2021 any existing hedges of non-financial items (such as inventory) that were already recognized in the Consolidated Statement of Financial Position, did not result in an opening balance transfer out of equity to the non-financial item as a result of the transition to IFRS 9. For the year ended December 31, 2021, €27.6 million was recognized as deferred hedging gains transferred to the carrying value of inventory. This is not a reclassification adjustment and will not be recognized in the Consolidated Statement of Other Comprehensive Income for the period. Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 – Interest Rate Benchmark Reform (Phase 2) In August 2020, the IASB issued Interest Rate Benchmark Reform (Phase 2), which amends other IFRS standards. The amendments provide temporary reliefs which address the financial reporting effects when an interbank offered rate (IBOR) is replaced with an alternative nearly risk-free interest rate (RFR). The amendments in this final phase relate to practical expedient for particular changes in contractual cash flows, relief from specific hedge accounting requirements and certain disclosure requirement. On June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing revolving credit facility of €80.0 million and replace it with a new €175.0 million facility, paying interest rate applicable to the respective drawn down currency. Per the restated Senior Facilities Agreement, the Sterling Overnight Index Average (“SONIA”) has replaced GBP LIBOR and is effective immediately if there is a drawdown on the facility. The Secured Overnight Financing Rate (“SOFR”) will replace USD LIBOR and Swiss Average Rate Overnight (“SARON”) will replace CHF LIBOR, when existing benchmark rates are replaced and borrowings are requested under the Facility. Equally, on June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. There is currently no indication of the timing of the phase-out of EURIBOR. The Company continues to assess changes in underlying markets and expects to be able to refinance its Senior EUR Loan once replacement reference rates become confirmed. The existing senior USD loan of $916.4 million (the "Senior USD Loan") paying interest at a rate per annum equal to LIBOR (subject to a zero floor) plus 2.25% per annum has not been refinanced during 2021. The Company uses cross currency interest rate swaps to convert cash flows payable under the Senior USD Loan into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge. The USD LIBOR phase out is expected to be completed by June 2023, and therefore in due course the Company will need to renegotiate the terms of our Senior Facilities Agreement with our lenders and amend the terms of linked interest rate hedging arrangements. Such an amendment is expected to be able to be achieved without material financial impact on the Company. The Amendments are effective for annual periods beginning on or after January 1, 2021. Phase 2 amendments will require the Company to account for a change in the basis for determining the cash flows of a financial asset or a financial liability measured at amortized cost, by updating the effective interest rates as required by IBOR reform. Management continues to assess implications as a result of these amendments on the wider business. These amendments had no impact on the financial statements of the Company for the year ended December 31, 2021. The Company intends to use the practical expedients in future periods as they become applicable.

Accounting policies (Policies)

Accounting policies (Policies)	12 Months Ended
	Dec. 31, 2021
Disclosure of types of insurance contracts [line items]
Measurement convention	Measurement conventionThe financial statements are prepared on the historical cost basis with the exception of derivative financial instruments, business combinations, share based payments, and founder preferred shares which are stated at fair value.
Business combination	Business combination The Company uses the acquisition method to account for business combinations. The consideration transferred for the acquisition of a subsidiary is the fair value of the assets transferred, the liabilities incurred and the equity interest issued by the Company. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. Acquisition-related costs are expensed as incurred. Non-controlling interests arise from business combinations in which the Company acquires less than a 100 per cent interest. Non-controlling interests are initially measured at either fair value or at the non-controlling interest’s proportionate share of the fair value of the acquiree’s identifiable net assets. Nomad determines on a transaction by transaction basis which measurement method is used. The excess of the consideration transferred, the amount of any non-controlling interests in the acquiree and the acquisition-date fair value of any previous equity interest in the acquiree over the fair value of the identifiable net assets is recorded as goodwill. Where selling shareholders have contractually agreed to indemnify Nomad Foods Limited for contingent liabilities, an indemnification asset is recognized equivalent to the fair value of the liability recognized by Nomad. The indemnification asset is deducted from consideration transferred for the business combination. The indemnification asset value will subsequently be revised where revisions are made to the value of the liability or where there are doubts over the ability to recover losses from the selling shareholders.
Basis of consolidation	Basis of consolidation The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions, and any unrealized income and expenses arising from intra-group transactions are eliminated. Accounting policies are applied consistently across the Company. Subsidiaries are all entities (including structured entities) over which Nomad has control; directly or indirectly. The Company controls an entity when the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. Where the Company owns less than a 100 per cent interest in a subsidiary, a non-controlling interest is recognized. The carrying amount of non-controlling interests is increased or decreased by the non-controlling interest’s share of subsequent changes in equity and payments to the non-controlling interest. Total comprehensive income is attributed to the non-controlling interests even if this results in the non-controlling interests having a negative balance.
Foreign currency	Foreign currency i) Foreign currency transactions Transactions in foreign currencies (currencies other than the functional currency of the transacting entity) are translated into the functional currency at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the functional currency at the foreign exchange rate ruling the financial year end. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates are generally recognized in profit or loss. They are deferred in equity if they relate to qualifying cash flow hedges, qualifying net investment hedges or are attributable to part of a net investment in a foreign operation. Non-monetary assets and liabilities in a foreign currency are translated into the functional currency to establish historical cost, using the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies that are stated at fair value are translated at foreign exchange rates ruling at the date the fair value was determined. Translation differences on assets and liabilities carried at fair value are reported as part of the fair value gain or loss. The revenues and expenses of foreign operations are translated at an average rate for the period (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated at the dates of the transaction). ii) Assets and liabilities of foreign operations For the purposes of presenting consolidated financial statements, the assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on consolidation, are translated at foreign exchange rates ruling at the financial year ended December 31, 2021 of £1:€1.19 (December 31, 2020: £1:€1.11). The revenues and expenses of foreign operations are translated at an average rate for the period where this rate approximates to the foreign exchange rates ruling at the dates of the transactions. The average rate used for year ended December 31, 2021 is £1:€1.16 (year ended December 31, 2020: £1:€1.13, year ended December 31, 2019: £1:€1.14). Foreign exchange gains and losses that relate to these assets and liabilities are presented in the Consolidated Statement of Profit or Loss within ‘finance income or costs’, except where hedge accounting applies. iii) Net investment in foreign operations Exchange differences arising from the translation of foreign operations and of any related qualifying hedges are taken directly to the translation reserve within equity. They are realized through the Consolidated Statement of Profit or Loss upon disposal of the related foreign operation.
Goodwill	Goodwill Goodwill represents amounts arising on acquisition of subsidiaries. Goodwill is the difference between the cost of the acquisition and the fair value of the net identifiable assets acquired. Goodwill is stated at cost less any accumulated impairment losses. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.
Other intangible assets	Other intangible assets Intangible assets acquired separately are recorded at cost and those acquired as part of a business combination are recorded at fair value as at the date of acquisition. i) Computer software Capitalized software costs include the cost of acquired computer software licenses and costs that are directly associated with the design, construction and testing of such software where this relates to a major business system. Costs associated with identifying, sourcing, evaluating or maintaining computer software are recognized as an expense within other operating expenses as incurred. The assets are stated at cost less accumulated amortization and impairment losses. Software costs are amortized by equal monthly installments over their estimated useful economic life of five ii) Brands Our largest brands, including Birds Eye , Iglo, Findus, Ledo and Frikom are considered to have indefinite lives. This is based on the market position of the brands, the significant levels of investment in advertising and promoting the brands, and the fact that they have been established for at least 20 years. Therefore these brands are not amortized, but instead held at historical cost less provision for any impairment. Brands that are deemed to not have an indefinite life are being amortized by equal monthly installments within other operating expenses over the course of their remaining useful economic life. iii) Customer relationships Long standing Food Service customer relationships have been identified as intangible assets as part of business combinations. These are deemed to not have an indefinite life and are being amortized by equal monthly installments within other operating expenses over their expected lives. The most significant of these assets were acquired as part of the Findus Acquisition in 2015 and are being amortized over 14 years.
Impairment of non-current assets	Impairment of non-current assets The carrying amounts of the Company’s non-current assets are reviewed annually to determine whether there is any indication of impairment. If any such indication exists, the asset’s recoverable amount is estimated. Impairment losses are recognized in the Consolidated Statement of Profit or Loss in the period in which they arise. For goodwill and assets that have an indefinite useful life an impairment review is performed at least annually. Assets that are subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the net carrying amount may not be recoverable. An impairment loss is recognized whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount. i) Calculation of recoverable amount Recoverable amount is the greater of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows of the business are discounted to their present value using a discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit to which the asset belongs. ii) Allocation of impairment losses Impairment losses recognized in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash-generating units, then to reduce the carrying amount of the other assets in the unit on a pro rata basis. A cash-generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets. iii) Reversals of impairment An impairment loss in respect of goodwill is not reversed. In respect of other assets, an impairment loss is reversed when there is an indication that the impairment loss may no longer exist and there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.
Property, plant and equipment	Property, plant and equipment i) Owned assets Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses. Cost includes the original purchase price of the asset and the costs attributable to bringing the asset to its working condition for its intended use. Where parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment. ii) Leased assets The Company leases various properties, equipment and cars. The Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Where a contract contains both lease and non-lease components, the Group has elected to account for the contract as a single lease. Leases are recognized as a right-of-use asset and a corresponding liability at the date at which the leased asset is available for use by the group. Each lease payment is allocated between the liability and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. The right-of-use asset is classified within property, plant and equipment and is depreciated over the shorter of the asset's useful life or the lease term on a straight-line basis. Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities are presented within loans and borrowings and include the net present value of expected lease payments, including those from extension options if the Company reasonably expects to exercise them. The lease payments are discounted using the interest rate implicit in the lease, if that rate can be determined, otherwise the Company’s incremental borrowing rate is used. Right-of-use assets are measured at cost comprising the amount of the lease liability, adjusted for payments made or received before the commencement date, initial direct costs and restoration costs. Payments associated with short-term leases and leases of low-value assets are recognized on a straight-line basis as an expense in profit or loss. Short-term leases are leases with a lease term of 12 months or less. Low-value assets primarily comprise IT equipment and small items of office furniture. iii) Depreciation Depreciation is charged to the Consolidated Statement of Profit or Loss on a straight line basis over the shorter of the lease term and the estimated useful lives of each part of an item of property, plant and equipment once the item is brought into use. Land is not depreciated. The estimated useful lives are as follows: • Buildings 40 years • Plant and equipment 5 to 14 years • Computer equipment 3 to 5 years The assets’ residual values and useful lives are reviewed on a frequent basis.
Inventories	InventoriesInventories are stated at the lower of cost and net realizable value. Cost is based on the weighted average principle and includes expenditure incurred in acquiring the inventories and bringing them to their existing location and condition. Inventories that are acquired through business combinations are fair valued at the time of acquisition. In the case of manufactured inventories and work in progress, cost includes an appropriate share of direct costs and overheads based on normal operating capacity. Provision is made for slow moving, obsolete and defective inventories.
Employee benefits	Employee benefits i) Defined contribution plans Obligations for contributions to defined contribution pension plans are recognized as an expense in the Consolidated Statement of Profit or Loss as incurred. Prepaid contributions are recognized as an asset to the extent that a cash refund or reduction in the future payments is available. ii) Defined benefit plans The Company’s net obligation in respect of defined benefit pension plans and other post-employment benefits is calculated separately for each plan by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. That net obligation is discounted to determine its present value. The calculation is performed by a qualified actuary using the projected unit credit method. The current service cost of the defined benefit plan, recognized in the Consolidated Statement of Profit or Loss in staff costs included within Operating profit/(loss), except where included in the cost of an asset, reflects the increase in the defined benefit obligation resulting from employee service in the current year, benefit changes, curtailments and settlements. Actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions are charged or credited to equity in Other Comprehensive Income in the period in which they arise. The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the Consolidated Statement of Profit or Loss. Past service cost is recognized immediately. iii) Share-based payment schemes Employee benefits given through share-based payment schemes are discussed further in section 3.15 of this note.
Founder Preferred Shares	Founder Preferred Shares Nomad Foods issued Founder Preferred Shares to both TOMS Acquisition I LLC and Mariposa Acquisition II, LLC (collectively the “Founder Entities”) in connection with its initial public offering in April 2014. Holders of the Founder Preferred Shares are entitled to receive annual dividend amounts subject to certain performance conditions (the “Founder Preferred Shares Dividend Amount”). The instrument and its component parts were analyzed under IFRS 2. The Company intends that any future Founder Preferred Shares Annual Dividend Amount will be equity settled. Accordingly, the Founder Preferred Shares Annual Dividend Amount as of June 1, 2015, of €531.5 million (the “Founder Preferred Shares Dividend reserve”) was classified as equity and no further revaluations will be required or recorded. Should a Founder Preferred Share Annual Dividend Amount become due and payable, the market value of any dividend paid will be deducted from the Founder Preferred Shares Dividend reserve, with any excess deducted from the accumulated profit/(deficit) reserve within equity.
Provisions/Onerous contracts provisions	ProvisionsProvisions are recognized when the Company has a legal or constructive present obligation as a result of a past event and it is probable that the Company will be required to settle that obligation. Provisions are measured at the Directors’ best estimate of the expenditure required to settle the obligation at the financial year end date and are discounted to present value where the effect is material.Where it is not possible to make a reliable estimate of the estimated financial effect of a provision, appropriate disclosure of the resulting contingent liability is made, but no provision is recognized.
Financial instruments	Financial instruments Financial assets and liabilities are recognized in the Company’s Statement of Financial Position when the Company becomes a party to the contractual provisions of the instrument. i) Trade receivables Trade receivables are amounts due from customers for goods sold when control of the products has transferred, being when the products are delivered in accordance with the contractual arrangements. At this point, there is no unfulfilled performance obligation that could affect the customer’s acceptance of the product, except for returns due to quality. The Company holds the trade receivables with the objective of collecting the contractual cash flows and so they are subsequently measured at amortized cost using the effective interest method, less any loss allowance. Since trade receivables are due within one year, this equates to initial carrying value less any loss allowance. To assist in managing operating cash flow, we may enter into non-recourse factoring arrangements with certain receivables whereby we sell specific account receivables to one or more external financial institutions. The risks and rewards of ownership are considered to have been transferred at the point of sale. Up to the point of sale, these receivables are treated as held for sale and measured at fair value through Profit or Loss. Under the terms of the contractual arrangements, the Company may continue to collect the cash from the customer receivables sold, albeit acting solely as a collecting agent on behalf of the purchaser of receivables. Any cash received from customers which is due to be paid to the agent is presented as a financial liability in the Statement of Financial Position and as a financing activity within the Statement of Cash Flows. Factoring fees associated with the sale of factored receivables were minimal for all periods presented. See Note 18. The Company applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables. Trade receivables are grouped by days past due. Expected loss rates are based on historical credit losses experienced in each market as well as forward looking information where this is significant. Trade receivables are written off when there is no reasonable expectation of recovery. Appropriate allowances for expected credit losses and estimated irrecoverable amounts are recognized in the Consolidated Statement of Profit or Loss. Trade receivables are presented net of associated contract liabilities, referred to as 'trade terms' as discussed further in Note 3.14 and Note 4. ii) Cash and cash equivalents Cash and cash equivalents comprise of cash balances and deposits that are readily convertible to a known amount of cash and are measured at amortized cost. Deposits held in money market funds are measured at fair value through Profit or Loss as the cash flows do not only represent principal and interest. iii) Loans and borrowings a. Valuation Interest bearing borrowings are recognized initially at fair value less attributable transaction costs. Subsequent to initial recognition, interest bearing loans and borrowings are stated at amortized cost with any difference between cost and redemption value being recognized in the Consolidated Statement of Profit or Loss over the expected period of the borrowings. b. Capitalization of transaction costs Fees paid on the establishment of loan facilities are recognized as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs. iv) Trade payables Trade payables are measured at initial recognition at fair value and are subsequently measured at amortized cost using the effective interest method. Since trade payables are largely due within one year, this equates to initial carrying value. v) Derivative financial instruments and hedge accounting Derivative financial instruments are recognized at fair value. When a derivative financial instrument is not designated in a hedge accounting relationship, all changes in its fair value are recognized immediately in the Consolidated Statement of Profit or Loss. However, where derivatives qualify for hedge accounting, recognition of any resultant gain or loss depends on the nature of the item being hedged. Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the Company has elected the cost of hedging approach for the fair value movement on currency basis spreads of all hedging relationships, whereby the movements will be recognized within equity, if material, to the extent that they relate to the hedged item. In cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition. The fair value of all financial derivative instruments (including but not limited to forward foreign exchange contracts, currency swaps and cross currency interest rates swaps), is determined per market standard using forward foreign exchange and interest rates at the balance sheet date, with the resulting value discounted back to present value. Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the Company applies the hedge accounting requirements of IFRS 9 to all hedging relationships. IAS 39 was beforehand with the impact of the changes disclosed in Note 2 Basis of preparation. a. Cash flow hedges Where a derivative financial instrument is designated as a hedge of the cash flow of a recognized asset or liability, (including a highly probable forecast transaction) the effective part of any gain or loss on the derivative financial instrument is recognized directly in the cash flow hedging reserve, within other reserves. Any ineffective portion of the hedge is recognized immediately in the Consolidated Statement of Profit or Loss. Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, if the result of a forecasted transaction is recognition of a non-financial asset (for example inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve (presented together as 'Other reserves') are included in the initial cost of the non-financial item upon its recognition. For all other hedged forecasted transactions, the amounts accumulated in the hedging reserve and cost of hedging reserve are reclassified to the Consolidated Statement of Profit or Loss in the same period, or periods, in which the hedged forecasted future cash flows affect the Consolidated Statement of Profit or Loss. When a hedging instrument expires or is sold, exercised or otherwise terminated, or the entity revokes designation of the hedge relationship but the hedged forecast transaction is still expected to occur, the cumulative gain or loss at that point remains in equity and is recognized when the transaction occurs. If the hedged transaction is no longer expected to take place, the cumulative unrealized gain or loss recognized in equity is recognized in the Consolidated Statement of Profit or Loss immediately. When a hedging instrument is substantially modified, any fair value gain or loss is recognized immediately in the Consolidated Statement of Profit or Loss. b. Net investment hedges Foreign currency differences arising on the retranslation of the spot rate component of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income to the extent that the hedge is effective, and are presented in the translation reserve within equity. Since the adoption of IFRS 9 for hedge accounting on January 1, 2021, the change in fair value of the future price element of the hedging instrument (‘forward element’) is not included as part of the hedging relationships and is recognized in the Consolidated Statement of Profit or Loss immediately. To the extent that any net investment hedge is entered into and the hedge is deemed effective, any foreign currency differences arising on the retranslation of the spot rate component of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income, and are presented in the translation reserve within equity. To the extent that the hedge is ineffective, such differences are recognized in the Consolidated Statement of Profit or Loss. When the hedged net investment is disposed of, the relevant amount in the translation reserve is transferred to the Consolidated Statement of Profit or Loss as part of the gain or loss on disposal. vi) Short-term investments The Company may invest surplus cash positions in short-term investments to manage liquidity and credit risk. Short‐term investments are held within managed investment funds and are measured at fair value with all changes in fair value are recognized immediately in the Consolidated Statement of Profit or Loss.
Revenue	Revenue from contracts with customers The Company manufactures and sells a range of frozen foods to retail, wholesale and Food Service markets. Revenue is recognized when control of the products has transferred, being when the products are delivered to the customer in accordance with the contractual arrangements. At this point, there is no unfulfilled performance obligation that could affect the customer’s acceptance of the product, except for returns due to quality. A provision for product return allowances, which is estimated based upon the Company’s historical performance and management’s experience, is recorded as a reduction of sales in the same period that the revenue is recognized. Revenue excludes sales taxes and intra-company sales. Products are often sold with variable pricing arrangements, including payment discounts, trade promotions and slotting fees. Discounts given by the Company include rebates, price reductions and incentives to customers, promotional couponing and trade communication costs. Trade promotions consist of pricing allowances, merchandising funds and customer coupons, which are offered through various programs to customers and consumers. Certain retailers require the payment of slotting fees to obtain space for the Company’s products on the retailers’ store shelves. Where variable pricing arrangements are in place, revenue is only recognized to the extent that it is highly probable that the amount recognized is unlikely to be reversed. Accumulated experience is used to estimate and provide for the discounts. Revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. Accruals for expected pay-outs under these programs are collectively known as ‘trade terms’ and are included within trade and other receivables or within trade and other payables in the Consolidated Statement of Financial Position. No element of financing is deemed present as the sales are made in line with market practice and accruals are typically settled within twelve months of the sale.
Share based payments	Share based payments The Nomad Foods Long-term Incentive Plan known as the (the "Management Share Awards"), which incorporates an annual Non-Executive Directors Restricted Stock Scheme, falls within the provisions of IFRS 2 “Share-based Payment” and awards under the Management Share Awards represent equity settled share based payments. A charge is taken to the Consolidated Statement of Profit or Loss for the difference between the fair value of the shares at grant date and the amount subscribed, spread over the vesting period. Share based payment arrangements in which Nomad receives goods or services as consideration for its own equity instruments are accounted for as equity-settled share based payment transactions, regardless of how the equity instruments are obtained by Nomad. The grant date fair value of share-based payment awards granted to any Director or employee is recognized as an expense, with a corresponding increase in equity, over the period that any Director or employee becomes unconditionally entitled to the awards. The fair value of the awards granted is measured using a valuation model, taking into account the terms and conditions upon which the awards were granted. The amount recognized as an expense is adjusted to reflect the actual number of awards for which the related service and non-market vesting conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the number of awards that do meet the related service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual outcomes. See Note 8(b) for further information on the Company’s share-based payment arrangements and details of the valuation model used.
Interest income	Interest incomeInterest income is recognized in the Consolidated Statement of Profit or Loss on an accruals basis using the effective interest method.
Expenses	Expenses & Exceptional items i) Borrowing costs Unless capitalized as part of the cost of borrowing (see Note 3.13(iii)), borrowing costs are recognized in the Consolidated Statement of Profit or Loss in the period in which they are incurred. ii) Exceptional items The separate reporting of exceptional items which are presented as exceptional within the relevant Consolidated Statement of Profit or Loss category, helps provide an indication of the Company’s underlying business performance. Exceptional items have been identified and presented by virtue of their size, nature or incidence. In determining whether an event or transaction is exceptional, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence. Exceptional items comprise restructuring costs, impairments or reversal of impairments of intangible assets, operational restructuring, integration and acquisition costs relating to new acquisitions, implementation of strategic opportunities and other significant items (see Note 7). iii) Research and development Expenditure on research activities is recognized in the Consolidated Statement of Profit or Loss as an expense as incurred.
Taxation	Taxation Tax on the profit or loss for the year comprises current and deferred tax. Tax is recognized in the Consolidated Statement of Profit and Loss except to the extent that it relates to items recognized in Other Comprehensive Income, in which case it is recognized within the Statement of Other Comprehensive Income. Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at the financial year end date, and any adjustment to tax payable in respect of previous years. Where tax exposures can be quantified, an accrual for uncertain tax positions is made based on the best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could in future periods experience adjustments to these accruals. Deferred tax is provided on temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting purposes and the amounts used for taxation purposes on an undiscounted basis. The following temporary differences are not provided for: the initial recognition of goodwill; the initial recognition of assets or liabilities that affect neither accounting nor taxable profit other than in a business combination, and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial year end date. A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized.
Segment reporting	Segment reporting The Chief Operating Decision Maker (“CODM”) has been determined to be the Chief Executive Officer as he is primarily responsible for the allocation of resources to the segments and the assessment of performance of the segments. Nomad’s operations are organized into one operating unit, "Frozen", which comprises all the brands, as well as the factories, private label business units and certain corporate overheads. The CODM primarily uses “Adjusted EBITDA”, disclosed in Note 5, as the key measure of the segment’s results. Adjusted EBITDA is EBITDA adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. EBITDA, disclosed in Note 5, is defined as profit/(loss) for the period before taxation, net financing costs, depreciation and amortization.
IFRSs not yet adopted	Recently Issued and Not Yet Adopted Accounting Pronouncements under IFRS Amendments to IAS 12 - Deferred Tax related to Assets and Liabilities arising from a Single Transaction In May 2021, the International Accounting Standards Board issued targeted amendments to IAS 12, Income Taxes. The amendments are effective for annual periods beginning on or after January 1, 2023, although earlier application is permitted. With a view to reducing diversity in reporting, the amendments will clarify that companies are required to recognize deferred taxes on transactions where both assets and liabilities are recognized, such as with leases and asset retirement (decommissioning) obligations. Based upon our current facts and circumstances, we do not expect our financial performance or disclosure to be materially affected by the application of the amended standard.
Onerous/ unfavorable contracts
Disclosure of types of insurance contracts [line items]
Provisions/Onerous contracts provisions	Onerous contracts provisionsWhere the costs of fulfilling a contract exceed the economic benefits that the Company expects to receive from it, an onerous contract provision is recognized for the net unavoidable costs. In estimating the net unavoidable costs, management estimate foreseeable income that may be received and offset this against the minimum future cash outflows from fulfilling the contract. All cash flows are discounted at an appropriate discount rate.

Segment reporting (Tables)

Segment reporting (Tables)	12 Months Ended
	Dec. 31, 2021
Operating Segments [Abstract]
Segment As Adjusted EBITDA	Segment Adjusted EBITDA Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Note €m €m €m Profit for the period 181.0 225.1 153.6 Taxation 55.7 70.4 56.7 Net financing costs 106.0 63.7 73.2 Depreciation and amortization 71.6 67.6 68.3 Acquisition purchase price adjustments 8.4 — — Exceptional items 7 45.3 20.6 54.5 Other add-backs 18.7 19.4 25.7 Adjusted EBITDA 486.7 466.8 432.0
External Revenue and Non-current Assets by Geography	External revenue by geography Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 €m €m €m United Kingdom 758.3 747.3 712.5 Italy 417.9 426.3 394.1 Germany 396.3 393.2 329.6 France 188.6 203.8 176.6 Sweden 148.1 158.7 175.7 Austria 129.3 127.9 108.2 Norway 121.7 115.6 120.4 Spain 75.1 82.6 79.5 Rest of Europe 371.3 260.5 227.7 Total external revenue by geography 2,606.6 2,515.9 2,324.3 Non-current assets by geography December 31, 2021 December 31, 2020 €m €m Germany 140.0 135.5 United Kingdom 139.6 132.1 Italy 64.8 68.5 Serbia 48.5 — Croatia 38.5 — Ireland 34.3 31.9 Norway 31.0 30.0 Sweden 29.8 28.5 Rest of Europe 72.3 52.7 Total non-current assets by geography 598.8 479.2

Operating profit_(loss) (Tables

Operating profit/(loss) (Tables)	12 Months Ended
	Dec. 31, 2021
Analysis of income and expense [abstract]
Disclosure of Detailed Information About Profit (Loss) from Operating Activities	Operating profit is stated after charging: Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Note €m €m €m Staff costs 8 340.6 340.2 308.6 Depreciation of property, plant and equipment 12 63.4 59.8 59.7 Impairment of property, plant and equipment 12 — — 0.1 Impairment of software and brands 13 1.7 — — Amortization of software and brands 13 8.2 7.8 8.6 Operating lease charges 6.1 3.0 4.5 Exchange losses/(gains) 27.0 (2.8) (14.6) Research & development expenditure 19.2 17.6 18.9 Inventories recognized as an expense within cost of goods sold 1,694.3 1,627.9 1,536.0

Exceptional items (Tables)

Exceptional items (Tables)	12 Months Ended
	Dec. 31, 2021
Analysis of income and expense [abstract]
Schedule of Exceptional Items	Exceptional items are made up as follows: Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 €m €m €m Supply chain reconfiguration (1) — (12.5) (3.6) Findus Group integration costs (2) — — 3.5 Fortenova Acquisition integration costs (3) 3.5 — — Findus Switzerland integration costs (4) 6.2 0.3 — Brexit (5) 5.3 1.6 1.6 Business Transformation program (6) 18.8 2.3 — Information Technology Transformation program (7) 4.2 — — Goodfella's Pizza & Aunt Bessie's integration costs (8) — 4.0 12.5 Factory optimization (9) 4.9 10.0 5.7 Settlement of legacy matters (10) (2.6) (2.9) (9.2) Release of indemnification assets (11) 5.0 17.8 44.0 Total exceptional items 45.3 20.6 54.5

Payroll costs, share based pa_2

Payroll costs, share based payments and management incentive schemes (Tables)	12 Months Ended
	Dec. 31, 2021
Employee Benefits And Share-Based Payments [Abstract]
Disclosure of Employee Information	The average number of persons employed by the Company (excluding non-Executive Directors) is analyzed and set out below: Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Production 3,310 3,043 3,308 Administration, distribution & sales 2,193 1,647 1,448 Total number of employees 5,503 4,690 4,756
Disclosure of Employee Benefit Expense	The table below discloses the Company’s aggregate payroll costs of these persons. Payroll costs exclude long term management incentive scheme and share based payment costs, but includes bonus costs. Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 €m €m €m Wages and salaries 266.4 276.4 250.4 Social security costs 56.1 49.2 45.2 Other pension costs 18.1 14.6 13.0 Total payroll costs 340.6 340.2 308.6
Disclosure of number and weighted average exercise prices of share options	management team (the “Management Share Awards”) as of the following four award dates: January 1, 2016 Award January 1, 2017 Award January 1, 2018 Award January 1, 2019 Award January 1, 2020 Award January 1, 2021 Award Total Number of awards outstanding at January 1, 2021 1,041,953 819,873 446,575 159,561 710,438 — 3,178,400 New awards granted in the period — — — — — 820,202 820,202 Awards vested and issued in the period (1,041,953) (819,873) — — — — (1,861,826) Forfeitures in the period — — (14,785) (6,866) (65,345) (32,925) (119,921) Number of awards outstanding at December 31, 2021 — — 431,790 152,695 645,093 787,277 2,016,855
Inputs and assumptions underlying the Monte Carlo Model	January 1, 2018 award January 1, 2019 award January 1, 2020 award January 1, 2021 award Grant date price $ 16.72 $ 20.15 $ 22.37 $ 25.42 Exercise price $ — $ — $ — $ — Expected life of restricted share 1.50 - 4.00 years 4.00 years 3.00 years 3.00 years Expected volatility of the share price 22.7 % 24.0 % 24.4 % 30.0 % Dividend yield expected — % — % — % — % Risk free rate 2.55 % 1.33 % 1.70 % 0.24 % Employee exit rate 14.0 % 14.0 % 27.3 % 14.0 % EBITDA Performance Target Condition 35.0 % 35.0 % 35.0 % 35.0 %

Directors and Key Management _2

Directors and Key Management compensation (Tables)	12 Months Ended
	Dec. 31, 2021
Related Party [Abstract]
Disclosure of transactions between related parties [text block]	Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Benefits are accruing to the following number of key management personnel under: Defined contribution plans 2 2 2 Share based payment schemes 2 2 2
Disclosure of information about key management personnel [text block]	Directors and Key Management compensation Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 €m €m €m Short-term employee benefits 2.2 3.9 2.8 Share-based payment expense 2.4 3.5 7.6 Non-Executive Director fees 0.3 0.3 0.4 Total Directors' and executive officers' compensation 4.9 7.7 10.8 All significant management decision making authority is vested within the Board of Directors and the executive team, therefore key management are considered to be the Directors and executive Officers. Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Benefits are accruing to the following number of key management personnel under: Defined contribution plans 2 2 2 Share based payment schemes 2 2 2

Finance income and costs (Table

Finance income and costs (Tables)	12 Months Ended
	Dec. 31, 2021
Analysis of income and expense [abstract]
Schedule of Finance income and costs	Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 €m €m €m Interest income 0.1 0.7 2.5 Net foreign exchange gains on translation of financial assets and liabilities — 4.0 — Finance income 0.1 4.7 2.5 Interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss (a) (59.8) (64.0) (79.0) Cross-currency interest rate swaps: cash flow hedges, transfer from equity 1.6 5.9 21.8 Net impairment loss on short-term investments (8.6) — — Net pension interest costs (1.7) (2.7) (3.8) Amortization of borrowing costs (2.0) (2.0) (2.0) Net foreign exchange losses on translation of financial assets and liabilities (4.0) — (3.9) Net fair value losses on derivatives held at fair value through profit or loss (b) (13.7) (5.6) (8.8) Financing costs incurred in amendment of terms of debt (c) (17.9) — — Finance costs (106.1) (68.4) (75.7) Net finance costs (106.0) (63.7) (73.2) (a) Includes the unwinding of discounting on lease liabilities. (b) Net fair value losses on derivatives held at fair value through profit or loss includes a one-off non-cash charge of €7.8 million for changes to cross currency interest rate swaps as disclosed in Note 34. (c) Charges of €17.9 million have been recognized as a consequence of the refinancing in June 2021, as disclosed in Note 34. Of this, €10.1 million relates to the extinguishment of the previous debts, including the write-off of deferred transaction costs.

Taxation (Tables)

Taxation (Tables)	12 Months Ended
	Dec. 31, 2021
Income Taxes [Abstract]
Components Of Tax Expense (Benefit)	Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, Note €m €m €m Current tax expense Current tax on profits for the period (117.5) (44.8) (66.4) Adjustments in respect of prior periods 0.6 (7.6) — (116.9) (52.4) (66.4) Deferred tax benefit/(expense) Origination and reversal of temporary differences 116.3 (1.2) 9.7 Impact of change in tax rates (55.1) (16.8) — 16 61.2 (18.0) 9.7 Total tax expense (55.7) (70.4) (56.7)
Reconciliation Of Effective Tax Rate	Reconciliation of effective tax rate: Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, €m €m €m Profit before tax 236.7 295.5 210.3 Tax charge at the standard UK corporation tax rate 19% (2020: 19%; 2019: 19%) (45.0) (56.1) (39.9) Difference in tax rates 22.7 (18.2) (11.9) Non tax deductible interest 0.1 (0.1) 0.6 Other income and expenses not taxable or deductible 2.5 (0.8) (1.2) Unrecognized tax assets (1.5) (6.3) (0.9) Provisions for uncertainties (52.5) 35.5 (3.4) Impact of change in tax rates (55.1) (16.8) — Change in tax base of assets due to step-up 72.5 — — Prior period adjustment 0.6 (7.6) — Total tax expense (55.7) (70.4) (56.7)
Income Tax Relating to Components Of Other Comprehensive Income	The tax (benefit)/expense relating to components of other comprehensive income is as follows: Before Tax After tax Year ended December 31, 2021 Note €m €m €m Remeasurement of post-employment benefit liabilities (36.1) 10.2 (25.9) Net investment hedge (18.8) — (18.8) Cash flow hedges (22.6) 13.6 (9.0) Other comprehensive (income)/loss (77.5) 23.8 (53.7) Current tax — Deferred tax 16 23.8 23.8 Before Tax benefit After tax Year ended December 31, 2020 Note €m €m €m Remeasurement of post-employment benefit liabilities 27.8 (8.3) 19.5 Net investment hedge 10.1 — 10.1 Cash flow hedges 17.3 (6.0) 11.3 Other comprehensive loss/(income) 55.2 (14.3) 40.9 Current tax — Deferred tax 16 (14.3) (14.3) Before Tax After tax Year ended December 31, 2019 €m €m €m Remeasurement of post-employment benefit liabilities 35.9 (6.7) 29.2 Net investment hedge (6.0) — (6.0) Cash flow hedges 27.3 (5.6) 21.7 Other comprehensive loss/(income) 57.2 (12.3) 44.9 Current tax — Deferred tax (12.3) (12.3)

Property, plant and equipment D

Property, plant and equipment Disclosure NBV of Tangible Assets and Right of use Assets (Tables)	12 Months Ended
	Dec. 31, 2021
Disclosure of detailed information about property, plant and equipment [abstract]
Disclosure NBV Tangible and Right of use Assets [Table Text Block]	12) Property, plant and equipment December 31, 2021 December 31, 2020 €m €m Owned property, plant and equipment (i) 489.2 373.2 Right-of-use assets (ii) 60.2 49.0 Property, plant and equipment 549.4 422.2
Disclosure of detailed information about property, plant and equipment [text block]	Land and Plant and Computer Total €m €m €m €m Cost Balance at December 31, 2019 156.2 331.9 13.8 501.9 Acquisitions through business combinations 5.1 3.5 — 8.6 Additions 6.8 54.6 2.1 63.5 Disposals (0.1) (2.6) (0.3) (3.0) Effect of movements in foreign exchange (2.7) (11.3) (0.3) (14.3) Balance at December 31, 2020 165.3 376.1 15.3 556.7 Acquisitions through business combinations 30.5 45.0 0.5 76.0 Additions 14.8 62.8 3.5 81.1 Disposals (0.1) (5.9) — (6.0) Effect of movements in foreign exchange 6.2 16.2 0.4 22.8 Balance at December 31, 2021 216.7 494.2 19.7 730.6 Accumulated depreciation and impairment Balance at December 31, 2019 23.0 125.0 3.9 151.9 Depreciation 7.6 33.5 3.0 44.1 Disposals — (1.8) (0.3) (2.1) Effect of movements in foreign exchange (1.4) (8.6) (0.4) (10.4) Balance at December 31, 2020 29.2 148.1 6.2 183.5 Depreciation 8.4 35.4 3.0 46.8 Disposals — (4.8) — (4.8) Effect of movements in foreign exchange 2.9 12.6 0.4 15.9 Balance at December 31, 2021 40.5 191.3 9.6 241.4 Net book value December 31, 2019 133.2 206.9 9.9 350.0 Net book value December 31, 2020 136.1 228.0 9.1 373.2 Balance at December 31, 2021 176.2 302.9 10.1 489.2
Asset Class of RIght of use Assets [Table Text Block]	(ii) Right-of-use assets December 31, 2021 December 31, 2020 €m €m Net book value Land and Buildings 44.8 38.5 Plant and equipment and motor vehicles 15.3 10.3 Computer equipment 0.1 0.2 Right-of-use assets 60.2 49.0 Additions to right-of-use assets during the year ended December 31, 2021 were €8.1 million. A further €19.0 million of additions were acquired through business combinations. Lease liabilities are included within loans and borrowings in Note 21. Interest on lease liabilities is presented as a finance cost in Note 10. Payments of lease liabilities are included as a financing activity within the Statement of Cash Flows.
Disclosure of depreciation and amortisation expense [text block]	Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 €m €m €m Depreciation Land and Buildings 10.9 10.6 10.7 Plant and equipment and motor vehicles 5.5 4.9 5.2 Computer equipment 0.2 0.2 0.2 Depreciation expense of right-of-use assets 16.6 15.7 16.1

Goodwill and Intangibles (Table

Goodwill and Intangibles (Tables)	12 Months Ended
	Dec. 31, 2021
Intangible assets and goodwill [abstract]
Disclosure of reconciliation of changes in intangible assets and goodwill	Goodwill Brands Computer Customer Total €m €m €m €m €m Cost Balance at December 31, 2019 1,862.9 2,051.1 29.8 31.0 3,974.8 Acquisitions through business combinations (restated) 40.1 66.0 0.1 — 106.2 Additions — — 8.8 — 8.8 Effect of movements in foreign exchange (0.5) 5.3 0.3 — 5.1 Balance at December 31, 2020 (restated) 1,902.5 2,122.4 39.0 31.0 4,094.9 Acquisitions through business combinations 192.6 296.5 1.1 4.3 494.5 Additions — — 5.8 — 5.8 Disposals — — (2.5) — (2.5) Effect of movements in foreign exchange 4.3 3.2 (0.5) — 7.0 Balance at December 31, 2021 2,099.4 2,422.1 42.9 35.3 4,599.7 Goodwill Brands Computer Customer Total €m €m €m €m €m Accumulated amortization and impairment Balance at December 31, 2019 — 4.4 15.2 9.2 28.8 Amortization — 1.2 4.4 2.2 7.8 Effect of movements in foreign exchange — — 0.1 — 0.1 Balance at December 31, 2020 — 5.6 19.7 11.4 36.7 Amortization — 1.2 4.6 2.4 8.2 Impairment — — 1.7 — 1.7 Disposals — — (1.7) — (1.7) Effect of movements in foreign exchange — — (0.3) — (0.3) Balance at December 31, 2021 — 6.8 24.0 13.8 44.6 Net book value December 31, 2019 1,862.9 2,046.7 14.6 21.8 3,946.0 Net book value December 31, 2020 (restated) 1,902.5 2,116.8 19.3 19.6 4,058.2 Net book value December 31, 2021 2,099.4 2,415.3 18.9 21.5 4,555.1

Acquisitions (Tables)

Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2021
Disclosure of detailed information about business combination [abstract]
Acquisitions	The final assessment of the assets and liabilities acquired are as follows: As reported December 31, 2020 Adjustments As restated December 31, 2020 €m €m €m Assets: Intangible assets 24.5 41.6 66.1 Property, plant and equipment, including Right-of-use assets 8.9 — 8.9 Current assets 0.2 — 0.2 Inventories 11.5 1.1 12.6 Total assets 45.1 42.7 87.8 Liabilities: Current liabilities 0.3 — 0.3 Non-current liabilities 6.8 — 6.8 Deferred tax liabilities 1.6 6.4 8.0 Total liabilities 8.7 6.4 15.1 Total identifiable net assets acquired 36.4 36.3 72.7 Total purchase consideration 112.0 0.8 112.8 Total identifiable net assets acquired (36.4) (36.3) (72.7) Goodwill 75.6 (35.5) 40.1 Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Outflow of cash for business combinations, net of cash acquired €m €m €m Cash consideration 640.9 113.0 — Less cash acquired (43.6) (0.1) — Contingent consideration paid related to acquisitions 24 — — 1.5 Net outflow of cash - investing activities 597.3 112.9 1.5 Year ended December 31, 2021 Year ended December 31, 2020 €m €m Balance at January 1 15.4 35.4 Release of indemnified provision (5.9) (20.0) Balance at December 31 9.5 15.4

Investments (Tables)

Investments (Tables)	12 Months Ended
	Dec. 31, 2021
Interests in Other Entities [Abstract]
Disclosure of Significant Investments	The following are the Company's significant investments as of December 31, 2021. Activity Country of Class of Ownership Nomad Foods Europe Holdings Limited Holding England Ordinary 100% Nomad Foods Europe Holdco Limited Holding England Ordinary 100% Nomad Foods Europe Finco Limited Holding England Ordinary 100% Nomad Foods Europe Midco Limited Holding/ England Ordinary 100% Nomad Foods Bondco Plc Finance England Ordinary 100% Nomad Foods Lux S.à.r.l. Finance Luxembourg Ordinary 100% Nomad Foods Europe Limited Management England Ordinary 100% Birds Eye Limited Trading England Ordinary 100% Nomad Foods Europe Finance Limited Finance England Ordinary 100% Birds Eye Ireland Limited Trading Republic of Ordinary 100% Iglo Holding GmbH Holding Germany Ordinary 100% Iglo Nederland B.V. Trading Netherlands Ordinary 100% Iglo Belgium S.A. Trading Belgium Ordinary 100% Iglo Portugal Trading Portugal Ordinary 100% Iglo Austria Holdings GmbH Holding Austria Ordinary 100% C.S.I. Compagnia Surgelati Italiana S.R.L Trading Italy Ordinary 100% Findus Sverige Holdings AB Holding Sweden Ordinary 100% Iglo GmbH Trading Germany Ordinary 100% Frozen Fish International GmbH Trading Germany Ordinary 100% Liberator Germany Newco GmbH Property Germany Ordinary 100% Iglo Austria GmbH Trading Austria Ordinary 100% Findus Sverige AB Trading Sweden Ordinary 100% Frionor Sverige AB Holding Sweden Ordinary 100% Findus Holdings France SAS Holding France Ordinary 100% Findus France SAS Trading France Ordinary 100% Findus Espana SLU Trading Spain Ordinary 100% Findus Danmark A/S Trading Denmark Ordinary 100% Findus Finland Oy Trading Finland Ordinary 100% Findus Norge AS Trading Norway Ordinary 100% Findus Norge Holding AS Holding Norway Ordinary 100% Toppfrys AB Trading Sweden Ordinary 100% Findus Switzerland AG Trading Switzerland Ordinary 100% LEDO plus d.o.o. Trading Croatia Ordinary 100% INDUSTRIJA SMRZNUTE HRANE FRIKOM DOO BEOGRAD Trading Serbia Ordinary 100% LEDO d.o.o. Čitluk Trading Bosnia & Herzegovina Ordinary 100% IRIDA d.o.o. Trading Croatia Ordinary 100% LEDO Jégkrém és Fagyasztott Élelmiszer Gyártó és Forgalmazó Korlátolt Felelősségű Társaság Trading Hungary Ordinary 100% Ledo d.o.o. (LEDO, podjetje za trgovino s sladoledom, zmrznjeno hrano in storitve, d.o.o.) Trading Slovenia Ordinary 100% Ledo d.o.o. Podgorica (Društvo Za Proizvodnju, promet roba i usluga “Ledo” d.o.o. Podgorica) Trading Montenegro Ordinary 100% Ledo Sh.p.k. Trading Kosovo Ordinary 100% FRIKOM BEOGRAD DOOEL Cucer Sandevo Trading North Macedonia Ordinary 100%

Deferred tax assets and liabi_2

Deferred tax assets and liabilities (Tables)	12 Months Ended
	Dec. 31, 2021
Disclosure of income tax [Abstract]
Schedule of Deferred Tax Assets and Liabilities	Deferred tax assets and liabilities are attributable to the following: December 31, 2021 December 31, 2020 (restated) Assets Liabilities Total Assets Liabilities Total €m €m €m €m €m €m Property, plant and equipment 8.9 (34.4) (25.5) 20.6 (27.3) (6.7) Intangible assets 33.8 (382.9) (349.1) 0.9 (384.4) (383.5) Employee benefits 36.4 — 36.4 48.3 (0.3) 48.0 Tax value of loss carry forwards 40.4 — 40.4 24.6 — 24.6 Derivative financial instruments 1.7 (7.0) (5.3) 9.3 (0.1) 9.2 Other 7.1 (13.3) (6.2) 9.8 (15.0) (5.2) Tax assets/(liabilities) 128.3 (437.6) (309.3) 113.5 (427.1) (313.6) Movement in deferred tax during the year: Opening balance Jan 1, 2021 (restated) Acquired in Recognized Recognized Movement Closing balance Dec 31, 2021 €m €m €m €m €m €m Property, plant and equipment (6.7) (2.2) (17.2) — 0.6 (25.5) Intangible assets (383.5) (30.1) 64.5 — — (349.1) Employee benefits 48.0 — (1.2) (10.2) (0.2) 36.4 Tax value of loss carry forwards 24.6 — 15.8 — — 40.4 Derivative financial instruments 9.2 — (0.3) (13.6) (0.6) (5.3) Other (5.2) (0.6) (0.4) — — (6.2) Total deferred tax (313.6) (32.9) 61.2 (23.8) (0.2) (309.3)

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2021
Inventories [Abstract]
Schedule of inventories	December 31, 2021 December 31, 2020 (restated) €m €m Raw materials and consumables 95.8 80.5 Work in progress 64.9 46.5 Finished goods and goods for resale 249.9 217.3 Total inventories 410.6 344.3

Trade and other receivables (Ta

Trade and other receivables (Tables)	12 Months Ended
	Dec. 31, 2021
Subclassifications of assets, liabilities and equities [abstract]
Disclosure of trade terms	Liabilities related to contracts with customers The Company has recognized the following liabilities related to contracts with customers:December 31, 2021December 31, 2020€m€mTrade terms liabilities reported within trade receivables(189.9)(200.5)Trade terms liabilities reported within trade and other payables (Note 22)(93.8)(89.7)Total trade terms liabilities(283.7)(290.2)Significant changes to trade termsNo significant changes to trade terms occurred in the year ended December 31, 2021.Revenue recognized in relation to trade termsTrade terms relate to sales made with variable consideration and are an estimate as disclosed in Note 4(a). Revenue recognized in the year ended December 31, 2021 relating to performance obligations that were satisfied in the prior year was €18.9 million (2020: €18.0 million).
Schedule of Trade and Other Receivables	December 31, 2021 December 31, 2020 Current assets €m €m Trade receivables 182.8 141.2 Prepayments and accrued income 15.4 9.2 Other receivables 32.3 31.2 Tax receivable 4.1 3.4 Total current trade and other receivables 234.6 185.0 Non-current assets Other receivables 8.9 1.1 Total non-current trade and other receivables 8.9 1.1 Total trade and other receivables 243.5 186.1
Disclosure of Aging Trade Receivables	The aging of trade receivables is detailed below: Gross Impaired Net December 31, 2021 €m €m €m Not past due 343.8 (0.1) 343.7 Past due less than 1 month 19.9 (0.1) 19.8 Past due 1 to 3 months 5.2 (0.6) 4.6 Past due 3 to 6 months 2.4 (0.1) 2.3 Past due more than 6 months 5.0 (2.7) 2.3 Sub-total 376.3 (3.6) 372.7 Reduction in trade-terms (189.9) Total trade receivables 182.8 Gross Impaired Net December 31, 2020 €m €m €m Not past due 308.6 (0.3) 308.3 Past due less than 1 month 20.5 (0.2) 20.3 Past due 1 to 3 months 4.0 (0.1) 3.9 Past due 3 to 6 months 1.1 (0.1) 1.0 Past due more than 6 months 11.9 (3.7) 8.2 Sub-total 346.1 (4.4) 341.7 Reduction in trade-terms (200.5) Total trade receivables 141.2

Indemnification assets (Tables)

Indemnification assets (Tables)	12 Months Ended
	Dec. 31, 2021
Business Combinations1 [Abstract]
Disclosure of detailed information about business combination	The final assessment of the assets and liabilities acquired are as follows: As reported December 31, 2020 Adjustments As restated December 31, 2020 €m €m €m Assets: Intangible assets 24.5 41.6 66.1 Property, plant and equipment, including Right-of-use assets 8.9 — 8.9 Current assets 0.2 — 0.2 Inventories 11.5 1.1 12.6 Total assets 45.1 42.7 87.8 Liabilities: Current liabilities 0.3 — 0.3 Non-current liabilities 6.8 — 6.8 Deferred tax liabilities 1.6 6.4 8.0 Total liabilities 8.7 6.4 15.1 Total identifiable net assets acquired 36.4 36.3 72.7 Total purchase consideration 112.0 0.8 112.8 Total identifiable net assets acquired (36.4) (36.3) (72.7) Goodwill 75.6 (35.5) 40.1 Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Outflow of cash for business combinations, net of cash acquired €m €m €m Cash consideration 640.9 113.0 — Less cash acquired (43.6) (0.1) — Contingent consideration paid related to acquisitions 24 — — 1.5 Net outflow of cash - investing activities 597.3 112.9 1.5 Year ended December 31, 2021 Year ended December 31, 2020 €m €m Balance at January 1 15.4 35.4 Release of indemnified provision (5.9) (20.0) Balance at December 31 9.5 15.4

Cash and cash equivalents (Tabl

Cash and cash equivalents (Tables)	12 Months Ended
	Dec. 31, 2021
Subclassifications of assets, liabilities and equities [abstract]
Schedule of Cash and Cash Equivalents per Statement of Cash Flows	December 31, 2021 December 31, 2020 Note €m €m Cash and cash equivalents 254.0 393.1 Restricted cash 0.2 0.1 Cash and cash equivalents 254.2 393.2 Bank overdraft 22 — (10.7) Cash and cash equivalents per Statement of Cash Flows 254.2 382.5

Loans and borrowings (Tables)

Loans and borrowings (Tables)	12 Months Ended
	Dec. 31, 2021
Financial Instruments [Abstract]
Repayment Profile and Individual Loan Details	The repayment profile of the syndicated and other loans held by the Company is as follows: December 31, 2021 December 31, 2020 €m €m Current liabilities Syndicated loans 8.5 7.8 Lease liabilities 22.6 16.7 Less deferred borrowing costs to be amortized within 1 year (2.0) (2.0) Total due in less than one year 29.1 22.5 Non-current liabilities Syndicated loans 1,347.4 1,287.5 2024 fixed rate senior secured notes — 400.0 2028 fixed rate senior secured notes 800.0 — Lease liabilities 58.3 53.7 Less deferred borrowing costs to be amortized in 2-5 years (5.7) (4.9) Less deferred borrowing costs to be amortized in more than 5 years (1.7) — Total due after more than one year 2,198.3 1,736.3 Total borrowings 2,227.4 1,758.8

Trade and other payables (Table

Trade and other payables (Tables)	12 Months Ended
	Dec. 31, 2021
Subclassifications of assets, liabilities and equities [abstract]
Disclosure of Detailed Information About Trade and Other Payables	December 31, 2021 December 31, 2020 (restated) Current liabilities €m €m Trade payables 413.2 363.7 Accruals and deferred income 120.4 134.5 Trade terms payable 93.8 89.7 Social security and other taxes 24.6 24.1 Other payables 20.3 21.2 Financial payables 19.7 3.3 Bank overdrafts — 10.7 Total current trade and other payables 692.0 647.2 Non-current liabilities Accruals and deferred income 1.8 2.2 Total non-current trade and other payables 1.8 2.2 Total trade and other payables 693.8 649.4

Employee benefits (Tables)

Employee benefits (Tables)	12 Months Ended
	Dec. 31, 2021
Employee Benefits [Abstract]
Schedule Of Net Defined Benefit Liability (Asset)	December 31, 2021 December 31, 2020 €m €m Net employee benefit obligations-Germany 149.3 181.2 Net employee benefit obligations-Sweden 70.3 74.1 Net employee benefit obligations-Austria 5.5 5.6 Net employee benefit obligations-Switzerland 5.8 6.6 Net employee benefit obligations-Italy 4.6 4.7 Net employee benefit obligations-total of other countries 8.7 4.0 Total net employee benefit obligations 244.2 276.2 The history of experience adjustments from inception of the Company for the employee benefit plans is as follows: December 31, 2021 December 31, 2020 December 31, 2019 €m €m €m Present value of defined benefit obligations 341.5 365.1 314.9 Fair value of plan assets (108.4) (97.9) (86.4) Recognized liability in the scheme 233.1 267.2 228.5 Experience losses/(gains) on plan liabilities 1.8 (0.8) 0.2 Experience gains on plan assets (9.6) (0.4) (5.1)
Schedule of Net Employee Benefit Obligations And Components	Reconciliation from the opening balances to the closing balances for the net employee benefit obligation and its components, including the amounts recognized in the Consolidated Statement of Profit or Loss and the Consolidated Statement of Comprehensive Income: Present value of defined benefit obligation Fair value of plan assets Net defined benefit obligation 2021 2020 2021 2020 2021 2020 €m €m €m €m €m €m Balance at January 1 374.1 323.9 (97.9) (86.4) 276.2 237.5 Included in the Consolidated Statement of Profit or Loss Current service cost 7.9 6.6 — — 7.9 6.6 Interest cost (income) 2.2 3.7 (0.5) (1.0) 1.7 2.7 10.1 10.3 (0.5) (1.0) 9.6 9.3 Included in the Consolidated Statement of Comprehensive Income Actuarial (gain) loss arising from: – demographic assumptions (1.5) — — — (1.5) — – financial assumptions (26.8) 29.1 — — (26.8) 29.1 – experience adjustment 1.8 (0.8) — — 1.8 (0.8) Return on plan assets, excluding interest income — — (9.6) (0.4) (9.6) (0.4) Exchange adjustments (0.3) 2.8 (0.6) — (0.9) 2.8 (26.8) 31.1 (10.2) (0.4) (37.0) 30.7 Other Acquired through business combinations 3.5 18.4 — (11.8) 3.5 6.6 Contributions by employer — — (1.2) (0.5) (1.2) (0.5) Contributions by members 0.8 0.4 (0.8) (0.5) — (0.1) Benefits paid (9.1) (10.0) 2.2 2.7 (6.9) (7.3) (4.8) 8.8 0.2 (10.1) (4.6) (1.3) Balance at December 31 352.6 374.1 (108.4) (97.9) 244.2 276.2
Schedule Of Cumulative Actuarial Losses Recognized	The cumulative amount of actuarial losses recognized is as follows: Year ended December 31, 2021 Year ended December 31, 2020 €m €m Cumulative amount of actuarial losses recognized in Consolidated Statement of Comprehensive Income 40.5 77.5
Schedule Of Plan Assets At Fair Value	The fair value of plan assets, all at quoted prices are as follows: December 31, 2021 December 31, 2020 €m €m Equities 32.7 24.5 Debt instruments 42.7 44.1 Property 20.3 17.1 Other 12.7 12.2 Total 108.4 97.9
Defined Benefit Plan Principal Actuarial Assumptions	The following are the principal actuarial assumptions at the reporting date for the defined benefit retirement plans in Germany, Sweden, Austria, Switzerland and Italy. The remaining employee benefit plans are not considered to be material, individually and in aggregate, and therefore we do not provide disclosure of the individual actuarial assumptions for those plans: Defined benefit December 31, 2021 Germany Sweden Austria Switzerland Italy Discount rate 1.10 % 1.80 % 0.90 % 0.10 % 0.35 % Inflation rate 2.00 % 2.20 % 2.00 % 1.00 % 1.50 % Rate of increase in salaries 2.80 % 3.20 % 2.00 % 1.50 % 2.63 % Rate of increase for pensions in payment 1%-2% 2.20 % — — — Defined benefit December 31, 2020 Germany Sweden Austria Switzerland Italy Discount rate 0.55 % 1.05 % 1.00 % 0.15 % 0.33 % Inflation rate 2.00 % 1.50 % 2.00 % 0.20 % 1.00 % Rate of increase in salaries 2.80 % 2.50 % 2.00 % 0%-2.50% 2.63 % Rate of increase for pensions in payment 1%-2% 1.50 % — — —
Actuarial Assumptions Of Life Expectancy	These references are to the specific standard rates of mortality that are published and widely used in each country for the use of actuarial assessment of pension liabilities and take account of local current and future average life expectancy. December 31, 2021 (years) Germany Sweden Austria Switzerland Italy Retiring at the end of the year: Male 21 22 23 22 21 Female 24 24 26 24 22 December 31, 2020 (years) Germany Sweden Austria Switzerland Italy Retiring at the end of the year: Male 21 22 23 21 21 Female 24 24 26 24 22
Disclosure Of Sensitivity Analysis For Actuarial Assumptions Explanatory	The effect of a 1 percentage point movement in the most significant assumptions for the year ended December 31, 2021 is as follows: Increase Decrease €m €m Discount rate (54.6) 71.9 Inflation rate 47.4 (38.7) Rate of increase in salaries 15.2 (11.5) Rate of increase for pensions in payment 47.6 (37.0)

Provisions (Tables)

Provisions (Tables)	12 Months Ended
	Dec. 31, 2021
Other Provisions, Contingent Liabilities and Contingent Assets [Abstract]
Disclosure of Detailed Information About Provisions	Restructuring Onerous/ Provisions Other Total €m €m €m €m €m Balance at December 31, 2019 7.4 1.2 6.9 31.3 46.8 Additional provision in the period 15.6 — 0.1 13.4 29.1 Release of provision — (0.7) (0.4) (6.0) (7.1) Utilization of provision (10.4) (0.5) — (5.9) (16.8) Foreign exchange 0.3 — — (0.5) (0.2) Balance at December 31, 2020 12.9 — 6.6 32.3 51.8 Acquired through business combinations — — 0.3 3.8 4.1 Additional provision in the period 2.6 — 1.0 2.5 6.1 Release of provision (0.1) — — (4.0) (4.1) Utilization of provision (9.8) — — (6.9) (16.7) Foreign exchange — — — 1.0 1.0 Balance at December 31, 2021 5.6 — 7.9 28.7 42.2 Analysis of total provisions: December 31, 2021 December 31, 2020 Current 39.3 45.7 Non-current 2.9 6.1 Total 42.2 51.8

Share capital and reserves (Tab

Share capital and reserves (Tables)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share Capital, Reserves and Other Equity Interest [Abstract]
Schedule of Share Capital and Capital Reserve	Share capital and capital reserve As at December 31, 2021 As at December 31, 2020 €m €m Authorized: Unlimited number of Ordinary Shares with nil nominal value issued at $10.00 per share n/a n/a Unlimited number of Founder Preferred Shares with nil nominal value issued at $10.00 per share n/a n/a Issued and fully paid: 173,559,173 (December 31, 2020: 172,180,897) Ordinary Shares with nil nominal value 1,639.6 1,636.9 1,500,000 (December 31, 2020: 1,500,000) Founder Preferred Shares with nil nominal value 10.6 10.6 Total share capital and capital reserve 1,650.2 1,647.5 Listing and share transaction costs (27.1) (27.0) Total net share capital and capital reserve 1,623.1 1,620.5 Ordinary Shares Issued and Repurchased Ordinary shares Balance at December 31, 2019 194.5 Shares issued in the year 7.6 Shares repurchased in the year (29.9) Balance at December 31, 2020 172.2 Shares issued in the year 5.0 Shares repurchased in the year (3.6) Balance at December 31, 2021 173.6
Summary of Listing and Share Transaction Costs		€m At December 31, 2019 24.9 Share transaction costs 2.1 At December 31, 2020 27.0 Share transaction costs 0.1 At December 31, 2021 27.1

Share-based compensation rese_2

Share-based compensation reserve (Tables)	12 Months Ended
	Dec. 31, 2021
Share Capital, Reserves and Other Equity Interest [Abstract]
Disclosure of detailed information about reserves within equity	Share based €m Balance as of January 1, 2021 8.3 Non-Executive Director restricted share awards charge 0.8 Directors and Senior Management share awards charge 4.3 Shares issued upon vesting of awards (0.7) Reclassification of awards for settlement of tax liabilities (5.8) Balance as of December 31, 2021 6.9 Founder €m Balance as of January 1, 2021 245.5 Settlement of dividend through share issue (79.5) Balance as of December 31, 2021 166.0

Founder Preferred Shares Divi_2

Founder Preferred Shares Dividend Reserve (Tables)	12 Months Ended
	Dec. 31, 2021
Share Capital, Reserves and Other Equity Interest [Abstract]
Disclosure of classes of share capital	Share based €m Balance as of January 1, 2021 8.3 Non-Executive Director restricted share awards charge 0.8 Directors and Senior Management share awards charge 4.3 Shares issued upon vesting of awards (0.7) Reclassification of awards for settlement of tax liabilities (5.8) Balance as of December 31, 2021 6.9 Founder €m Balance as of January 1, 2021 245.5 Settlement of dividend through share issue (79.5) Balance as of December 31, 2021 166.0

Translation reserve Translati_2

Translation reserve Translation reserve table (Tables)	12 Months Ended
	Dec. 31, 2021
Disclosure of reserves within equity [line items]
Cash flow hedging reserve	Share-based compensation reserve The Company's discretionary share award scheme, the LTIP, enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. However, it is the Committee’s current intention that Awards be granted only to Directors and senior management, whilst recognizing a separate annual Restricted Stock Award for Non-Executive Directors. All Awards are to be settled by physical delivery of shares. Note 8(b) sets out the Non-Executive Director and Director and Senior Management Restricted share awards. Share based €m Balance as of January 1, 2021 8.3 Non-Executive Director restricted share awards charge 0.8 Directors and Senior Management share awards charge 4.3 Shares issued upon vesting of awards (0.7) Reclassification of awards for settlement of tax liabilities (5.8) Balance as of December 31, 2021 6.9 Nomad has issued Founder Preferred Shares to its Founder Entities. A summary of the key terms of the Founder Preferred Shares is set out in Note 25. The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. Commencing in 2015, the Founder Preferred Share Annual Dividend Amount became payable because the Company’s volume weighted average ordinary share price was above $11.50 for the last ten consecutive trading days of the 2015 financial year. The Preferred Shares Annual Dividend amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last ten consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of our ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts (currently $25.2127) multiplied by 140,220,619 Preferred Share Dividend Equivalent (the “Preferred Share Dividend Equivalent”). The Preferred Share Dividend Equivalent is equal to the number of ordinary shares outstanding immediately following the Iglo Acquisition, but excluding the 13.7 million ordinary shares issued to the seller of the Iglo Group. The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding. The amounts used for the purposes of calculating the Founder Preferred Shares Annual Dividend Amount and the relevant numbers of ordinary shares are subject to such adjustments for share splits, share dividends and certain other recapitalization events as the Directors in their absolute discretion determine to be fair and reasonable in the event of a consolidation or sub-division of the ordinary shares in issue, as determined in accordance with Nomad Foods’ Memorandum and Articles of Association. Dividends on the Founder Preferred Shares are payable until the Founder Preferred Shares are converted into Ordinary Shares. The Founder Preferred Shares automatically convert on a one for one basis (i) on the last day of the seventh full financial year following our acquisition of Iglo Foods (or if such day is not a trading day, the next trading day) or (ii) in the event of a change of control (unless the independent directors of our board of directors determine otherwise). The holders of Founder Preferred Shares may also be converted to Ordinary shares on a one for one basis at the option of the holder. In the event of an automatic conversion, a dividend on the Founder Preferred Shares shall be payable with respect to the shorted dividend year on the trading day immediately prior to the conversion. In the event of an optional conversion by the holder, no dividend on the Founder Preferred Shares shall be payable with respect to the year in which the conversion occurred. On December 31, 2019, the Company’s Board of Directors approved a share dividend of an aggregate of 6,421,074 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2018 dividend price of $16.7538 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $21.7289 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2019) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 2, 2020. On December 31, 2020, the Company’s Board of Directors approved a share dividend of an aggregate of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by the Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten consecutive trading days of 2020) and the ordinary shares underlying the Founder Preferred Share Dividend were issued on January 4, 2021. As of December 31, 2021, no Founder Preferred Shares Annual Dividend Amount was due, as the average price per ordinary share for the last ten consecutive trading days of the year did not reach the previously achieved 2020 Dividend Price of $25.2127. Founder €m Balance as of January 1, 2021 245.5 Settlement of dividend through share issue (79.5) Balance as of December 31, 2021 166.0 The translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign operations, as well as from the translation of liabilities that hedge the Company’s net investment in a foreign subsidiary. Year ended December 31, 2021 2020 2019 €m €m €m Balance as of January 1 84.7 94.8 88.8 Adjustment on adoption of hedge accounting under IFRS 9 1.6 — — Restated balance as of January 1 86.3 94.8 88.8 Foreign currency translation adjustments 31.7 (23.6) 19.2 Net deferred (losses)/gains on net investment hedges (1) (12.9) 13.5 (13.2) Total presented in Other Comprehensive Income 18.8 (10.1) 6.0 Balance as of December 31 105.1 84.7 94.8 (1) (Losses)/gains on net investment hedges are offset by €24.6 million of gains (2020: losses of €25.7 million, 2019: gains of €19.0 million) on GBP net investments included within the foreign currency translation adjustments. The translation reserve as at December 31, 2021 does not include any balances relating to continuing hedging relationships. As at December 31, 2020, the translation reserve included €17.3 million relating to continuing hedging relationships in respect of GBP net investments. The translation reserve as at December 31, 2021 included €50.8 million (2020: €46.4 million) relating to a discontinued hedging relationship in respect of GBP net investments. Under IFRS, cost of hedging allows firms to separately account for the fair value movement attributable to foreign currency basis under other comprehensive income (OCI) thereby excluding its impact from the hedge designation itself. Details of the Company's cash flow hedge accounting is detailed in Note 33. The table below shows the movement in the cash flow hedging reserve and cost of hedging reserve during the year, including the gains or losses arising on the revaluation of hedging instruments during the year and the amount reclassified from Other Comprehensive Income ("OCI") to the Consolidated Statement of Profit or Loss in the year. Cross currency interest rate swaps Forward currency contracts Total Cash flow hedge reserve Cost of Hedging reserve Total Other reserves €m €m €m €m €m Balance as of January 1, 2019 0.9 7.6 8.5 — 8.5 Change in fair value of hedging instrument recognized in OCI for the year 28.1 3.8 31.9 — 31.9 Reclassified to cost of goods sold — (21.8) (21.8) — (21.8) Reclassified from OCI to finance costs (37.4) — (37.4) — (37.4) Deferred tax 1.6 4.0 5.6 — 5.6 Balance as of December 31, 2019 (6.8) (6.4) (13.2) — (13.2) Change in fair value of hedging instrument recognized in OCI for the year (63.7) (20.0) (83.7) — (83.7) Reclassified to cost of goods sold — 0.2 0.2 — 0.2 Reclassified from OCI to finance costs 66.2 — 66.2 — 66.2 Deferred tax (0.2) 6.2 6.0 — 6.0 Balance as of December 31, 2020 (4.5) (20.0) (24.5) — (24.5) Reallocation for IFRS 9 changes to policy (start of the year) 2.8 — 2.8 (4.4) (1.6) Transferred to the carrying value of inventory — 27.6 27.6 — 27.6 Change in fair value of hedging instrument recognized in OCI for the year 73.3 9.3 82.6 2.4 85.0 Reclassified from OCI to finance costs (64.1) — (64.1) 1.7 (62.4) Deferred tax (2.4) (11.1) (13.5) (0.1) (13.6) Balance as of December 31, 2021 5.1 5.8 10.9 (0.4) 10.5
Reserve of exchange differences on translation [member]
Disclosure of reserves within equity [line items]
Cash flow hedging reserve	investment in a foreign subsidiary. Year ended December 31, 2021 2020 2019 €m €m €m Balance as of January 1 84.7 94.8 88.8 Adjustment on adoption of hedge accounting under IFRS 9 1.6 — — Restated balance as of January 1 86.3 94.8 88.8 Foreign currency translation adjustments 31.7 (23.6) 19.2 Net deferred (losses)/gains on net investment hedges (1) (12.9) 13.5 (13.2) Total presented in Other Comprehensive Income 18.8 (10.1) 6.0 Balance as of December 31 105.1 84.7 94.8 (1) (Losses)/gains on net investment hedges are offset by €24.6 million of gains (2020: losses of €25.7 million, 2019: gains of €19.0 million) on GBP net investments included within the foreign currency translation adjustments. The translation reserve as at December 31, 2021 does not include any balances relating to continuing hedging relationships. As at December 31, 2020, the translation reserve included €17.3 million relating to continuing hedging relationships in respect of GBP net investments. The translation reserve as at December 31, 2021 included €50.8 million (2020: €46.4 million) relating to a discontinued hedging relationship in respect of GBP net investments.

Cash flow hedging reserve (Tabl

Cash flow hedging reserve (Tables)	12 Months Ended
	Dec. 31, 2021
Share Capital, Reserves and Other Equity Interest [Abstract]
Movement in cash flow hedging reserve	The table below shows the movement in the cash flow hedging reserve and cost of hedging reserve during the year, including the gains or losses arising on the revaluation of hedging instruments during the year and the amount reclassified from Other Comprehensive Income ("OCI") to the Consolidated Statement of Profit or Loss in the year. Cross currency interest rate swaps Forward currency contracts Total Cash flow hedge reserve Cost of Hedging reserve Total Other reserves €m €m €m €m €m Balance as of January 1, 2019 0.9 7.6 8.5 — 8.5 Change in fair value of hedging instrument recognized in OCI for the year 28.1 3.8 31.9 — 31.9 Reclassified to cost of goods sold — (21.8) (21.8) — (21.8) Reclassified from OCI to finance costs (37.4) — (37.4) — (37.4) Deferred tax 1.6 4.0 5.6 — 5.6 Balance as of December 31, 2019 (6.8) (6.4) (13.2) — (13.2) Change in fair value of hedging instrument recognized in OCI for the year (63.7) (20.0) (83.7) — (83.7) Reclassified to cost of goods sold — 0.2 0.2 — 0.2 Reclassified from OCI to finance costs 66.2 — 66.2 — 66.2 Deferred tax (0.2) 6.2 6.0 — 6.0 Balance as of December 31, 2020 (4.5) (20.0) (24.5) — (24.5) Reallocation for IFRS 9 changes to policy (start of the year) 2.8 — 2.8 (4.4) (1.6) Transferred to the carrying value of inventory — 27.6 27.6 — 27.6 Change in fair value of hedging instrument recognized in OCI for the year 73.3 9.3 82.6 2.4 85.0 Reclassified from OCI to finance costs (64.1) — (64.1) 1.7 (62.4) Deferred tax (2.4) (11.1) (13.5) (0.1) (13.6) Balance as of December 31, 2021 5.1 5.8 10.9 (0.4) 10.5

Earnings_(loss) per share (Tabl

Earnings/(loss) per share (Tables)	12 Months Ended
	Dec. 31, 2021
Earnings per share [abstract]
Basic and diluted earnings/(loss) per share	Basic earnings per share Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Profit for the period attributable to equity owners of the parent (€m) 181.0 225.2 154.0 Weighted average Ordinary Shares and Founder Preferred Shares 178,070,770 194,019,070 192,004,803 Basic earnings per share (€’s) 1.02 1.16 0.80
Diluted earnings (loss) per share	Diluted earnings per share Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Profit for the period attributable to equity owners of the parent (€m) 181.0 225.2 154.0 Weighted average Ordinary Shares and Founder Preferred Shares 178,070,770 197,894,106 198,425,877 Diluted earnings per share (€’s) 1.02 1.14 0.78

Reconciliation of liabilities_2

Reconciliation of liabilities arising from financing activities (Tables)	12 Months Ended
	Dec. 31, 2021
Disclosure of reconciliation of liabilities arising from financing activities [abstract]
Disclosure of reconciliation of liabilities arising from financing activities [text block]	The table below details changes in the Company's liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flows were, or future cash flows will be classified in the Company's consolidated statements of cash flows from financing activities. Cash / non-cash Total loans and borrowings (Note 21) Financial payables (Note 22) Derivatives: (Net) Fair value of forward foreign exchange and currency swap contracts FVPTL Derivatives: (Net) Fair value of cross currency interest rate swaps €m €m €m €m Opening balance January 1, 2021 1,758.8 3.3 0.2 72.3 Cash inflow (1) Cash 800.0 — 0.3 1.4 Cash outflow (2) Cash (436.0) (38.1) — (2.3) Interest accretion (3) Cash 2.2 57.6 — — Acquired through business combinations Non-cash 19.6 — — — Exchange movement Non-cash 64.1 (0.2) — — Fair value changes Non-cash — — (0.1) (44.0) Other non-cash adjustments Non-cash 18.7 (2.9) — (6.8) Closing balance December 31, 2021 2,227.4 19.7 0.4 20.6 Cash / non-cash Total loans and borrowings (Note 21) Financial payables (Note 22) Derivatives: (Net) Fair value of forward foreign exchange and currency swap contracts FVPTL Derivatives: (Net) Fair value of cross currency interest rate swaps €m €m €m €m Opening balance January 1, 2020 1,875.3 4.1 (0.2) 15.3 Cash inflow (1) Cash — — — 6.8 Cash outflow (2) Cash (32.0) (57.0) (2.2) (3.9) Interest accretion (3) Cash 5.2 58.8 — — Acquired through business combinations Non-cash 0.4 — — — Exchange movement Non-cash (71.7) 0.9 — — Fair value changes Non-cash — — 2.6 54.1 Other non-cash adjustments Non-cash (18.4) (3.5) — — Closing balance December 31, 2020 1,758.8 3.3 0.2 72.3 (1) Cash inflows from cross currency interest rate swaps are part of effective cash flow hedging relationships and are presented within interest paid within the Consolidated Statements of Cash Flows. (2) Cash outflows from cross currency interest rate swaps are not part of a cash flow hedge and are presented within proceeds on settlement of derivatives within the Consolidated Statements of Cash Flows.

Cash flows from operating act_2

Cash flows from operating activities (Tables)	12 Months Ended
	Dec. 31, 2021
Cash Flow Statement [Abstract]
Schedule of cash flow disclosures	Year ended December 31, 2021 Year ended December 31, 2020 Year ended December 31, 2019 Note €m €m €m Cash flows from operating activities Profit for the period 181.0 225.1 153.6 Adjustments for: Exceptional items 7 45.3 20.6 54.5 Non-cash fair value purchase price adjustment of inventory 5 8.4 — — Share based payments expense 5.1 9.0 14.9 Depreciation and amortization 71.6 67.6 68.3 Loss on disposal and impairment of property, plant and equipment 0.7 0.9 0.6 Net finance costs 10 106.0 63.7 73.2 Taxation 11 55.7 70.4 56.7 Operating cash flow before changes in working capital, provisions and exceptional items 473.8 457.3 421.8 (Increase)/decrease in inventories (23.8) (12.7) 23.5 Decrease/(increase) in trade and other receivables 24.1 (1.8) (34.4) (Decrease)/increase in trade and other payables (25.0) 107.2 (40.6) Increase in employee benefit and other provisions 1.2 2.0 6.6 Cash generated from operations before tax and exceptional items 450.3 552.0 376.9

Financial risk management (Tabl

Financial risk management (Tables)	12 Months Ended
	Dec. 31, 2021
Financial Instruments [Abstract]
Disclosure of financial instruments	The effects of the cash flow hedging instruments on the Company's financial position and performance are as follows: All amounts stated in €m, unless otherwise stated December 31, 2021 December 31, 2020 USD - cross currency interest rate swaps Carrying amount of liability (20.6) (89.5) Notional amount (USD) $916.4 $926.0 Maturity date 5/15/2024 5/15/2022 Change in fair value of outstanding hedging instruments since January 1 68.9 (71.0) (Gain)/loss in value of hedged item used to determine effectiveness (69.6) 71.0 Weighted average hedged rate for the year 1.11 1.11 The effects of the net investment hedging instruments on the Company's financial position and performance are as follows: All amounts stated in €m, unless otherwise stated December 31, 2021 December 31, 2020 UK cross-currency interest rate swaps hedge Carrying amount of cross-currency interest rate swaps — 14.3 Notional amount (GBP) — £220.2 Maturity date 7/29/2021 5/15/2022 Change in fair value of cross-currency interest rate swaps as a result of foreign currency movements since January 1 (12.9) 13.5 Loss/(gain) in value of hedged item used to determine hedge effectiveness 12.9 (13.5) Weighted average hedged rate for the year 1.19 1.19 As at December 31, 2021 EUR/USD GBP/USD GBP/EUR SEK/EUR SEK/USD Other Currencies €m €m €m €m €m €m Derivative financial instruments - forward currency contracts Carrying amount of (liability)/asset 17.5 1.2 (6.7) 0.5 0.1 0.3 Notional amount 343.6 58.4 244.7 70.4 4.5 96.4 Fair value (gains)/losses of outstanding hedging instruments since January 1 (26.3) (0.5) 12.0 (0.9) 13.5 0.6 Weighted average hedge rate for the year 1.20 1.38 1.15 0.10 0.11 — As at December 31, 2020 EUR/USD GBP/USD GBP/EUR SEK/EUR SEK/USD Other Currencies €m €m €m €m €m €m Derivative financial instruments - forward currency contracts Carrying amount of asset/(liability) (21.9) (3.7) 1.4 (4.0) (2.6) (0.5) Notional amount 249.0 53.5 159.0 77.3 14.1 16.8 Fair value (gains)/losses of outstanding hedging instruments since January 1 (20.6) (2.0) 8.5 (4.2) (2.2) 0.8 Weighted average hedge rate for the year 1.13 1.28 1.12 0.09 0.10 0.21 Categories of financial instruments The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 'Financial Instruments'. Financial assets at amortized cost Financial Assets at Fair Value through profit or loss Derivatives at Derivatives designated in hedge relationships Financial Total 2021 €m €m €m €m €m €m Assets Trade and other receivables 201.6 — — — — 201.6 Derivative financial instruments — — 0.5 19.7 — 20.2 Cash and cash equivalents 254.2 — — — — 254.2 Liabilities Trade and other payables excluding non-financial liabilities — — — — (647.1) (647.1) Derivative financial instruments — — (0.1) (28.0) — (28.1) Loans and borrowings (1) — — — — (2,236.8) (2,236.8) Total 455.8 — 0.4 (8.3) (2,883.9) (2,436.0) (1) Loans and borrowings excludes €9.4 million of deferred borrowing costs which are included within €2,227.4 million of total loans and borrowings in Note 21. Financial assets at amortized cost Financial Assets at Fair Value through profit or loss Derivatives at Derivatives designated in hedge relationships Financial Total 2020 €m €m €m €m €m €m Assets Trade and other receivables 141.2 — — — — 141.2 Derivative financial instruments — — 2.9 19.8 — 22.7 Cash and cash equivalents 393.2 — — — — 393.2 Short - term investments — 25.0 — — — 25.0 Liabilities Trade and other payables excluding non-financial liabilities — — — — (601.1) (601.1) Derivative financial instruments — — (0.2) (124.8) — (125.0) Loans and borrowings (2) — — — — (1,765.7) (1,765.7) Total 534.4 25.0 2.7 (105.0) (2,366.8) (1,909.7) (2) Loans and borrowings excludes €6.9 million of deferred borrowing costs which are included within €1,758.8 million of total non-current loans and borrowings in Note 21. Fair values Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, Nomad uses various methods including market, income and cost approaches. Based on these approaches, Nomad utilizes certain assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs may be readily observable, market corroborated, or generally unobservable inputs. The fair value hierarchy ranks the quality and reliability of the information used to determine fair values. Financial assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories: Level 1—Quoted prices for identical assets and liabilities traded in active exchange markets, such as the New York Stock Exchange. Level 2—Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data. Level 3—Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation; also includes observable inputs for non binding single dealer quotes not corroborated by observable market data. Where market information is not available to support internal valuations, reviews of third party valuations are performed. While Nomad believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The following is a description of the valuation methodologies and assumptions used for estimating the fair values of financial instruments held by the Company. (i) Derivative financial instruments Derivative financial instruments are held at fair value. There is no difference between carrying value and fair value. The valuation technique utilized by the Company maximizes the use of observable market data where it is available. All significant inputs required to fair value the instrument are observable. The Company has classified its derivative financial instruments as level 2 instruments as defined in IFRS 13 ‘Fair value measurement’. (ii) Trade and other payables/receivables The notional amount of trade and other payables/receivables are deemed to be carried at fair value, short term and settled in cash. (iii) Cash and cash equivalents The carrying value of cash and cash equivalents is deemed to equal fair value. (iv) Short-term investments Short-term investments are valued using inputs that are derived principally from or corroborated by observable market data. The Company has classified these as level 2 instruments as defined in IFRS 13 “Fair value measurement”. (v) Interest bearing loans and liabilities The fair value of secured notes is determined by reference to price quotations in the active market in which they are traded. They are classified as level 1 instruments. The fair value of the senior loans is calculated by discounting the expected future cash flows at the year end’s prevailing interest rates. They are classified as level 2 instruments. There is no requirement to determine or disclose the fair value of lease liabilities. On June 24, 2021, the Company through its indirect, wholly-owned subsidiary, Nomad Foods Bondco Plc, repaid the €400.0 million 3.25% senior secured notes due 2024 and completed a private offering of €750.0 million aggregate principal amount of 2.5% senior secured notes due June 24, 2028 (the “Notes”). Interest on the Notes accrues from the date of issue and is payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2022. The Notes are guaranteed on a senior basis by the Company and certain subsidiaries thereof. This transaction was accounted for as an extinguishment of the existing Notes and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Notes, eligible transaction costs of approximately €4.0 million were capitalized and will be amortized over the life of the debt. On July 9, 2021 the Company announced that Nomad Foods Bondco Plc, an indirect, wholly-owned subsidiary of the Company, completed its private offering of €50.0 million aggregate principal amount of additional 2.5% senior secured notes due 2028, representing a tack-on to the €750.0 million aggregate principal amount of senior secured notes due 2028 issued on June 24, 2021, and issued at a price of €100.75. On June 24, 2021, the Company amended and restated the Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility originally due in May 2024, through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. This transaction was accounted for as an extinguishment of the existing debt and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Senior EUR Loan, eligible transaction costs of approximately €3.8 million were capitalized and will be amortized over the life of the debt. Under the refinancing, the existing revolving credit facility of €80.0 million due 2023, was replaced with a new €175.0 million facility (the "Revolving Credit Facility") available until June 2026 with an applicable margin of 2.25% per annum and that includes a leverage ratchet. The Revolving Credit Facility may be utilized to support working capital requirements, including letters of credit and bank guarantees. The structure of the Revolving Credit Facility now also includes a pricing structure linked to environmental impact metrics during the life of the facility, and by doing so demonstrates further commitment to the Company’s sustainability strategy by incorporating ESG target KPIs covering areas of sourcing, packaging and carbon emissions. The Company continues to have outstanding senior USD loans as at December 31, 2021 of $916.4 million (€808.6 million) (the “Senior USD Loan”). The Senior USD Loan is repayable in May 2024. The Senior USD Loan requires a repayment of $9.6 million (€8.5 million) in May each year until maturity equivalent to 1.0% of the original issued notional. Furthermore as part of the senior loan structure, the Company is additionally required to undertake an annual excess cash flow calculation whereby additional principal could be paid. The Company uses cross currency interest rate swaps (“CCIRS”) to convert its $916.4 million of floating rate Senior USD Loans into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge. On July 29, 2021 the Company extended its CCIRS used to hedge the foreign currency and interest rate risk on the current Senior Secured USD Term Loan from May 2022 to May 2024 to align with the maturity date of the USD Term Loan. As part of the transaction, the EUR fixed rate paid by the Company has been amended and reflected in the underlying interest cost. The transaction is considered to be a substantial modification of the hedging instruments, so is considered to be a new hedging relationship which will give rise to some ineffectiveness in future periods. CCIRS contracts that have previously been used as a net investment hedge of the Company’s investments in Pound Sterling have also been extinguished. A change in fair value of the CCIRS arose as a consequence of the transaction, which the Company has elected to write-off immediately as a cost of extinguishment. This non-cash loss, as well as the write-off of the cost of hedging reserves associated with the discontinued net investment hedge, are presented as a one-off charge for the transaction as disclosed in Note 10. The cash flow hedge reserve related to the previous hedge relationship will be released on a straight line basis until May 2022. The senior loans, Senior Secured Notes and any drawn balances of the Revolving Credit Facility are secured with equal ranking against assets of the Company and specified subsidiaries. Fair value Carrying value December 31, 2021 December 31, 2020 December 31, 2021 December 31, 2020 €m €m €m €m Senior EUR/USD loans 1,360.8 1,300.4 1,355.8 1,295.1 Other external debt 0.1 0.2 0.1 0.2 2024 fixed rate senior secured notes — 405.8 — 400.0 2028 fixed rate senior secured notes 802.6 — 800.0 — Less deferred borrowing costs — — (9.4) (6.9) 2,163.5 1,706.4 2,146.5 1,688.4 Derivatives As at December 31, 2021 As at December 31, 2020 €m €m Cross Currency Interest Rate Swaps — 17.2 Forward foreign exchange contracts 20.2 5.5 Total assets 20.2 22.7 Cross Currency Interest Rate Swaps (20.6) (89.5) Forward foreign exchange contracts (7.3) (35.5) Total liabilities (27.9) (125.0) Total (7.7) (102.3) Offsetting of derivatives Derivative contracts are held under International Swaps and Derivatives Association (ISDA) agreements with financial institutions. An ISDA is an enforceable master netting agreement that permits the Company to settle net in the event of default. The following table sets out the carrying amounts of recognized financial instruments that are subject to the above agreements. Gross amount Related Net amount As at Dec 31, 2021 €m €m €m Derivatives - assets 20.2 (10.8) 9.4 Derivatives - liabilities (27.9) 10.8 (17.1) Gross amount Related Net amount As at Dec 31, 2020 €m €m €m Derivatives - assets 22.7 (22.7) — Derivatives - liabilities (125.0) 22.7 (102.3)
Disclosure of maturity analysis for derivative financial liabilities	The tables below show a maturity analysis of contractual undiscounted cash flows prepared using forward interest rates where applicable, showing items at the earliest date on which the Company could be required to pay the liability: 2021 2022 2023 2024 2025 2026 Over 5 years Total €m €m €m €m €m €m €m Borrowings-principal 8.5 8.5 791.7 — — 1,353.2 2,161.9 Borrowings-interest 57.5 63.5 50.4 34.0 34.1 67.0 306.5 Forward contracts Sell 805.3 — — — — — 805.3 Forward contracts Buy (818.0) — — — — — (818.0) Cross Currency Interest Rate Swaps Pay 25.0 24.9 818.5 — — — 868.4 Cross Currency Interest Rate Swaps Receive (30.8) (38.0) (808.0) — — — (876.8) Lease Liabilities 23.1 18.2 11.2 7.3 5.6 25.2 90.6 Trade and other payables excluding non-financial liabilities 647.1 — — — — — 647.1 Total 717.7 77.1 863.8 41.3 39.7 1,445.4 3,185.0 2020 2021 2022 2023 2024 2025 Over 5 years Total €m €m €m €m €m €m €m Borrowings-principal 7.8 7.8 7.8 1,683.1 — — 1,706.5 Borrowings-interest 46.6 46.8 47.2 20.4 — — 161.0 Forward contracts Sell 677.3 — — — — — 677.3 Forward contracts Buy (647.5) — — — — — (647.5) Cross Currency Interest Rate Swaps Pay 38.5 1,135.9 — — — — 1,174.4 Cross Currency Interest Rate Swaps Receive (34.6) (1,059.0) — — — — (1,093.6) Lease Liabilities 17.2 13.6 9.9 6.2 5.2 28.1 80.2 Trade and other payables excluding non-financial liabilities 601.1 — — — — — 601.1 Total 706.4 145.1 64.9 1,709.7 5.2 28.1 2,659.4
Disclosure of maturity analysis for non-derivative financial liabilities	The tables below show a maturity analysis of contractual undiscounted cash flows prepared using forward interest rates where applicable, showing items at the earliest date on which the Company could be required to pay the liability: 2021 2022 2023 2024 2025 2026 Over 5 years Total €m €m €m €m €m €m €m Borrowings-principal 8.5 8.5 791.7 — — 1,353.2 2,161.9 Borrowings-interest 57.5 63.5 50.4 34.0 34.1 67.0 306.5 Forward contracts Sell 805.3 — — — — — 805.3 Forward contracts Buy (818.0) — — — — — (818.0) Cross Currency Interest Rate Swaps Pay 25.0 24.9 818.5 — — — 868.4 Cross Currency Interest Rate Swaps Receive (30.8) (38.0) (808.0) — — — (876.8) Lease Liabilities 23.1 18.2 11.2 7.3 5.6 25.2 90.6 Trade and other payables excluding non-financial liabilities 647.1 — — — — — 647.1 Total 717.7 77.1 863.8 41.3 39.7 1,445.4 3,185.0 2020 2021 2022 2023 2024 2025 Over 5 years Total €m €m €m €m €m €m €m Borrowings-principal 7.8 7.8 7.8 1,683.1 — — 1,706.5 Borrowings-interest 46.6 46.8 47.2 20.4 — — 161.0 Forward contracts Sell 677.3 — — — — — 677.3 Forward contracts Buy (647.5) — — — — — (647.5) Cross Currency Interest Rate Swaps Pay 38.5 1,135.9 — — — — 1,174.4 Cross Currency Interest Rate Swaps Receive (34.6) (1,059.0) — — — — (1,093.6) Lease Liabilities 17.2 13.6 9.9 6.2 5.2 28.1 80.2 Trade and other payables excluding non-financial liabilities 601.1 — — — — — 601.1 Total 706.4 145.1 64.9 1,709.7 5.2 28.1 2,659.4

Financial instruments (Tables)

Financial instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Financial Instruments [Abstract]
Disclosure of financial instruments	The effects of the cash flow hedging instruments on the Company's financial position and performance are as follows: All amounts stated in €m, unless otherwise stated December 31, 2021 December 31, 2020 USD - cross currency interest rate swaps Carrying amount of liability (20.6) (89.5) Notional amount (USD) $916.4 $926.0 Maturity date 5/15/2024 5/15/2022 Change in fair value of outstanding hedging instruments since January 1 68.9 (71.0) (Gain)/loss in value of hedged item used to determine effectiveness (69.6) 71.0 Weighted average hedged rate for the year 1.11 1.11 The effects of the net investment hedging instruments on the Company's financial position and performance are as follows: All amounts stated in €m, unless otherwise stated December 31, 2021 December 31, 2020 UK cross-currency interest rate swaps hedge Carrying amount of cross-currency interest rate swaps — 14.3 Notional amount (GBP) — £220.2 Maturity date 7/29/2021 5/15/2022 Change in fair value of cross-currency interest rate swaps as a result of foreign currency movements since January 1 (12.9) 13.5 Loss/(gain) in value of hedged item used to determine hedge effectiveness 12.9 (13.5) Weighted average hedged rate for the year 1.19 1.19 As at December 31, 2021 EUR/USD GBP/USD GBP/EUR SEK/EUR SEK/USD Other Currencies €m €m €m €m €m €m Derivative financial instruments - forward currency contracts Carrying amount of (liability)/asset 17.5 1.2 (6.7) 0.5 0.1 0.3 Notional amount 343.6 58.4 244.7 70.4 4.5 96.4 Fair value (gains)/losses of outstanding hedging instruments since January 1 (26.3) (0.5) 12.0 (0.9) 13.5 0.6 Weighted average hedge rate for the year 1.20 1.38 1.15 0.10 0.11 — As at December 31, 2020 EUR/USD GBP/USD GBP/EUR SEK/EUR SEK/USD Other Currencies €m €m €m €m €m €m Derivative financial instruments - forward currency contracts Carrying amount of asset/(liability) (21.9) (3.7) 1.4 (4.0) (2.6) (0.5) Notional amount 249.0 53.5 159.0 77.3 14.1 16.8 Fair value (gains)/losses of outstanding hedging instruments since January 1 (20.6) (2.0) 8.5 (4.2) (2.2) 0.8 Weighted average hedge rate for the year 1.13 1.28 1.12 0.09 0.10 0.21 Categories of financial instruments The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 'Financial Instruments'. Financial assets at amortized cost Financial Assets at Fair Value through profit or loss Derivatives at Derivatives designated in hedge relationships Financial Total 2021 €m €m €m €m €m €m Assets Trade and other receivables 201.6 — — — — 201.6 Derivative financial instruments — — 0.5 19.7 — 20.2 Cash and cash equivalents 254.2 — — — — 254.2 Liabilities Trade and other payables excluding non-financial liabilities — — — — (647.1) (647.1) Derivative financial instruments — — (0.1) (28.0) — (28.1) Loans and borrowings (1) — — — — (2,236.8) (2,236.8) Total 455.8 — 0.4 (8.3) (2,883.9) (2,436.0) (1) Loans and borrowings excludes €9.4 million of deferred borrowing costs which are included within €2,227.4 million of total loans and borrowings in Note 21. Financial assets at amortized cost Financial Assets at Fair Value through profit or loss Derivatives at Derivatives designated in hedge relationships Financial Total 2020 €m €m €m €m €m €m Assets Trade and other receivables 141.2 — — — — 141.2 Derivative financial instruments — — 2.9 19.8 — 22.7 Cash and cash equivalents 393.2 — — — — 393.2 Short - term investments — 25.0 — — — 25.0 Liabilities Trade and other payables excluding non-financial liabilities — — — — (601.1) (601.1) Derivative financial instruments — — (0.2) (124.8) — (125.0) Loans and borrowings (2) — — — — (1,765.7) (1,765.7) Total 534.4 25.0 2.7 (105.0) (2,366.8) (1,909.7) (2) Loans and borrowings excludes €6.9 million of deferred borrowing costs which are included within €1,758.8 million of total non-current loans and borrowings in Note 21. Fair values Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, Nomad uses various methods including market, income and cost approaches. Based on these approaches, Nomad utilizes certain assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs may be readily observable, market corroborated, or generally unobservable inputs. The fair value hierarchy ranks the quality and reliability of the information used to determine fair values. Financial assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories: Level 1—Quoted prices for identical assets and liabilities traded in active exchange markets, such as the New York Stock Exchange. Level 2—Observable inputs other than Level 1 including quoted prices for similar assets or liabilities, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data. Level 3—Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation; also includes observable inputs for non binding single dealer quotes not corroborated by observable market data. Where market information is not available to support internal valuations, reviews of third party valuations are performed. While Nomad believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The following is a description of the valuation methodologies and assumptions used for estimating the fair values of financial instruments held by the Company. (i) Derivative financial instruments Derivative financial instruments are held at fair value. There is no difference between carrying value and fair value. The valuation technique utilized by the Company maximizes the use of observable market data where it is available. All significant inputs required to fair value the instrument are observable. The Company has classified its derivative financial instruments as level 2 instruments as defined in IFRS 13 ‘Fair value measurement’. (ii) Trade and other payables/receivables The notional amount of trade and other payables/receivables are deemed to be carried at fair value, short term and settled in cash. (iii) Cash and cash equivalents The carrying value of cash and cash equivalents is deemed to equal fair value. (iv) Short-term investments Short-term investments are valued using inputs that are derived principally from or corroborated by observable market data. The Company has classified these as level 2 instruments as defined in IFRS 13 “Fair value measurement”. (v) Interest bearing loans and liabilities The fair value of secured notes is determined by reference to price quotations in the active market in which they are traded. They are classified as level 1 instruments. The fair value of the senior loans is calculated by discounting the expected future cash flows at the year end’s prevailing interest rates. They are classified as level 2 instruments. There is no requirement to determine or disclose the fair value of lease liabilities. On June 24, 2021, the Company through its indirect, wholly-owned subsidiary, Nomad Foods Bondco Plc, repaid the €400.0 million 3.25% senior secured notes due 2024 and completed a private offering of €750.0 million aggregate principal amount of 2.5% senior secured notes due June 24, 2028 (the “Notes”). Interest on the Notes accrues from the date of issue and is payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2022. The Notes are guaranteed on a senior basis by the Company and certain subsidiaries thereof. This transaction was accounted for as an extinguishment of the existing Notes and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Notes, eligible transaction costs of approximately €4.0 million were capitalized and will be amortized over the life of the debt. On July 9, 2021 the Company announced that Nomad Foods Bondco Plc, an indirect, wholly-owned subsidiary of the Company, completed its private offering of €50.0 million aggregate principal amount of additional 2.5% senior secured notes due 2028, representing a tack-on to the €750.0 million aggregate principal amount of senior secured notes due 2028 issued on June 24, 2021, and issued at a price of €100.75. On June 24, 2021, the Company amended and restated the Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility originally due in May 2024, through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to EURIBOR with a zero floor plus a margin of 2.5%. This transaction was accounted for as an extinguishment of the existing debt and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 10. On the new Senior EUR Loan, eligible transaction costs of approximately €3.8 million were capitalized and will be amortized over the life of the debt. Under the refinancing, the existing revolving credit facility of €80.0 million due 2023, was replaced with a new €175.0 million facility (the "Revolving Credit Facility") available until June 2026 with an applicable margin of 2.25% per annum and that includes a leverage ratchet. The Revolving Credit Facility may be utilized to support working capital requirements, including letters of credit and bank guarantees. The structure of the Revolving Credit Facility now also includes a pricing structure linked to environmental impact metrics during the life of the facility, and by doing so demonstrates further commitment to the Company’s sustainability strategy by incorporating ESG target KPIs covering areas of sourcing, packaging and carbon emissions. The Company continues to have outstanding senior USD loans as at December 31, 2021 of $916.4 million (€808.6 million) (the “Senior USD Loan”). The Senior USD Loan is repayable in May 2024. The Senior USD Loan requires a repayment of $9.6 million (€8.5 million) in May each year until maturity equivalent to 1.0% of the original issued notional. Furthermore as part of the senior loan structure, the Company is additionally required to undertake an annual excess cash flow calculation whereby additional principal could be paid. The Company uses cross currency interest rate swaps (“CCIRS”) to convert its $916.4 million of floating rate Senior USD Loans into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge. On July 29, 2021 the Company extended its CCIRS used to hedge the foreign currency and interest rate risk on the current Senior Secured USD Term Loan from May 2022 to May 2024 to align with the maturity date of the USD Term Loan. As part of the transaction, the EUR fixed rate paid by the Company has been amended and reflected in the underlying interest cost. The transaction is considered to be a substantial modification of the hedging instruments, so is considered to be a new hedging relationship which will give rise to some ineffectiveness in future periods. CCIRS contracts that have previously been used as a net investment hedge of the Company’s investments in Pound Sterling have also been extinguished. A change in fair value of the CCIRS arose as a consequence of the transaction, which the Company has elected to write-off immediately as a cost of extinguishment. This non-cash loss, as well as the write-off of the cost of hedging reserves associated with the discontinued net investment hedge, are presented as a one-off charge for the transaction as disclosed in Note 10. The cash flow hedge reserve related to the previous hedge relationship will be released on a straight line basis until May 2022. The senior loans, Senior Secured Notes and any drawn balances of the Revolving Credit Facility are secured with equal ranking against assets of the Company and specified subsidiaries. Fair value Carrying value December 31, 2021 December 31, 2020 December 31, 2021 December 31, 2020 €m €m €m €m Senior EUR/USD loans 1,360.8 1,300.4 1,355.8 1,295.1 Other external debt 0.1 0.2 0.1 0.2 2024 fixed rate senior secured notes — 405.8 — 400.0 2028 fixed rate senior secured notes 802.6 — 800.0 — Less deferred borrowing costs — — (9.4) (6.9) 2,163.5 1,706.4 2,146.5 1,688.4 Derivatives As at December 31, 2021 As at December 31, 2020 €m €m Cross Currency Interest Rate Swaps — 17.2 Forward foreign exchange contracts 20.2 5.5 Total assets 20.2 22.7 Cross Currency Interest Rate Swaps (20.6) (89.5) Forward foreign exchange contracts (7.3) (35.5) Total liabilities (27.9) (125.0) Total (7.7) (102.3) Offsetting of derivatives Derivative contracts are held under International Swaps and Derivatives Association (ISDA) agreements with financial institutions. An ISDA is an enforceable master netting agreement that permits the Company to settle net in the event of default. The following table sets out the carrying amounts of recognized financial instruments that are subject to the above agreements. Gross amount Related Net amount As at Dec 31, 2021 €m €m €m Derivatives - assets 20.2 (10.8) 9.4 Derivatives - liabilities (27.9) 10.8 (17.1) Gross amount Related Net amount As at Dec 31, 2020 €m €m €m Derivatives - assets 22.7 (22.7) — Derivatives - liabilities (125.0) 22.7 (102.3)
Disclosure of Financial Assets	The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 'Financial Instruments'. Financial assets at amortized cost Financial Assets at Fair Value through profit or loss Derivatives at Derivatives designated in hedge relationships Financial Total 2021 €m €m €m €m €m €m Assets Trade and other receivables 201.6 — — — — 201.6 Derivative financial instruments — — 0.5 19.7 — 20.2 Cash and cash equivalents 254.2 — — — — 254.2 Liabilities Trade and other payables excluding non-financial liabilities — — — — (647.1) (647.1) Derivative financial instruments — — (0.1) (28.0) — (28.1) Loans and borrowings (1) — — — — (2,236.8) (2,236.8) Total 455.8 — 0.4 (8.3) (2,883.9) (2,436.0) (1) Loans and borrowings excludes €9.4 million of deferred borrowing costs which are included within €2,227.4 million of total loans and borrowings in Note 21. Financial assets at amortized cost Financial Assets at Fair Value through profit or loss Derivatives at Derivatives designated in hedge relationships Financial Total 2020 €m €m €m €m €m €m Assets Trade and other receivables 141.2 — — — — 141.2 Derivative financial instruments — — 2.9 19.8 — 22.7 Cash and cash equivalents 393.2 — — — — 393.2 Short - term investments — 25.0 — — — 25.0 Liabilities Trade and other payables excluding non-financial liabilities — — — — (601.1) (601.1) Derivative financial instruments — — (0.2) (124.8) — (125.0) Loans and borrowings (2) — — — — (1,765.7) (1,765.7) Total 534.4 25.0 2.7 (105.0) (2,366.8) (1,909.7)
Disclosure of Financial Liabilities	The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 'Financial Instruments'. Financial assets at amortized cost Financial Assets at Fair Value through profit or loss Derivatives at Derivatives designated in hedge relationships Financial Total 2021 €m €m €m €m €m €m Assets Trade and other receivables 201.6 — — — — 201.6 Derivative financial instruments — — 0.5 19.7 — 20.2 Cash and cash equivalents 254.2 — — — — 254.2 Liabilities Trade and other payables excluding non-financial liabilities — — — — (647.1) (647.1) Derivative financial instruments — — (0.1) (28.0) — (28.1) Loans and borrowings (1) — — — — (2,236.8) (2,236.8) Total 455.8 — 0.4 (8.3) (2,883.9) (2,436.0) (1) Loans and borrowings excludes €9.4 million of deferred borrowing costs which are included within €2,227.4 million of total loans and borrowings in Note 21. Financial assets at amortized cost Financial Assets at Fair Value through profit or loss Derivatives at Derivatives designated in hedge relationships Financial Total 2020 €m €m €m €m €m €m Assets Trade and other receivables 141.2 — — — — 141.2 Derivative financial instruments — — 2.9 19.8 — 22.7 Cash and cash equivalents 393.2 — — — — 393.2 Short - term investments — 25.0 — — — 25.0 Liabilities Trade and other payables excluding non-financial liabilities — — — — (601.1) (601.1) Derivative financial instruments — — (0.2) (124.8) — (125.0) Loans and borrowings (2) — — — — (1,765.7) (1,765.7) Total 534.4 25.0 2.7 (105.0) (2,366.8) (1,909.7) Fair value Carrying value December 31, 2021 December 31, 2020 December 31, 2021 December 31, 2020 €m €m €m €m Senior EUR/USD loans 1,360.8 1,300.4 1,355.8 1,295.1 Other external debt 0.1 0.2 0.1 0.2 2024 fixed rate senior secured notes — 405.8 — 400.0 2028 fixed rate senior secured notes 802.6 — 800.0 — Less deferred borrowing costs — — (9.4) (6.9) 2,163.5 1,706.4 2,146.5 1,688.4
Disclosure of Derivatives	As at December 31, 2021 As at December 31, 2020 €m €m Cross Currency Interest Rate Swaps — 17.2 Forward foreign exchange contracts 20.2 5.5 Total assets 20.2 22.7 Cross Currency Interest Rate Swaps (20.6) (89.5) Forward foreign exchange contracts (7.3) (35.5) Total liabilities (27.9) (125.0) Total (7.7) (102.3)
Disclosure of offsetting of financial assets and financial liabilities [text block]	The following table sets out the carrying amounts of recognized financial instruments that are subject to the above agreements. Gross amount Related Net amount As at Dec 31, 2021 €m €m €m Derivatives - assets 20.2 (10.8) 9.4 Derivatives - liabilities (27.9) 10.8 (17.1) Gross amount Related Net amount As at Dec 31, 2020 €m €m €m Derivatives - assets 22.7 (22.7) — Derivatives - liabilities (125.0) 22.7 (102.3)

Commitments (Tables)

Commitments (Tables)	12 Months Ended
	Dec. 31, 2021
Leases1 [Abstract]
Future Aggregate Minimum Lease Payments for non-cancellable Service agreements and low value or short-lived Lease Rentals	on-cancellable service agreements and lease rentals for short-lived and low-value assets are payable as follows: As at December 31, 2021 As at December 31, 2020 €m €m Less than one year 2.2 1.9 Between one and three years 4.1 3.5 Between three and five years 2.2 2.0 More than five years 0.2 0.1 Total 8.7 7.5

Capital commitments (Tables)

Capital commitments (Tables)	12 Months Ended
	Dec. 31, 2021
Additional information [abstract]
Schedule of capital commitments	Capital expenditure contracted for at the end of the reporting period but not yet incurred is as follows: As at December 31, 2021 As at December 31, 2020 €m €m Property, plant and equipment 21.3 13.6 Intangible assets 1.7 3.4 Total 23.0 17.0

Impact of adoption of IFRS 9 fo

Impact of adoption of IFRS 9 for hedge accounting (Details) - EUR (€) € in Millions	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of initial application of standards or interpretations [line items]
Reserve of cash flow hedges	€ 10.5	€ (21.7)	€ (24.5)	€ (13.2)	€ 8.5
Reserve of change in value of forward elements of forward contracts		(4.4)	0
Other reserves		(26.1)	(24.5)
Translation reserve	€ 105.1	86.3	€ 84.7
Increase (decrease) due to changes in accounting policy [member]
Disclosure of initial application of standards or interpretations [line items]
Reserve of cash flow hedges		2.8
Reserve of change in value of forward elements of forward contracts		(4.4)
Other reserves		(1.6)
Translation reserve		€ 1.6

Basis of preparation Impact of

Basis of preparation Impact of change in accounting standard IFRS16 (Details) - EUR (€) € / shares in Units, € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of initial application of standards or interpretations [line items]
Disclosure of maturity analysis ofcommitments [text block]	8.7	7.5
Property, plant and equipment	€ 489.2	€ 373.2	€ 350
Other provisions	42.2	51.8	46.8
Retained earnings	387.4	191.6
Profit (loss) before tax	236.7	295.5	210.3
Depreciation, right-of-use assets	€ 16.6	€ 15.7	€ 16.1
Impact on Earnings per share	€ 1.02	€ 1.16	€ 0.80
Loans and borrowings	€ 2,198.3	€ 1,736.3
Current	39.3	45.7
Provisions	2.9	6.1
Trade and other payables	693.8	€ 649.4
Deferred hedging gains transferred to the carrying value of inventory	€ 27.6

Basis of preparation (Details)

Basis of preparation (Details) - EUR (€) € in Millions	Dec. 31, 2021	Jun. 24, 2021	Dec. 31, 2020
Revolving Credit Facility (new)
Disclosure of initial application of standards or interpretations [line items]
Line of credit facility, maximum borrowing capacity		€ 175
Revolving Credit Facility (existing - replaced)
Disclosure of initial application of standards or interpretations [line items]
Line of credit facility, maximum borrowing capacity			€ 80
Senior USD Debt
Disclosure of initial application of standards or interpretations [line items]
Interest rate	2.25%

Accounting policies (Details)

Accounting policies (Details) € in Millions	12 Months Ended
	Dec. 31, 2021EUR (€)segment	Dec. 31, 2020EUR (€)	Jun. 01, 2015EUR (€)
Disclosure of detailed information about property, plant and equipment [line items]
Trade receivables	€ 372.7	€ 341.7
Founder Preferred Shares Dividend Reserve	€ 166	245.5	€ 531.5
Number of operating segments | segment	1
Cost
Disclosure of detailed information about property, plant and equipment [line items]
Trade receivables	€ 376.3	€ 346.1
Buildings
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	40 years
Plant and equipment | Bottom of range
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	5 years
Plant and equipment | Top of range
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	14 years
Computer equipment | Bottom of range
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	3 years
Computer equipment | Top of range
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful life	5 years
Computer software | Bottom of range
Disclosure of detailed information about intangible assets [line items]
Intangible assets useful life	5 years
Computer software | Top of range
Disclosure of detailed information about intangible assets [line items]
Intangible assets useful life	10 years
Brands
Disclosure of detailed information about intangible assets [line items]
Years established	20 years
Customer relationships
Disclosure of detailed information about intangible assets [line items]
Intangible assets useful life	14 years

Accounting policies IFRS 16 dis

Accounting policies IFRS 16 disclosure (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure changes in accounting policy IFRS 16 [Line Items]
Right-of-use assets	€ 60.2	€ 49
Other provisions	42.2	51.8	€ 46.8
Increase (decrease) in accounting estimate	€ 236.7	€ 295.5	€ 210.3

Segment reporting - Additional

Segment reporting - Additional Information (Details) € in Millions	12 Months Ended
	Dec. 31, 2021EUR (€)segment	Dec. 31, 2020EUR (€)	Dec. 31, 2019EUR (€)
Operating Segments [Abstract]
Number of operating segments | segment	1
adjustments for share based payments including employer tax	€ 5.8	€ 12.1	€ 22.4
Adjustments for acquisition related costs	€ 12.9	€ 7.3	€ 3.3

Segment reporting - Segment as

Segment reporting - Segment as Adjusted EBITDA (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of operating segments [line items]
Profit (loss)	€ 181	€ 225.1	€ 153.6
Profit (loss), attributable to owners of parent	181	225.2	154
adjustments for share based payments including employer tax	5.8	12.1	22.4
Taxation	55.7	70.4	56.7
Net financing costs	106	63.7	73.2
Depreciation and amortization	71.6	67.6	68.3
Exceptional items	45.3	20.6	54.5
Other add-backs			25.7
Material reconciling items
Disclosure of operating segments [line items]
Acquisition purchase price adjustments	8.4	0	0
Exceptional items	45.3	20.6	54.5
Other add-backs	18.7	19.4
Adjusted EBITDA	€ 486.7	€ 466.8	€ 432

Segment reporting - Geographica

Segment reporting - Geographical information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of geographical areas [line items]
Revenue	€ 2,606.6	€ 2,515.9	€ 2,324.3
Non-current assets	598.8	479.2
Revenue	2,606.6	2,515.9	2,324.3
United Kingdom
Disclosure of geographical areas [line items]
Revenue	758.3	747.3	712.5
Non-current assets	139.6	132.1
Revenue	758.3	747.3	712.5
Italy
Disclosure of geographical areas [line items]
Revenue	417.9	426.3	394.1
Non-current assets	64.8	68.5
Revenue	417.9	426.3	394.1
Germany
Disclosure of geographical areas [line items]
Revenue	396.3	393.2	329.6
Non-current assets	140	135.5
Revenue	396.3	393.2	329.6
FRANCE
Disclosure of geographical areas [line items]
Revenue	188.6	203.8	176.6
Revenue	188.6	203.8	176.6
SWEDEN
Disclosure of geographical areas [line items]
Revenue	148.1	158.7	175.7
Non-current assets	29.8	28.5
Revenue	148.1	158.7	175.7
Austria
Disclosure of geographical areas [line items]
Revenue	129.3	127.9	108.2
Revenue	129.3	127.9	108.2
NORWAY
Disclosure of geographical areas [line items]
Revenue	121.7	115.6	120.4
Non-current assets	31	30
Revenue	121.7	115.6	120.4
Spain
Disclosure of geographical areas [line items]
Revenue	75.1	82.6	79.5
Revenue	75.1	82.6	79.5
Rest of Europe
Disclosure of geographical areas [line items]
Revenue	371.3	260.5	227.7
Non-current assets	72.3	52.7
Revenue	371.3	260.5	€ 227.7
SERBIA
Disclosure of geographical areas [line items]
Non-current assets	48.5	0
CROATIA
Disclosure of geographical areas [line items]
Non-current assets	38.5	0
IRELAND
Disclosure of geographical areas [line items]
Non-current assets	€ 34.3	€ 31.9

Operating profit_(loss) (Detail

Operating profit/(loss) (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Analysis of income and expense [abstract]
Staff costs	€ 340.6	€ 340.2	€ 308.6
Depreciation of property, plant and equipment	63.4	59.8	59.7
Impairment of property, plant and equipment	0	0	0.1
Impairment loss recognised in profit or loss, intangible assets and goodwill	1.7	0	0
Amortization of software and brands	8.2	7.8	8.6
Operating lease charges	6.1	3	4.5
Exchange losses/(gains)	27	(2.8)	(14.6)
Research & development expenditure	19.2	17.6	18.9
Inventories recognized as an expense within cost of goods sold	€ 1,694.3	€ 1,627.9	€ 1,536

Exceptional items (Details)

Exceptional items (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Unusual Or Infrequent Item1 [Line Items]
Expenses From Supply Chain Reconfiguration, Restructuring Activities	€ 0	€ (12.5)	€ (3.6)
Findus Group integration costs	0	0	3.5
Findus Switzerland integration costs	6.2	0.3	0
Brexit costs	5.3	1.6	1.6
Business Transformation Program	18.8	2.3	0
Information Technology Transformation Program	4.2	0	0
Goodfella's Pizza and Aunt Bessie's Integration Related Costs	0	4	12.5
Factory Optimization	4.9	10	5.7
Settlement of legacy matters	(2.6)	(2.9)	(9.2)
Remeasurement of indemnification assets	5	17.8	44
Adjustments For Exceptional Items	45.3	20.6	54.5
Fortenova Group Integration Costs	€ 3.5	€ 0	€ 0

Exceptional items - Additional

Exceptional items - Additional Information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Analysis Of Income And Expense [Line Items]
Restructuring activities charges	€ 0	€ 12.5	€ 3.6
Integration costs	0	0	3.5
Income (charge) related to legacy matters	2.6	2.9	9.2
Contingent Consideration Arrangements And Indemnification Assets Recognised As Of Acquisition Date, Release of Provision	5.9	20
Gain from reassessment of sales tax provision			0.7
Tax impact of exceptional items	8.4	3.5	3.1
Cash flows used relating to exceptional items	48.8	12.1	15.9
Goodfella's Pizza and Aunt Bessie's Integration Related Costs	0	4	12.5
Factory Optimization	€ 4.9	€ 10	5.7
La Cocinera [Member]
Analysis Of Income And Expense [Line Items]
Contingent Consideration Arrangements And Indemnification Assets Recognised As Of Acquisition Date, Release of Provision			€ 2.7

Payroll costs, share based pa_3

Payroll costs, share based payments and management incentive schemes - Information About the Number of Persons Employed by the Company (Details) - employee	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Employee Information [Line Items]
Average number of employees	5,503	4,690	4,756
Production
Employee Information [Line Items]
Average number of employees	3,310	3,043	3,308
Administration, distribution & sales
Employee Information [Line Items]
Average number of employees	2,193	1,647	1,448

Payroll costs, share based pa_4

Payroll costs, share based payments and management incentive schemes - Number of Persons Employed by the Company (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Employee Benefits And Share-Based Payments [Abstract]
Wages and salaries	€ 266.4	€ 276.4	€ 250.4
Social security costs	56.1	49.2	45.2
Other pension costs	18.1	14.6	13
Total payroll costs	€ 340.6	€ 340.2	€ 308.6

Payroll costs, share based pa_5

Payroll costs, share based payments and management incentive schemes - Non Executive Director Restricted Share Awards (Details)	Jun. 30, 2021EUR (€)shares	Jun. 30, 2021$ / shares	Jun. 17, 2020shares$ / shares	Jun. 14, 2019EUR (€)shares	Jun. 14, 2019$ / shares	Jun. 19, 2018shares$ / shares	May 31, 2020shares	Jul. 31, 2019shares	Dec. 31, 2021EUR (€)shares	Dec. 31, 2021USD ($)shares	Dec. 31, 2020EUR (€)	Dec. 31, 2019EUR (€)shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Share based payment charge | €									€ 5,100,000		€ 9,000,000	€ 14,900,000
Share based compensation reserve
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Share based payment charge | €									€ 5,100,000		9,000,000	14,900,000
Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
New awards granted in the period									820,202	820,202
Number of equity instruments exercised (in shares)									1,861,826	1,861,826
Non-Executive Director
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Expense from share-based payment transactions with employees | €									€ 800,000		€ 700,000	€ 900,000
Non-Executive Director | Restricted Shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of shares issued per director | $										$ 100,000
New awards granted in the period	24,759		32,140	39,370		32,172
Share price (in Dollars per share) | $ / shares		$ 30.14	$ 21.78		$ 20.74
Number of equity instruments exercised (in shares)	32,140		34,447	44,272			49,196	2,460				56,250
Reclassification of awards for settlement of tax liabilities	7,734		8,656	12,100
Exercise price (in dollars per share) | $ / shares		$ 28.27	$ 21.78		$ 20.32	$ 18.07
Non-Executive Director | Restricted Shares | Share based compensation reserve
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Share based payment charge | €	€ 0.2			€ 100,000

Payroll costs, share based pa_6

Payroll costs, share based payments and management incentive schemes - Director and Senior Management Share Awards (Details) - Restricted Shares - shares	1 Months Ended		12 Months Ended
	Jan. 31, 2020	Sep. 30, 2019	Dec. 31, 2021
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			3,178,400
New awards granted in the period			820,202
Awards vested and issued in the period			(1,861,826)
Forfeitures in the period			(119,921)
Number of other equity instruments outstanding in share-based payment arrangement at end of period			2,016,855
January 1, 2016
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			1,041,953
New awards granted in the period			0
Awards vested and issued in the period			(1,041,953)
Forfeitures in the period			0
Number of other equity instruments outstanding in share-based payment arrangement at end of period			0
January 1, 2017
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			819,873
New awards granted in the period			0
Awards vested and issued in the period			(819,873)
Forfeitures in the period			0
Number of other equity instruments outstanding in share-based payment arrangement at end of period			0
January 1, 2018
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			446,575
New awards granted in the period			0
Awards vested and issued in the period			0
Forfeitures in the period			(14,785)
Number of other equity instruments outstanding in share-based payment arrangement at end of period			431,790
January 1, 2019
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			159,561
New awards granted in the period		166,427	0
Awards vested and issued in the period			0
Forfeitures in the period			(6,866)
Number of other equity instruments outstanding in share-based payment arrangement at end of period			152,695
January 1, 2020
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			710,438
New awards granted in the period	761,979		0
Awards vested and issued in the period			0
Forfeitures in the period			(65,345)
Number of other equity instruments outstanding in share-based payment arrangement at end of period			645,093
january 1, 2021
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period			0
New awards granted in the period			820,202
Awards vested and issued in the period			0
Forfeitures in the period			(32,925)
Number of other equity instruments outstanding in share-based payment arrangement at end of period			787,277

Payroll costs, share based pa_7

Payroll costs, share based payments and management incentive schemes - Director and Senior Management Share Awards Narrative (Details) € in Millions

1 Months Ended

12 Months Ended

Feb. 28, 2021shares

Jan. 31, 2021shares

Sep. 30, 2020shares

Feb. 29, 2020shares

Jan. 31, 2020shares

Sep. 30, 2019shares

Jan. 31, 2019shares

Dec. 31, 2021EUR (€)shares

Dec. 31, 2020EUR (€)

Dec. 31, 2019EUR (€)

Dec. 31, 2021shares$ / shares

Feb. 01, 2021$ / shares

Jan. 30, 2021$ / shares

Jan. 01, 2021$ / shares

Dec. 31, 2020shares$ / shares

Sep. 01, 2020$ / shares

Aug. 01, 2020$ / shares

Feb. 01, 2020$ / shares

Jan. 01, 2020$ / shares

EBITDA

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Vesting period

3 years

Vesting period

3 years

Share price performance

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Vesting period

3 years

Vesting period

3 years

Cumulative net sales

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Vesting period

3 years

Vesting period

3 years

Ordinary shares

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Share price (in Dollars per share) | $ / shares

$ 24.50

$ 25.29

$ 21.04

$ 25.50

Management Award 2018 | EBITDA

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Vesting period

4 years

Vesting period

4 years

Management Award 2018 | Share price performance

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Vesting period

3 years

2 years

Vesting period

3 years

2 years

Management Award 2018 | Share price performance | Bottom of range

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Vesting period

2 years

Vesting period

2 years

Management Award 2018 | Share price performance | Top of range

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Vesting period

5 years

Vesting period

5 years

Restricted Shares

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Number of equity instruments outstanding in share-based payment arrangement (in shares)

2,016,855

3,178,400

New awards granted in the period

820,202

Number of equity instruments exercised (in shares)

1,861,826

Restricted Shares | Key management personnel

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Expense from share-based payment transactions with employees | €

€ 4.3

€ 8.3

€ 14

Restricted Shares | Management Award 2017

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Number of equity instruments exercised (in shares)

451,719

368,154

85,315

Reclassification of awards for settlement of tax liabilities

180,268

150,926

33,383

Share price (in Dollars per share) | $ / shares

$ 25.89

$ 25.42

Restricted Shares | Management Award 2017 | Ordinary shares

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Number of equity instruments exercised (in shares)

271,451

217,228

51,932

Restricted Shares | Management Award 2016

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Number of equity instruments exercised (in shares)

1,041,953

1,626,006

284,555

Reclassification of awards for settlement of tax liabilities

454,320

697,964

120,739

Share price (in Dollars per share) | $ / shares

$ 25.42

$ 19.53

$ 22.37

Restricted Shares | Management Award 2016 | Ordinary shares

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Number of equity instruments exercised (in shares)

587,633

928,042

163,816

Restricted Shares | Management Award 2018

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Number of equity instruments exercised (in shares)

42,825

Reclassification of awards for settlement of tax liabilities

17,170

Share price (in Dollars per share) | $ / shares

$ 25.30

Restricted Shares | Management Award 2018 | Ordinary shares

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Number of equity instruments exercised (in shares)

25,655

January 1, 2016 | Restricted Shares

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Number of equity instruments outstanding in share-based payment arrangement (in shares)

0

1,041,953

New awards granted in the period

0

Number of equity instruments exercised (in shares)

1,041,953

January 1, 2017 | Restricted Shares

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Number of equity instruments outstanding in share-based payment arrangement (in shares)

0

819,873

New awards granted in the period

0

Number of equity instruments exercised (in shares)

819,873

January 1, 2019 | Restricted Shares

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Number of equity instruments outstanding in share-based payment arrangement (in shares)

152,695

159,561

New awards granted in the period

166,427

0

Number of equity instruments exercised (in shares)

0

January 1, 2020 | Restricted Shares

Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]

Number of equity instruments outstanding in share-based payment arrangement (in shares)

645,093

710,438

New awards granted in the period

761,979

0

Number of equity instruments exercised (in shares)

0

Payroll costs, share based pa_8

Payroll costs, share based payments and management incentive schemes - Inputs and Assumptions Underlying the Monte Carlo Model (Details) $ / shares in Units, € in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021$ / shares	Dec. 31, 2020	Jan. 01, 2021USD ($)	Jan. 01, 2021EUR (€)	Jan. 01, 2020USD ($)	Jan. 01, 2020EUR (€)	Jan. 01, 2019USD ($)	Jan. 01, 2019EUR (€)	Jan. 01, 2018USD ($)	Jan. 01, 2018EUR (€)
Disclosure of terms and conditions of share-based payment arrangement [line items]
FV of equity instruments			$ 7	€ 5.8	$ 4.8	€ 4.3	$ 1.4	€ 1.2	$ 1.6	€ 1.3
January 1, 2018 | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date price (in Dollar per share)	$ 16.72
Exercise price (in Dollar per share)	$ 0
Expected volatility of the share price	22.70%
Dividend yield expected	0.00%
Risk free rate	2.55%
Employee exit rate	14.00%
EBITDA Performance Target Condition	35.00%
January 1, 2018 | Minimum | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Expected life of restricted share	1 year 6 months
January 1, 2018 | Top of range | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Expected life of restricted share	4 years
January 1, 2019 | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date price (in Dollar per share)	$ 20.15
Exercise price (in Dollar per share)	$ 0
Expected life of restricted share	4 years
Expected volatility of the share price	24.00%
Dividend yield expected	0.00%
Risk free rate	1.33%
Employee exit rate	14.00%
EBITDA Performance Target Condition	35.00%
January 1, 2020 | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date price (in Dollar per share)	$ 22.37
Exercise price (in Dollar per share)	$ 0
Expected volatility of the share price	24.40%
Dividend yield expected	0.00%
Risk free rate	1.70%
Employee exit rate	27.30%
EBITDA Performance Target Condition	35.00%
january 1, 2021 | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date price (in Dollar per share)	$ 25.42
Exercise price (in Dollar per share)	$ 0
Expected life of restricted share	3 years	3 years
Expected volatility of the share price	30.00%
Dividend yield expected	0.00%
Risk free rate	0.24%
Employee exit rate	14.00%
EBITDA Performance Target Condition	35.00%

Payroll costs, share based pa_9

Payroll costs, share based payments and management incentive schemes - Initial Options (Details) € in Millions	Jun. 30, 2021shares	Jun. 17, 2020shares	Jun. 14, 2019shares	May 31, 2020EUR (€)shares	Jul. 31, 2019shares	Dec. 31, 2021shares	Dec. 31, 2020EUR (€)	Dec. 31, 2019EUR (€)shares	Dec. 31, 2014$ / sharesshares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of shares reserved for issue under options and contracts for sale of shares (in shares) | shares									125,000
Vesting of Non-Executive Restricted Stock award | €							€ 0	€ (0.8)
Initial options exercise cost | €								€ 0.6
Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of equity instruments exercised (in shares) | shares						1,861,826
Non-Executive Director | Restricted Shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of equity instruments exercised (in shares) | shares	32,140	34,447	44,272	49,196	2,460			56,250
Initial options exercise cost | €				€ 0.6
Ordinary shares | Non-Executive Director
Disclosure of terms and conditions of share-based payment arrangement [line items]
Exercise price of share options granted (in Dollar per share) | $ / shares									$ 11.50

Directors and Key Management _3

Directors and Key Management compensation (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Related Party [Abstract]
Short-term employee benefits	€ 2.2	€ 3.9	€ 2.8
Share-based payment expense	2.4	3.5	7.6
Non-Executive Director fees	0.3	0.3	0.4
Total Directors' and executive officers' compensation	€ 4.9	€ 7.7	€ 10.8

Directors and Key Management _4

Directors and Key Management compensation - Additional Information (Details)	12 Months Ended
	Dec. 31, 2021directorexecutive_officer	Dec. 31, 2020directorexecutive_officer	Dec. 31, 2019directorexecutive_officer
Related Party [Abstract]
Number of Members of Key Management Accruing Benefits Under Money Purchase Schemes | director	2	2	2
Number of executive Officers accruing benefits under share-based payment schemes | executive_officer	2	2	2

Finance income and costs (Detai

Finance income and costs (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Analysis of income and expense [abstract]
Interest income	€ 0.1	€ 0.7	€ 2.5
Net foreign exchange gains on translation of financial assets and liabilities	0	4	0
Finance income	0.1	4.7	2.5
Interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss (a)	(59.8)	(64)	(79)
Cross-currency interest rate swaps: cash flow hedges, transfer from equity	1.6	5.9	21.8
Impairment loss recognised in profit or loss, loans and advances	(8.6)	0	0
Net pension interest costs	(1.7)	(2.7)	(3.8)
Amortization of borrowing costs	(2)	(2)	(2)
Net foreign exchange losses on translation of financial assets and liabilities	(4)	0	(3.9)
Net fair value losses on derivatives held at fair value through profit or loss (b)	(13.7)	(5.6)	(8.8)
Financing costs incurred in amendment of terms of debt	17.9	0	0
Finance costs	(106.1)	(68.4)	(75.7)
Net finance costs	(106)	€ (63.7)	€ (73.2)
Non-cash loss recognized in relation to cross currency interest rate swaps	7.8
Disclosure of attribution of expenses by nature to their function [line items]
Gains (Losses) on Restructuring of previous debt	€ (10.1)

Taxation - Components of Tax Ex

Taxation - Components of Tax Expense (Income) (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Abstract]
Current tax on profits for the period	€ (117.5)	€ (44.8)	€ (66.4)
Adjustments in respect of prior periods	0.6	(7.6)	0
Total current tax expense and adjustments	(116.9)	(52.4)	(66.4)
Origination and reversal of temporary differences	116.3	(1.2)	9.7
Impact of change in tax rates	(55.1)	(16.8)	0
Total deferred tax expense and adjustments	61.2	(18)	9.7
Total tax expense	€ (55.7)	€ (70.4)	€ (56.7)

Taxation - Reconciliation of Ef

Taxation - Reconciliation of Effective Tax Rate (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Abstract]
Profit (loss) before tax	€ 236.7	€ 295.5	€ 210.3
Tax charge at the standard UK corporation tax rate 19% (2020: 19%; 2019: 19%)	(45)	(56.1)	(39.9)
Difference in tax rates	22.7	(18.2)	(11.9)
Non tax deductible interest	0.1	(0.1)	0.6
Other income and expenses not taxable or deductible	2.5	(0.8)	(1.2)
Unrecognized tax assets	(1.5)	(6.3)	(0.9)
Provisions for uncertainties	(52.5)	35.5	(3.4)
Impact of change in tax rates	(55.1)	(16.8)	0
Change in tax base of assets due to step-up	(72.5)	0	0
Prior period adjustment	0.6	(7.6)	0
Total tax expense	€ (55.7)	€ (70.4)	€ (56.7)
Standard tax rate	19.00%	19.00%	19.00%
Current tax payable	€ 198.5	€ 166.2
Deferred tax assets	128.3	113.5
Provisions for tax uncertainties	€ 163.4	€ 103.9
Effective tax rate	23.50%	23.80%

Taxation - Tax charge_(credit)

Taxation - Tax charge/(credit) Relating To Components Of Other Comprehensive Income (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Abstract]
Remeasurement of post-employment benefit liabilities, before tax	€ (36.1)	€ 27.8	€ 35.9
Remeasurement of post-employment benefit liabilities, tax charge/(credit)	10.2	(8.3)	(6.7)
Remeasurement of post-employment benefit liabilities, after tax	(25.9)	19.5	29.2
Net investment hedge, before tax	(18.8)	10.1	(6)
Net investment hedge, tax charge/(credit)	0	0	0
Net investment hedge, after tax	(18.8)	10.1	(6)
Cash flow hedges, before tax	(22.6)	17.3	27.3
Cash flow hedges, tax charge/(credit)	13.6	(6)	(5.6)
Cash flow hedges, after tax	(9)	11.3	21.7
Other comprehensive (income)/loss, before tax	(77.5)	55.2	57.2
Other comprehensive (income)/loss, tax charges/(credits)	23.8	(14.3)	(12.3)
Other comprehensive (income)/loss, after tax	(53.7)	40.9	44.9
Current and deferred tax relating to items charged or credited directly to equity [abstract]
Current tax	0	0	0
Deferred tax	23.8	(14.3)	(12.3)
Total current and deferred tax	€ 23.8	€ (14.3)	€ (12.3)
Standard tax rate	19.00%	19.00%	19.00%

Property, plant and equipment (

Property, plant and equipment (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of detailed information about property, plant and equipment [line items]
Property, plant and equipment	€ 549.4	€ 422.2
Guarantor Group, Percentage Of Consolidated Gross Assets Or Adjusted EBITDA Individually Held	5.00%
Guarantor Group, Percentage Of Consolidated Gross Assets Or Adjusted EBITDA Held In Total	80.00%
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	€ 373.2	350
Acquisitions through business combinations	76
Depreciation	63.4	59.8	€ 59.7
Impairment loss recognised in profit or loss, property, plant and equipment	0	0	0.1
Impairment	0	0	(0.1)
Property, plant and equipment	489.2	373.2	350
Acquisitions through business combinations	76
Impairment loss recognised in profit or loss, property, plant and equipment	0	0	0.1
Cost
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	556.7	501.9
Acquisitions through business combinations			8.6
Additions	81.1	63.5
Disposals	(6)	(3)
Effect of movements in foreign exchange	(22.8)	14.3
Disposals, property, plant and equipment	6	3
Property, plant and equipment	730.6	556.7	501.9
Acquisitions through business combinations			8.6
Disposals, property, plant and equipment	6	3
Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	(183.5)	(151.9)
Disposals	4.8	2.1
Effect of movements in foreign exchange	15.9	(10.4)
Depreciation	46.8	44.1
Disposals, property, plant and equipment	(4.8)	(2.1)
Property, plant and equipment	(241.4)	(183.5)	(151.9)
Disposals, property, plant and equipment	(4.8)	(2.1)
Land and buildings
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	136.1	133.2
Property, plant and equipment	176.2	136.1	133.2
Land and buildings | Cost
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	165.3	156.2
Acquisitions through business combinations	30.5		5.1
Additions	14.8	6.8
Disposals	(0.1)	(0.1)
Effect of movements in foreign exchange	(6.2)	2.7
Disposals, property, plant and equipment	0.1	0.1
Property, plant and equipment	216.7	165.3	156.2
Acquisitions through business combinations	30.5		5.1
Disposals, property, plant and equipment	0.1	0.1
Land and buildings | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	(29.2)	(23)
Disposals	0	0
Effect of movements in foreign exchange	2.9	(1.4)
Depreciation	8.4	7.6
Disposals, property, plant and equipment	0	0
Property, plant and equipment	(40.5)	(29.2)	(23)
Disposals, property, plant and equipment	0	0
Plant and equipment
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	228	206.9
Property, plant and equipment	302.9	228	206.9
Plant and equipment | Cost
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	376.1	331.9
Acquisitions through business combinations	45		3.5
Additions	62.8	54.6
Disposals	(5.9)	(2.6)
Effect of movements in foreign exchange	(16.2)	11.3
Disposals, property, plant and equipment	5.9	2.6
Property, plant and equipment	494.2	376.1	331.9
Acquisitions through business combinations	45		3.5
Disposals, property, plant and equipment	5.9	2.6
Plant and equipment | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	(148.1)	(125)
Disposals	4.8	1.8
Effect of movements in foreign exchange	12.6	(8.6)
Depreciation	35.4	33.5
Disposals, property, plant and equipment	(4.8)	(1.8)
Property, plant and equipment	(191.3)	(148.1)	(125)
Disposals, property, plant and equipment	(4.8)	(1.8)
Computer equipment
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	9.1	9.9
Property, plant and equipment	10.1	9.1	9.9
Computer equipment | Cost
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	15.3	13.8
Acquisitions through business combinations	0.5		0
Additions	3.5	2.1
Disposals	0	(0.3)
Effect of movements in foreign exchange	(0.4)	0.3
Disposals, property, plant and equipment	0	0.3
Property, plant and equipment	19.7	15.3	13.8
Acquisitions through business combinations	0.5		0
Disposals, property, plant and equipment	0	0.3
Computer equipment | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in property, plant and equipment [abstract]
Property, plant and equipment	(6.2)	(3.9)
Disposals	0	0.3
Effect of movements in foreign exchange	0.4	(0.4)
Depreciation	3	3
Disposals, property, plant and equipment	0	(0.3)
Property, plant and equipment	(9.6)	(6.2)	€ (3.9)
Disposals, property, plant and equipment	€ 0	€ (0.3)

Property, plant and equipment -

Property, plant and equipment - Additional Information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disclosure of detailed information about property, plant and equipment [line items]
Construction in progress	€ 40.5	€ 24.5
Percentage of consolidated gross assets or adjusted EBITDA held individually by companies in Guarantor Group	5.00%
Percentage of consolidated gross assets or adjusted EBITDA held by Guarantor Group in total	80.00%

Property, plant and equipment_2

Property, plant and equipment Disclosure NBV of Right of Use Assets (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Asset Class of RIght of use Assets [Line Items]
Right-of-use assets	€ 60.2	€ 49
Additions to right-of-use assets	8.1
Acquisitions through business combinations,	19
Land and buildings [member]
Asset Class of RIght of use Assets [Line Items]
Right-of-use assets	44.8	38.5
Property, plant and equipment [member]
Asset Class of RIght of use Assets [Line Items]
Right-of-use assets	15.3	10.3
Computer equipment [member]
Asset Class of RIght of use Assets [Line Items]
Right-of-use assets	€ 0.1	€ 0.2

Property, plant and equipment_3

Property, plant and equipment Disclosure Depreciation of Right of use Assets (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of quantitative information about right-of-use assets [line items]
Depreciation, right-of-use assets	€ 16.6	€ 15.7	€ 16.1
Land and buildings [member]
Disclosure of quantitative information about right-of-use assets [line items]
Depreciation, right-of-use assets	10.9	10.6	10.7
Property, plant and equipment [member]
Disclosure of quantitative information about right-of-use assets [line items]
Depreciation, right-of-use assets	5.5	4.9	5.2
Computer equipment [member]
Disclosure of quantitative information about right-of-use assets [line items]
Depreciation, right-of-use assets	€ 0.2	€ 0.2	€ 0.2

Goodwill and Intangibles - Cost

Goodwill and Intangibles - Cost (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	€ 4,058.2	€ 3,946
Amortization of software and brands	8.2	7.8	€ 8.6
Intangible assets and goodwill	4,555.1	4,058.2	3,946
Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	4,094.9	3,974.8
Acquisitions through business combinations (restated)		494.5	106.2
Additions	5.8	8.8
Disposals, intangible assets and goodwill	(2.5)
Effect of movements in foreign exchange	7	5.1
Intangible assets and goodwill	4,599.7	4,094.9	3,974.8
Additions	5.8	8.8
Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	(36.7)	(28.8)
Disposals, intangible assets other than goodwill	(1.7)
Effect of movements in foreign exchange	0.3	(0.1)
Amortization of software and brands	(8.2)	(7.8)
Intangible assets and goodwill	(44.6)	(36.7)	(28.8)
Disposals, intangible assets other than goodwill	(1.7)
Goodwill
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	1,902.5	1,862.9
Intangible assets and goodwill	2,099.4	1,902.5	1,862.9
Goodwill | Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	1,902.5	1,862.9
Acquisitions through business combinations (restated)		192.6	40.1
Additions	0	0
Disposals, intangible assets and goodwill	0
Effect of movements in foreign exchange	4.3	(0.5)
Intangible assets and goodwill	2,099.4	1,902.5	1,862.9
Additions	0	0
Goodwill | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	0	0
Disposals, intangible assets other than goodwill	0
Effect of movements in foreign exchange	0	0
Amortization of software and brands	0	0
Intangible assets and goodwill	0	0	0
Disposals, intangible assets other than goodwill	0
Brands
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	2,116.8	2,046.7
Intangible assets and goodwill	2,415.3	2,116.8	2,046.7
Brands | Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	2,122.4	2,051.1
Acquisitions through business combinations (restated)	296.5		66
Additions	0	0
Disposals, intangible assets and goodwill	0
Effect of movements in foreign exchange	3.2	5.3
Intangible assets and goodwill	2,422.1	2,122.4	2,051.1
Additions	0	0
Brands | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	(5.6)	(4.4)
Disposals, intangible assets other than goodwill	0
Effect of movements in foreign exchange	0	0
Amortization of software and brands	(1.2)	(1.2)
Intangible assets and goodwill	(6.8)	(5.6)	(4.4)
Disposals, intangible assets other than goodwill	0
Computer software
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	19.3	14.6
Intangible assets and goodwill	18.9	19.3	14.6
Computer software | Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	39	29.8
Acquisitions through business combinations (restated)	1.1		0.1
Additions	5.8	8.8
Disposals, intangible assets and goodwill	(2.5)
Effect of movements in foreign exchange	(0.5)	0.3
Intangible assets and goodwill	42.9	39	29.8
Additions	5.8	8.8
Computer software | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	(19.7)	(15.2)
Disposals, intangible assets other than goodwill	(1.7)
Effect of movements in foreign exchange	0.3	(0.1)
Amortization of software and brands	(4.6)	(4.4)
Intangible assets and goodwill	(24)	(19.7)	(15.2)
Disposals, intangible assets other than goodwill	(1.7)
Customer relationships
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	19.6	21.8
Intangible assets and goodwill	21.5	19.6	21.8
Customer relationships | Cost
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	31	31
Acquisitions through business combinations (restated)	4.3		0
Additions	0	0
Disposals, intangible assets and goodwill	0
Effect of movements in foreign exchange	0	0
Intangible assets and goodwill	35.3	31	31
Additions	0	0
Customer relationships | Accumulated depreciation, amortisation and impairment [member]
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill	(11.4)	(9.2)
Disposals, intangible assets other than goodwill	0
Effect of movements in foreign exchange	0	0
Amortization of software and brands	(2.4)	(2.2)
Intangible assets and goodwill	(13.8)	€ (11.4)	€ (9.2)
Disposals, intangible assets other than goodwill	€ 0

Goodwill and Intangibles - Accu

Goodwill and Intangibles - Accumulated Amortization and Impairment (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	€ (4,058.2)	€ (3,946)
Amortisation, intangible assets other than goodwill	(8.2)	(7.8)	€ (8.6)
Intangible assets and goodwill	(4,555.1)	(4,058.2)	(3,946)
Intangible assets and goodwill	4,555.1	4,058.2	3,946
Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	36.7	28.8
Amortisation, intangible assets other than goodwill	8.2	7.8
Impairment loss recognised in profit or loss, intangible assets other than goodwill	(1.7)
Disposals, intangible assets other than goodwill	(1.7)
Increase (decrease) through net exchange differences, intangible assets and goodwill	(0.3)	0.1
Intangible assets and goodwill	44.6	36.7	28.8
Intangible assets and goodwill	(44.6)	(36.7)	(28.8)
Goodwill
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	(1,902.5)	(1,862.9)
Intangible assets and goodwill	(2,099.4)	(1,902.5)	(1,862.9)
Intangible assets and goodwill	2,099.4	1,902.5	1,862.9
Goodwill | Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	0	0
Amortisation, intangible assets other than goodwill	0	0
Impairment loss recognised in profit or loss, intangible assets other than goodwill	0
Disposals, intangible assets other than goodwill	0
Increase (decrease) through net exchange differences, intangible assets and goodwill	0	0
Intangible assets and goodwill	0	0	0
Intangible assets and goodwill	0	0	0
Customer relationships
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	(19.6)	(21.8)
Intangible assets and goodwill	(21.5)	(19.6)	(21.8)
Intangible assets and goodwill	21.5	19.6	21.8
Customer relationships | Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	11.4	9.2
Amortisation, intangible assets other than goodwill	2.4	2.2
Impairment loss recognised in profit or loss, intangible assets other than goodwill	0
Disposals, intangible assets other than goodwill	0
Increase (decrease) through net exchange differences, intangible assets and goodwill	0	0
Intangible assets and goodwill	13.8	11.4	9.2
Intangible assets and goodwill	(13.8)	(11.4)	(9.2)
Brands
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	(2,116.8)	(2,046.7)
Intangible assets and goodwill	(2,415.3)	(2,116.8)	(2,046.7)
Intangible assets and goodwill	2,415.3	2,116.8	2,046.7
Brands | Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	5.6	4.4
Amortisation, intangible assets other than goodwill	1.2	1.2
Impairment loss recognised in profit or loss, intangible assets other than goodwill	0
Disposals, intangible assets other than goodwill	0
Increase (decrease) through net exchange differences, intangible assets and goodwill	0	0
Intangible assets and goodwill	6.8	5.6	4.4
Intangible assets and goodwill	(6.8)	(5.6)	(4.4)
Computer software
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	(19.3)	(14.6)
Intangible assets and goodwill	(18.9)	(19.3)	(14.6)
Intangible assets and goodwill	18.9	19.3	14.6
Computer software | Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill	19.7	15.2
Amortisation, intangible assets other than goodwill	4.6	4.4
Impairment loss recognised in profit or loss, intangible assets other than goodwill	(1.7)
Disposals, intangible assets other than goodwill	(1.7)
Increase (decrease) through net exchange differences, intangible assets and goodwill	(0.3)	0.1
Intangible assets and goodwill	24	19.7	15.2
Intangible assets and goodwill	€ (24)	€ (19.7)	€ (15.2)

Goodwill and Intangibles - Addi

Goodwill and Intangibles - Additional Information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Amortization	€ (8.2)	€ (7.8)	€ (8.6)
Discount rate	6.40%	5.80%
Long-term growth rate	1.00%	1.00%
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss	€ 9.9	€ 7.8	€ 8.6
Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Amortization	€ 8.2	€ 7.8

Acquisitions - Findus Switzerla

Acquisitions - Findus Switzerland (Details) - EUR (€) € in Millions	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Disclosure of detailed information about business combination [line items]
Assets	€ 6,170.8		€ 5,580.6
Total liabilities	3,871.8		3,454.5
Goodwill	2,099.4		1,902.5
Intangibles	2,455.7		2,155.7
Inventories	410.6		344.3
Deferred tax liabilities	(437.6)		(427.1)
Trade and other current payables	(692)		(647.2)
Other assets			(1,202.1)
Assets (liabilities)	2,299		2,126.1
Increase (decrease) due to corrections of prior period errors [member]
Disclosure of detailed information about business combination [line items]
Goodwill			(35.5)
Intangibles			41.6
Inventories			1.1
Deferred tax liabilities			6.4
Trade and other current payables			0.8
Other assets			0
Assets (liabilities)			0
Previously stated [member]
Disclosure of detailed information about business combination [line items]
Goodwill			1,938
Intangibles			2,114.1
Inventories			343.2
Deferred tax liabilities			(420.7)
Trade and other current payables			(646.4)
Other assets			(1,202.1)
Assets (liabilities)			2,126.1
Findus Switzerland
Disclosure of detailed information about business combination [line items]
Cash transferred	0.8		€ 112.8
Intangible assets	66.1
Property, plant and equipment, including Right-of-use assets	8.9
Current assets	0.2
Inventories	12.6
Assets	87.8
Current liabilities	0.3
Non-current liabilities	6.8
Deferred tax liabilities	8
Total liabilities	15.1
Total identifiable net assets acquired	72.7
Total purchase consideration	112.8
Goodwill	40.1	€ 40.1
Findus Switzerland | Increase (decrease) due to corrections of prior period errors [member]
Disclosure of detailed information about business combination [line items]
Intangible assets	41.6
Property, plant and equipment, including Right-of-use assets	0
Current assets	0
Inventories	1.1
Assets	42.7
Current liabilities	0
Non-current liabilities	0
Deferred tax liabilities	6.4
Total liabilities	6.4
Total identifiable net assets acquired	36.3
Total purchase consideration	0.8
Goodwill	(35.5)
Findus Switzerland | Previously stated [member]
Disclosure of detailed information about business combination [line items]
Intangible assets	24.5
Property, plant and equipment, including Right-of-use assets	8.9
Current assets	0.2
Inventories	11.5
Assets	45.1
Current liabilities	0.3
Non-current liabilities	6.8
Deferred tax liabilities	1.6
Total liabilities	8.7
Total identifiable net assets acquired	36.4
Total purchase consideration	112
Goodwill	€ 75.6
Fortenova Group
Disclosure of detailed information about business combination [line items]
Cash transferred		640.1
Intangible assets		301.9
Property, plant and equipment, including Right-of-use assets		95
Current assets		71.7
Inventories		46.9
Assets		573.9
Current liabilities		62.1
Non-current liabilities		16.6
Deferred tax liabilities		47.7
Total liabilities		126.4
Total identifiable net assets acquired		447.5
Total purchase consideration		640.1
Goodwill		€ 192.6

Acquisitions (Details)

Acquisitions (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of detailed information about business combination [line items]
Acquisition-related costs recognised as expense for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination	€ 12.9	€ 4.8
Revenue of combined entity as if combination occurred at beginning of period	2,851.7
Profit (loss) of combined entity as if combination occurred at beginning of period	279.9
Cash consideration	640.9	113	€ 0
Less cash acquired	(43.6)	(0.1)	0
Contingent consideration paid related to acquisitions	0	0	1.5
Net outflow of cash - investing activities	€ 597.3	€ 112.9	€ 1.5

Acquisitions (Fortenova) (Detai

Acquisitions (Fortenova) (Details) - EUR (€) € in Millions	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Disclosure of detailed information about business combination [line items]
Total assets	€ 6,170.8		€ 5,580.6
Total liabilities	3,871.8		€ 3,454.5
Findus Switzerland
Disclosure of detailed information about business combination [line items]
Intangible assets	66.1
Property, plant and equipment, including Right-of-use assets	8.9
Current assets	0.2
Inventories	12.6
Total assets	87.8
Current liabilities	0.3
Non-current liabilities	6.8
Deferred tax liabilities	8
Total liabilities	15.1
Total identifiable net assets acquired	(72.7)
Total purchase consideration	112.8
Goodwill	€ 40.1	€ 40.1
Fortenova Group
Disclosure of detailed information about business combination [line items]
Intangible assets		301.9
Property, plant and equipment, including Right-of-use assets		95
Current assets		71.7
Cash and cash equivalents recognised as of acquisition date		43.6
Inventories		46.9
Deferred tax assets recognised as of acquisition date		14.8
Total assets		573.9
Current liabilities		62.1
Non-current liabilities		16.6
Deferred tax liabilities		47.7
Total liabilities		126.4
Total identifiable net assets acquired		(447.5)
Total purchase consideration		640.1
Goodwill		€ 192.6

Investments (Details)

Investments (Details)	12 Months Ended
	Dec. 31, 2021
Nomad Foods Europe Holdings Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Europe Holdco Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Europe Finco Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Europe Midco Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Bondco Plc
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Lux S.à.r.l.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Europe Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Birds Eye Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Nomad Foods Europe Finance Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Birds Eye Ireland Limited
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo Holding GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo Nederland B.V.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo Belgium S.A.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo Portugal
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo Austria Holdings GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
C.S.I. Compagnia Surgelati Italiana S.R.L
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Sverige Holdings AB
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Frozen Fish International GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Liberator Germany Newco GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Iglo Austria GmbH
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Sverige AB
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Frionor Sverige AB
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Holdings France SAS
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus France SAS
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Espana SLU
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Danmark A/S
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Finland Oy
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Norge AS
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Norge Holding AS [Member] [Domain]
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Topprys AB [Domain]
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Findus Switzerland
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
LEDO plus d.o.o.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
INDUSTRIJA SMRZNUTE HRANE FRIKOM DOO BEOGRAD
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
LEDO d.o.o. Čitluk
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
IRIDA d.o.o.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
LEDO Jégkrém és Fagyasztott Élelmiszer Gyártó és Forgalmazó Korlátolt Felelősségű Társaság
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Ledo d.o.o. (LEDO, podjetje za trgovino s sladoledom, zmrznjeno hrano in storitve, d.o.o.)
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Ledo d.o.o. Podgorica (Društvo Za Proizvodnju, promet roba i usluga “Ledo” d.o.o. Podgorica)
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
Ledo Sh.p.k.
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%
FRIKOM BEOGRAD DOOEL Čučer Sandevo
Disclosure of subsidiaries [line items]
Ownership	100.00%
Ownership	100.00%

Deferred tax assets and liabi_3

Deferred tax assets and liabilities - Summary of Deferred Tax Assets and Liabilities (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	€ 128.3	€ 113.5
Deferred tax liabilities	(437.6)	(427.1)
Tax assets/(liabilities)	(309.3)	(313.6)	€ (301.8)
Deferred tax assets not recognized in the financial statements	70.4	72.7
Deferred tax items credited (charged) to equity	(23.8)	14.3	12.3
Property, plant and equipment
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	8.9	20.6
Deferred tax liabilities	(34.4)	(27.3)
Tax assets/(liabilities)	(25.5)	(6.7)	(6.3)
Intangible assets
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	33.8	0.9
Deferred tax liabilities	(382.9)	(384.4)
Tax assets/(liabilities)	(349.1)	(383.5)	(356.6)
Employee benefits
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	36.4	48.3
Deferred tax liabilities	0	(0.3)
Tax assets/(liabilities)	36.4	48	39.8
Tax value of loss carry forwards
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	40.4	24.6
Deferred tax liabilities	0	0
Tax assets/(liabilities)	40.4	24.6	20.7
Derivative financial instruments
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	1.7	9.3
Deferred tax liabilities	(7)	(0.1)
Tax assets/(liabilities)	(5.3)	9.2	2.9
Other
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets	7.1	9.8
Deferred tax liabilities	(13.3)	(15)
Tax assets/(liabilities)	€ (6.2)	€ (5.2)	€ (2.3)

Deferred tax assets and liabi_4

Deferred tax assets and liabilities - Changes in Deferred tax (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	€ (313.6)	€ (301.8)
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	(32.9)	(8)
Recognized  in Statement of Profit or Loss	61.2	(18)
Recognized in Other Comprehensive Income	(23.8)	14.3	€ 12.3
Movement in foreign exchange	(0.2)	(0.1)
Closing balance	(309.3)	(313.6)	(301.8)
Property, plant and equipment
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	(6.7)	(6.3)
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	(2.2)	(1.3)
Recognized  in Statement of Profit or Loss	(17.2)	1
Recognized in Other Comprehensive Income	0	0
Movement in foreign exchange	0.6	(0.1)
Closing balance	(25.5)	(6.7)	(6.3)
Intangible assets
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	(383.5)	(356.6)
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	(30.1)	(6.3)
Recognized  in Statement of Profit or Loss	64.5	(20.6)
Recognized in Other Comprehensive Income	0	0
Movement in foreign exchange	0	0
Closing balance	(349.1)	(383.5)	(356.6)
Employee benefits
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	48	39.8
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	0	0
Recognized  in Statement of Profit or Loss	(1.2)	0
Recognized in Other Comprehensive Income	(10.2)	8.3
Movement in foreign exchange	(0.2)	(0.1)
Closing balance	36.4	48	39.8
Tax value of loss carry forwards
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	24.6	20.7
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	0	0
Recognized  in Statement of Profit or Loss	15.8	3.9
Recognized in Other Comprehensive Income	0	0
Movement in foreign exchange	0	0
Closing balance	40.4	24.6	20.7
Derivative financial instruments
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	9.2	2.9
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	0	0
Recognized  in Statement of Profit or Loss	(0.3)	0.3
Recognized in Other Comprehensive Income	(13.6)	6
Movement in foreign exchange	(0.6)	0
Closing balance	(5.3)	9.2	2.9
Other
Reconciliation of changes in deferred tax liability (asset) [abstract]
Opening balance	(5.2)	(2.3)
Changes in deferred tax liability (asset) [abstract]
Acquired through business combinations	(0.6)	(0.4)
Recognized  in Statement of Profit or Loss	(0.4)	(2.6)
Recognized in Other Comprehensive Income	0	0
Movement in foreign exchange	0	0.1
Closing balance	€ (6.2)	€ (5.2)	€ (2.3)

Inventories (Details)

Inventories (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Inventories [Abstract]
Raw materials and consumables	€ 95.8	€ 80.5
Work in progress	64.9	46.5
Finished goods and goods for resale	249.9	217.3
Total inventories	410.6	344.3
Inventory write-down	€ 8.3	€ 8.5	€ 9

Trade and other receivables (De

Trade and other receivables (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Subclassifications of assets, liabilities and equities [abstract]
Revenue from performance obligations satisfied or partially satisfied in previous periods	€ 18.9	€ 18
Recognised assets representing continuing involvement in derecognised financial assets	0	0
Current Trade Receivables, Reduction in Trade Terms	189.9	200.5
Current trade payables, relating to trade terms	(93.8)	(89.7)
Total trade terms liabilities	(283.7)	(290.2)
Current assets
Trade receivables	182.8	141.2
Prepayments and accrued income	15.4	9.2
Other receivables	32.3	31.2
Tax receivable	4.1	3.4
Total current trade and other receivables	234.6	185
Non-current assets
Other non-current assets	8.9	1.1
Total non-current trade and other receivables	8.9	1.1
Total trade and other receivables	€ 243.5	€ 186.1

Trade and other receivables - A

Trade and other receivables - Aging of Trade Receivables (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Trade Receivables [Line Items]
Trade receivables	€ 372.7	€ 341.7
Reduction in trade-terms	(189.9)	(200.5)
Total trade receivables	182.8	141.2
Not past due
Trade Receivables [Line Items]
Trade receivables	343.7	308.3
Past due less than 1 month
Trade Receivables [Line Items]
Trade receivables	19.8	20.3
Past due 1 to 3 months
Trade Receivables [Line Items]
Trade receivables	4.6	3.9
Past due 3 to 6 months
Trade Receivables [Line Items]
Trade receivables	2.3	1
Past due more than 6 months
Trade Receivables [Line Items]
Trade receivables	2.3	8.2
Gross
Trade Receivables [Line Items]
Trade receivables	376.3	346.1
Gross | Not past due
Trade Receivables [Line Items]
Trade receivables	343.8	308.6
Gross | Past due less than 1 month
Trade Receivables [Line Items]
Trade receivables	19.9	20.5
Gross | Past due 1 to 3 months
Trade Receivables [Line Items]
Trade receivables	5.2	4
Gross | Past due 3 to 6 months
Trade Receivables [Line Items]
Trade receivables	2.4	1.1
Gross | Past due more than 6 months
Trade Receivables [Line Items]
Trade receivables	5	11.9
Impaired
Trade Receivables [Line Items]
Trade receivables	(3.6)	(4.4)
Impaired | Not past due
Trade Receivables [Line Items]
Trade receivables	(0.1)	(0.3)
Impaired | Past due less than 1 month
Trade Receivables [Line Items]
Trade receivables	(0.1)	(0.2)
Impaired | Past due 1 to 3 months
Trade Receivables [Line Items]
Trade receivables	(0.6)	(0.1)
Impaired | Past due 3 to 6 months
Trade Receivables [Line Items]
Trade receivables	(0.1)	(0.1)
Impaired | Past due more than 6 months
Trade Receivables [Line Items]
Trade receivables	€ (2.7)	€ (3.7)

Indemnification assets (Details

Indemnification assets (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of detailed information about business combination [line items]
Indemnification assets		€ 9.5	€ 15.4	€ 35.4
Release of indemnified provision		(5.9)	(20)
Goodfella's Pizza [Member]
Disclosure of detailed information about business combination [line items]
Indemnification Assets Recognised As Of Acquisition Date		2.5	3.4
Release of indemnified provision		(0.9)
Findus
Disclosure of detailed information about business combination [line items]
Indemnification assets		7	€ 12
Release of indemnified provision	€ (7)	€ (5)

Indemnification assets - Additi

Indemnification assets - Additional Information (Details) € / shares in Units, € in Millions	12 Months Ended
	Dec. 31, 2022EUR (€)	Dec. 31, 2021EUR (€)€ / sharesshares	Dec. 31, 2020EUR (€)€ / sharesshares	Dec. 31, 2019EUR (€)	Jan. 01, 2022shares	Dec. 31, 2021$ / shares	Dec. 31, 2020$ / shares
Disclosure of detailed information about business combination [line items]
Release of indemnified provision		€ 5.9	€ 20
Indemnification assets		9.5	15.4	€ 35.4
Remeasurement of indemnification assets		5	17.8	€ 44
Findus
Disclosure of detailed information about business combination [line items]
Release of indemnified provision	€ 7	5
Indemnification assets		€ 7	€ 12
Shares held in escrow as a result of indemnification asset | shares		342,190	618,099
Value of shares held in escrow as a result of indemnification asset (price per share) | (per share)		€ 22.40	€ 20.69			$ 25.39	$ 25.42
Contingent Consideration Arrangements And Indemnification Assets Recognised as of Acquisition Date, shares released from escrow | shares		275,909			342,190
Goodfella's Pizza [Member]
Disclosure of detailed information about business combination [line items]
Release of indemnified provision		€ 0.9
Indemnification Assets Recognised As Of Acquisition Date		€ 2.5	€ 3.4

Cash and cash equivalents (Deta

Cash and cash equivalents (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Subclassifications of assets, liabilities and equities [abstract]
Cash and cash equivalents	€ 254	€ 393.1
Restricted cash	0.2	0.1
Cash and cash equivalents	254.2	393.2	€ 824.8	€ 327.6
Bank overdrafts	0	(10.7)
Cash and cash equivalents if different from statement of financial position	€ 254.2	€ 382.5	€ 824.8

Loans and borrowings - Repaymen

Loans and borrowings - Repayment Profile (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	€ 29.1	€ 22.5
Loans and borrowings	2,198.3	1,736.3
Borrowings	2,227.4	1,758.8
Gross | Syndicated loans
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	8.5	7.8
Loans and borrowings	1,347.4	1,287.5
Gross | 2024 fixed rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	0	400
Lease Liabilities | Less than one year
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	22.6	16.7
Lease Liabilities | Later than one year [member]
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	58.3	53.7
Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	9.4	6.9
Deferred borrowing costs | Less than one year
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	(2)	(2)
Deferred borrowing costs | 2 to 5 years
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	(5.7)	(4.9)
Deferred borrowing costs | More than five years
Disclosure of detailed information about borrowings [line items]
Loans and borrowings	€ (1.7)	€ 0

Loans and borrowings - Details

Loans and borrowings - Details of Individual Loans (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	€ 29.1	€ 22.5
Total non-current loans and borrowings	2,198.3	1,736.3
Borrowings	2,227.4	1,758.8
Gross | Syndicated loans
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	8.5	7.8
Total non-current loans and borrowings	1,347.4	1,287.5
Gross | 2024 fixed rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	0	400
Gross | Twenty Twenty-Eight Fixed Rate Senior Secured Notes
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	800	0
Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	9.4	6.9
Less than one year | Lease Liabilities
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	22.6	16.7
Less than one year | Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Total current loans and borrowings	(2)	(2)
Later than one year [member] | Lease Liabilities
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	58.3	53.7
2 to 5 years | Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	(5.7)	(4.9)
More than five years | Deferred borrowing costs
Disclosure of detailed information about borrowings [line items]
Total non-current loans and borrowings	€ (1.7)	€ 0

Loans and borrowings - Addition

Loans and borrowings - Additional Information (Details) kr in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021EUR (€)	Dec. 31, 2021USD ($)	Dec. 31, 2020EUR (€)	Dec. 31, 2019EUR (€)	Dec. 31, 2022EUR (€)	Dec. 31, 2022USD ($)	Dec. 31, 2021USD ($)	Dec. 31, 2021SEK (kr)	Jul. 29, 2021EUR (€)	Jul. 09, 2021EUR (€)	Jun. 24, 2021EUR (€)	Dec. 31, 2020USD ($)	Dec. 31, 2020SEK (kr)
Disclosure of detailed information about borrowings [line items]
Annual principal payment	€ 0
Percentage of consolidated gross assets or adjusted EBITDA held individually by companies in Guarantor Group	5.00%	5.00%
Percentage of consolidated gross assets or adjusted EBITDA held by Guarantor Group in total	80.00%	80.00%
Guarantee amount	€ 62,400,000		€ 44,700,000					kr 640					kr 450
Financing costs incurred in amendment of terms of debt	(17,900,000)		0	€ 0
Findus Sverige AB
Disclosure of detailed information about borrowings [line items]
Guarantee amount	29,300,000		29,800,000					kr 300
Senior USD Debt
Disclosure of detailed information about borrowings [line items]
Notional amount	€ 808,600,000					$ 916.4	$ 916.4		€ 827,800,000			$ 926
Interest rate	2.25%						2.25%	2.25%
Repayments of non-current borrowings	€ 8,500,000	$ 9.6
Repayments Of Non-current Borrowings - percentage of original issued notional	1.00%						1.00%	1.00%
Senior EURO Debt
Disclosure of detailed information about borrowings [line items]
Notional amount	€ 553,200,000
Interest rate	2.50%						2.50%	2.50%
Financing costs incurred in amendment of terms of debt	€ 3,800,000
2024 fixed rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Notional amount											€ 400,000,000
Interest rate											3.25%
Revolving Credit Facility
Disclosure of detailed information about borrowings [line items]
Letters of credit, overdrafts, customer bonds and bank guarantees utilized against the credit facility	€ 2,800,000		€ 16,100,000
Twenty Twenty-Eight Fixed Rate Senior Secured Notes
Disclosure of detailed information about borrowings [line items]
Notional amount										€ 50,000,000	€ 750,000,000
Interest rate	2.50%						2.50%	2.50%
Financing costs incurred in amendment of terms of debt	€ 4,000,000
Issued price of Senior Secured Notes (2028)										€ 100.75
Derivative financial instruments | Cross currency interest rate swap | Cash flow hedges
Disclosure of detailed information about borrowings [line items]
Notional amount	€ 827,800,000				€ 827,800,000
Findus Sverige AB
Disclosure of detailed information about borrowings [line items]
Proportion of ownership interest in subsidiary	100.00%	100.00%

Trade and other payables (Detai

Trade and other payables (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Current liabilities
Trade payables	€ 413.2	€ 363.7
Accruals and deferred income	120.4	134.5
Current trade payables, relating to trade terms	93.8	89.7
Social security and other taxes	24.6	24.1
Other payables	20.3	21.2
Financial payables	19.7	3.3
Bank overdrafts	0	10.7
Total current trade and other payables	692	647.2
Non-current liabilities
Accruals and deferred income	1.8	2.2
Total non-current trade and other payables	1.8	2.2
Total trade and other payables	€ 693.8	€ 649.4

Employee benefits - Additional

Employee benefits - Additional Information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of defined benefit plans [line items]
Post-employment benefit expense, defined contribution plans	€ 10.2	€ 8.3	€ 9
Recognized liability for net employee benefit obligations	244.2	276.2	237.5
Estimate of contributions expected to be paid to plan for next annual reporting period	€ 6.7
Weighted average duration of defined benefit obligation	18 years 10 months 24 days
Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Recognized liability for net employee benefit obligations	€ 352.6	374.1	€ 323.9
Present value of defined benefit obligation | Other countries
Disclosure of defined benefit plans [line items]
Recognized liability for net employee benefit obligations	€ 8.7	€ 4

Employee benefits - Defined Ben

Employee benefits - Defined Benefit Plans (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	€ 244.2	€ 276.2	€ 237.5
Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	352.6	374.1	€ 323.9
Germany | Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	149.3	181.2
SWEDEN | Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	70.3	74.1
Austria | Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	5.5	5.6
SWITZERLAND | Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	5.8	6.6
Italy | Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	4.6	4.7
Other countries | Present value of defined benefit obligation
Disclosure of fair value measurement of liabilities [line items]
Net defined benefit liability (asset)	€ 8.7	€ 4

Employee benefits - Amount Incl

Employee benefits - Amount Included in the Statement of Financial Position Arising from the Company's Obligations (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Present value of defined benefit obligation
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	€ 352.6	€ 374.1
Present value of defined benefit obligation | Defined benefit retirement plans
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	341.5	365.1
Present value of defined benefit obligation | Post-employment medical benefits and other benefits
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	11.1	9
Present value of defined benefit obligation | Unfunded Plan
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	88.6	88.6
Present value of defined benefit obligation | Unfunded Plan | Defined benefit retirement plans
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	77.5	79.6
Present value of defined benefit obligation | Unfunded Plan | Post-employment medical benefits and other benefits
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	11.1	9
Present value of defined benefit obligation | Funded Plan
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	264	285.5
Present value of defined benefit obligation | Funded Plan | Defined benefit retirement plans
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	264	285.5
Present value of defined benefit obligation | Funded Plan | Post-employment medical benefits and other benefits
Disclosure of defined benefit plans [line items]
Defined benefit obligation, at present value	0	0
Plan assets
Disclosure of defined benefit plans [line items]
Plan assets, at fair value	(108.4)	(97.9)
Plan assets | Defined benefit retirement plans
Disclosure of defined benefit plans [line items]
Plan assets, at fair value	(108.4)	(97.9)
Plan assets | Post-employment medical benefits and other benefits
Disclosure of defined benefit plans [line items]
Plan assets, at fair value	0	0
Plan assets, at fair value	108.4	97.9
Net defined benefit liability (asset)	244.2	276.2	€ 237.5
Defined benefit retirement plans
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	233.1	267.2	€ 228.5
Post-employment medical benefits and other benefits
Disclosure of defined benefit plans [line items]
Net defined benefit liability (asset)	€ 11.1	€ 9

Employee benefits - Reconciliat

Employee benefits - Reconciliation of Opening and Closing Balances of Net Employee Benefit Plans and Components (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disclosure of net defined benefit liability (asset) [line items]
Balance at January 1	€ 276.2	€ 237.5
Current service cost	7.9	6.6
Interest cost (income)	1.7	2.7
Post-employment benefit expense, defined benefit plans	9.6	9.3
Demographic assumptions	(1.5)	0
Financial assumptions	26.8	(29.1)
Actuarial experience (gains) losses	(1.8)	0.8
Return on plan assets, excluding interest income	(9.6)	(0.4)
Exchange adjustments	(0.9)	2.8
Gain (loss) on remeasurement, net defined benefit liability (asset)	(37)	30.7
Acquired through business combinations	3.5	6.6
Contributions by employer	(1.2)	(0.5)
Contributions by members	0	(0.1)
Benefits paid	(6.9)	(7.3)
Increase (decrease) in net defined benefit liability (asset) resulting from other changes	(4.6)	(1.3)
Balance at December 31	244.2	276.2
Present value of defined benefit obligation
Disclosure of net defined benefit liability (asset) [line items]
Balance at January 1	374.1	323.9
Current service cost	7.9	6.6
Interest cost (income)	2.2	3.7
Post-employment benefit expense, defined benefit plans	10.1	10.3
Demographic assumptions	(1.5)	0
Financial assumptions	26.8	(29.1)
Actuarial experience (gains) losses	(1.8)	0.8
Exchange adjustments	(0.3)	2.8
Gain (loss) on remeasurement, net defined benefit liability (asset)	(26.8)	31.1
Acquired through business combinations	3.5	18.4
Contributions by employer	0
Contributions by members	0.8	0.4
Benefits paid	(9.1)	(10)
Increase (decrease) in net defined benefit liability (asset) resulting from other changes	(4.8)	8.8
Balance at December 31	352.6	374.1
Plan assets
Disclosure of net defined benefit liability (asset) [line items]
Balance at January 1	(97.9)	(86.4)
Interest cost (income)	(0.5)	(1)
Post-employment benefit expense, defined benefit plans	(0.5)	(1)
Return on plan assets, excluding interest income	(9.6)	(0.4)
Exchange adjustments	(0.6)	0
Gain (loss) on remeasurement, net defined benefit liability (asset)	(10.2)	(0.4)
Acquired through business combinations	0	(11.8)
Contributions by employer	(1.2)	(0.5)
Contributions by members	(0.8)	(0.5)
Benefits paid	2.2	2.7
Increase (decrease) in net defined benefit liability (asset) resulting from other changes	0.2	(10.1)
Balance at December 31	€ (108.4)	€ (97.9)

Employee benefits - Actuarial L

Employee benefits - Actuarial Losses Recognized (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Employee Benefits [Abstract]
Other Comprehensive Income, Before Tax, Cumulative Gain (Loss) On Remeasurements Of Defined Benefit Plans	€ 40.5	€ 77.5

Employee benefits - Fair Value

Employee benefits - Fair Value of Plan Assets (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Employee Benefits [Abstract]
Equities	€ 32.7	€ 24.5
Debt instruments	42.7	44.1
Property	20.3	17.1
Other	12.7	12.2
Total	€ 108.4	€ 97.9

Employee benefits - Actuarial A

Employee benefits - Actuarial Assumptions (Details)	Dec. 31, 2021	Dec. 31, 2020
Bottom of range | Germany | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Rate of increase for pensions in payment	1.00%	1.00%
Bottom of range | SWITZERLAND | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Rate of increase in salaries		0.00%
Top of range | Germany | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Rate of increase for pensions in payment	2.00%	2.00%
Top of range | SWITZERLAND | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Rate of increase in salaries		2.50%
Germany | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	1.10%	0.55%
Inflation rate	2.00%	2.00%
Rate of increase in salaries	2.80%	2.80%
SWEDEN | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	1.80%	1.05%
Inflation rate	2.20%	1.50%
Rate of increase in salaries	3.20%	2.50%
Rate of increase for pensions in payment	2.20%	1.50%
Austria | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	0.90%	1.00%
Inflation rate	2.00%	2.00%
Rate of increase in salaries	2.00%	2.00%
Rate of increase for pensions in payment	0.00%	0.00%
Italy
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	0.35%	0.33%
Inflation rate	1.50%	1.00%
Rate of increase in salaries	2.63%	2.63%
Rate of increase for pensions in payment	0.00%	0.00%
SWITZERLAND | Defined benefit retirement plans
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Discount rate	0.10%	0.15%
Inflation rate	1.00%	0.20%
Rate of increase in salaries	1.50%
Rate of increase for pensions in payment	0.00%	0.00%

Employee benefits - Average Lif

Employee benefits - Average Life Expectancy After Retirement (Details) - Defined benefit retirement plans - yr	Dec. 31, 2021	Dec. 31, 2020
Germany
Disclosure of defined benefit plans [line items]
Male	21	21
Female	24	24
SWEDEN
Disclosure of defined benefit plans [line items]
Male	22	22
Female	24	24
Austria
Disclosure of defined benefit plans [line items]
Male	23	23
Female	26	26
Italy
Disclosure of defined benefit plans [line items]
Male	21	21
Female	22	22
SWITZERLAND
Disclosure of defined benefit plans [line items]
Male	22	21
Female	24	24

Employee benefits - History of

Employee benefits - History of Experience Adjustments From Inception (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net employee benefit obligations	€ 244.2	€ 276.2	€ 237.5
Defined benefit retirement plans
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net employee benefit obligations	233.1	267.2	228.5
Experience losses/(gains) on plan liabilities	1.8	(0.8)	0.2
Experience gains on plan assets	(9.6)	(0.4)	(5.1)
Present value of defined benefit obligation
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net employee benefit obligations	352.6	374.1	323.9
Present value of defined benefit obligation | Defined benefit retirement plans
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net employee benefit obligations	341.5	365.1	314.9
Plan assets
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net employee benefit obligations	(108.4)	(97.9)	(86.4)
Plan assets | Defined benefit retirement plans
Disclosure of net defined benefit liability (asset) [line items]
Recognized liability for net employee benefit obligations	€ (108.4)	€ (97.9)	€ (86.4)

Employee benefits - Defined B_2

Employee benefits - Defined Benefit Obligation Sensitivity Analysis (Details) € in Millions	Dec. 31, 2021EUR (€)
Discount rate
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Effect on the post-employment benefit obligation with a 1% increase	€ (54.6)
Effect on the post-employment benefit obligation with a 1% decrease	71.9
Actuarial assumption of expected rates of inflation [member]
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Effect on the post-employment benefit obligation with a 1% increase	47.4
Effect on the post-employment benefit obligation with a 1% decrease	(38.7)
Actuarial assumption of expected rates of salary increases [member]
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Effect on the post-employment benefit obligation with a 1% increase	15.2
Effect on the post-employment benefit obligation with a 1% decrease	(11.5)
Actuarial assumption of expected rates of pension increases [member]
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Effect on the post-employment benefit obligation with a 1% increase	47.6
Effect on the post-employment benefit obligation with a 1% decrease	€ (37)

Provisions (Details)

Provisions (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	€ 51.8	€ 46.8
Acquisitions through business combinations, other provisions	4.1
Additional provision in the period	6.1	29.1
Release of provision	(4.1)	(7.1)
Utilization of provision	(16.7)	(16.8)
Foreign exchange	1	(0.2)
Provisions, ending balance	42.2	51.8
Provisions	42.2	51.8
Current	39.3	45.7
Non-current	(2.9)	(6.1)
Provisions	(42.2)	(51.8)
Restructuring
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	12.9	7.4
Acquisitions through business combinations, other provisions	0
Additional provision in the period	2.6	15.6
Release of provision	(0.1)	0
Utilization of provision	(9.8)	(10.4)
Foreign exchange	0	0.3
Provisions, ending balance	5.6	12.9
Onerous/ unfavorable contracts
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	0	1.2
Acquisitions through business combinations, other provisions	0
Additional provision in the period	0	0
Release of provision	0	(0.7)
Utilization of provision	0	(0.5)
Foreign exchange	0	0
Provisions, ending balance	0	0
Provisions related to other taxes
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	6.6	6.9
Acquisitions through business combinations, other provisions	0.3
Additional provision in the period	1	0.1
Release of provision	0	(0.4)
Utilization of provision	0	0
Foreign exchange	0	0
Provisions, ending balance	7.9	6.6
Other
Reconciliation of changes in other provisions [abstract]
Provisions, beginning balance	32.3	31.3
Acquisitions through business combinations, other provisions	3.8
Additional provision in the period	2.5	13.4
Release of provision	(4)	(6)
Utilization of provision	(6.9)	(5.9)
Foreign exchange	1	(0.5)
Provisions, ending balance	€ 28.7	€ 32.3

Provisions - Additional Informa

Provisions - Additional Information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of other provisions [line items]
Provisions	€ 42.2	€ 51.8	€ 46.8
Acquisitions through business combinations, other provisions	4.1
Provision used	16.7	16.8
Release of provision	4.1	7.1
Restructuring
Disclosure of other provisions [line items]
Provisions	5.6	12.9	7.4
Acquisitions through business combinations, other provisions	0
Provision used	9.8	10.4
Release of provision	0.1	0
Onerous/ unfavorable contracts
Disclosure of other provisions [line items]
Provisions	0	0	1.2
Acquisitions through business combinations, other provisions	0
Provision used	0	0.5
Release of provision	0	0.7
Provisions related to other taxes
Disclosure of other provisions [line items]
Provisions	7.9	6.6	6.9
Acquisitions through business combinations, other provisions	0.3
Provision used	0	0
Release of provision	0	0.4
Other provision
Disclosure of other provisions [line items]
Provisions	28.7	32.3	€ 31.3
Acquisitions through business combinations, other provisions	3.8
Provision used	6.9	5.9
Release of provision	4	6
Asset retirement obligation [Member]
Disclosure of other provisions [line items]
Provisions	4.6	6.1
Goodfella's Pizza [Member] | indemnification asset liability with customers
Disclosure of other provisions [line items]
Provisions	3.9	4.4
Italy | Other provision
Disclosure of other provisions [line items]
Provisions	4.3	4.7
Aunt Bessie's [Member] [Member] | Other provision
Disclosure of other provisions [line items]
Provisions	1.3	1.9
Restricted Shares | Provisions related to other taxes
Disclosure of other provisions [line items]
Provisions	€ 2.4	€ 6.6

Share capital and reserves - Sc

Share capital and reserves - Schedule of Share Capital and Capital Reserve (Details) € in Millions	Dec. 31, 2021$ / shares	Dec. 31, 2021EUR (€)shares	Dec. 31, 2020$ / shares	Dec. 31, 2020EUR (€)shares	Dec. 31, 2019EUR (€)
Disclosure of classes of share capital [line items]
Total share capital and capital reserve		€ 1,650.2		€ 1,647.5
Listing and share transaction costs		(27.1)		(27)	€ (24.9)
Total net share capital and capital reserve		1,623.1		1,620.5
Ordinary shares
Disclosure of classes of share capital [line items]
Total share capital and capital reserve		1,639.6		1,636.9
Founder Preferred shares
Disclosure of classes of share capital [line items]
Total share capital and capital reserve		€ 10.6		€ 10.6
Issued Capital and Capital Reserve | Ordinary shares
Disclosure of classes of share capital [line items]
Par value per share | $ / shares	$ 10		$ 10
Number of shares issued and fully paid (in shares) | shares		173,559,173		172,180,897
Issued Capital and Capital Reserve | Founder Preferred shares
Disclosure of classes of share capital [line items]
Par value per share | $ / shares	$ 10		$ 10
Number of shares issued and fully paid (in shares) | shares		1,500,000		1,500,000

Share capital and reserves - Or

Share capital and reserves - Ordinary Shares (Details) - Ordinary shares - shares shares in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of number of shares outstanding [abstract]
Number of shares outstanding, beginning balance (in shares)	172.2	194.5
Shares issued in the year	5	7.6
Shares repurchased in the year	3.6	29.9
Number of shares outstanding, ending balance (in shares)	173.6	172.2

Share capital and reserves - _2

Share capital and reserves - Ordinary Shares Narrative (Details)	Aug. 05, 2021USD ($)shares	Jun. 30, 2021shares$ / shares	Jan. 30, 2021EUR (€)shares	Jan. 30, 2021USD ($)$ / sharesshares	Jun. 17, 2020shares$ / shares	Mar. 13, 2020EUR (€)shares	Mar. 13, 2020USD ($)shares	Jun. 14, 2019shares$ / shares	Aug. 31, 2020EUR (€)shares	Aug. 31, 2020USD ($)shares	May 31, 2020shares	Jul. 31, 2019shares	Mar. 02, 2022EUR (€)shares	Mar. 02, 2022USD ($)shares	Dec. 31, 2021EUR (€)shares	Dec. 31, 2021USD ($)shares$ / shares	Dec. 31, 2020EUR (€)	Dec. 31, 2019EUR (€)shares	Aug. 05, 2021EUR (€)	Dec. 31, 2020$ / shares	Aug. 01, 2020$ / shares
Disclosure of classes of share capital [line items]
Share repurchase programme | $	$ 500,000,000						$ 300,000,000			$ 500,000,000
Proceeds from issuance of Ordinary Shares | €															€ 0		€ 600,000	€ 354,100,000
Payments to acquire or redeem entity's shares | €															77,600,000		608,600,000	0
Share based payment charge | €															€ 5,100,000		€ 9,000,000	€ 14,900,000
Shares repurchased, payable | €																			€ 3,000,000
Events after Reporting Period
Disclosure of classes of share capital [line items]
Number of shares repurchased (in shares) | shares	135,621
Restricted Shares
Disclosure of classes of share capital [line items]
Number of equity instruments exercised (in shares) | shares															1,861,826	1,861,826
Non-Executive Director | Restricted Shares
Disclosure of classes of share capital [line items]
Share price (in dollars per share) | $ / shares		$ 30.14			$ 21.78			$ 20.74
Number of equity instruments exercised (in shares) | shares		32,140			34,447			44,272			49,196	2,460						56,250
Ordinary shares
Disclosure of classes of share capital [line items]
Share price (in dollars per share) | $ / shares				$ 25.29												$ 24.50				$ 21.04	$ 25.50
Costs related to transactions | €						€ 200,000			€ 1,900,000						€ 100,000
Number of shares repurchased (in shares) | shares			507,396	507,396		11,913,682	11,913,682		18,061,952	18,061,952					3,090,082	3,090,082
Payments to acquire or redeem entity's shares			€ 10.5	$ 12.8		€ 217,400,000	$ 250,900,000		€ 389,300,000	$ 460,600,000					€ 67,100,000	$ 75,800,000
Ordinary shares | Events after Reporting Period
Disclosure of classes of share capital [line items]
Number of shares repurchased (in shares) | shares													1,160,547	1,160,547
Payments to acquire or redeem entity's shares													€ 26,900,000	$ 30,500,000

Share capital and reserves - Li

Share capital and reserves - Listing and Share Transaction Costs (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share Capital, Reserves and Other Equity Interest [Abstract]
Share issue related cost, beginning balance	€ 27	€ 24.9
Share transaction costs	0.1	2.1
Share issue related cost, ending balance	€ 27.1	€ 27

Share capital and reserves - Fo

Share capital and reserves - Founder Preferred Shares Annual Dividend Amount and Warrant Redemption Amount (Details)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2021vote$ / sharesshares	Dec. 31, 2018	Dec. 31, 2015$ / shares	Dec. 31, 2020$ / shares
Disclosure of classes of share capital [line items]
Preferred stocks issued (in shares) | shares			1,500,000
Number of votes per Founder Preferred Share | vote			1
Preference shares, dividend payment terms, weighted average share price, minimum term required					10 days
Preferred stock, conversion terms, weighted average share price (in dollars per share) | $ / shares					$ 11.50
Percentage increase in dividend price	20.00%	20.00%	20.00%
Preference shares, conversion ratio				1
Founder Preferred shares | Issued Capital and Capital Reserve
Disclosure of classes of share capital [line items]
Par value per share | $ / shares			$ 10			$ 10
Founder entities
Disclosure of classes of share capital [line items]
Preferred stocks issued (in shares) | shares			750,000

Share-based compensation rese_3

Share-based compensation reserve (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of reserves within equity [line items]
Beginning balance, Reserve of share-based payments	€ 8.3
Increase (decrease) through share-based payment transactions, equity	5.1	€ 9	€ 14.9
Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity		0	(0.8)
Reclassification of awards for settlement of tax liabilities	(16.9)	(14.7)	€ 0.4
Ending balance, Reserve of share-based payments	6.9	8.3
Share based compensation reserve
Disclosure of reserves within equity [line items]
Beginning balance, Reserve of share-based payments	8.3
Ending balance, Reserve of share-based payments	6.9	€ 8.3
Non-Executive Director | Share based compensation reserve
Disclosure of reserves within equity [line items]
Increase (decrease) through share-based payment transactions, equity	0.8
Key management personnel | Share based compensation reserve
Disclosure of reserves within equity [line items]
Increase (decrease) through share-based payment transactions, equity	4.3
Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity	0.7
Restricted Shares | Non-Executive Director
Disclosure of reserves within equity [line items]
Reclassification of awards for settlement of tax liabilities	€ (5.8)

Share-based compensation rese_4

Share-based compensation reserve - Additional Information (Details) - EUR (€)	Jun. 30, 2021	Jun. 17, 2020	Jun. 14, 2019	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of reserves within equity [line items]
Vesting of Non-Executive Restricted Stock award					€ 0	€ (800,000)
Share based payment charge				€ 5,100,000	9,000,000	14,900,000
Non-Executive Director | Share based compensation reserve
Disclosure of reserves within equity [line items]
Share based payment charge				800,000
Non-Executive Director | Restricted Shares
Disclosure of reserves within equity [line items]
Shares paid for tax withholding for share based compensation	7,734	8,656	12,100
Key management personnel | Share based compensation reserve
Disclosure of reserves within equity [line items]
Vesting of Non-Executive Restricted Stock award				700,000
Share based payment charge				4,300,000
Share based compensation reserve
Disclosure of reserves within equity [line items]
Vesting of Non-Executive Restricted Stock award				(600,000)	(700,000)	(800,000)
Share based payment charge				€ 5,100,000	€ 9,000,000	€ 14,900,000
Share based compensation reserve | Non-Executive Director | Restricted Shares
Disclosure of reserves within equity [line items]
Share based payment charge	€ 0.2		€ 100,000

Founder Preferred Shares Divi_3

Founder Preferred Shares Dividend Reserve - Narrative (Details)	Dec. 31, 2021$ / shares	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2021shares	Dec. 31, 2020$ / sharesshares	Dec. 31, 2019$ / sharesshares	Jan. 12, 2016	Dec. 31, 2015$ / shares
Disclosure of classes of share capital [line items]
Preferred stock, conversion terms, weighted average share price (in dollars per share) | $ / shares								$ 11.50
Dividends recognised as distributions to owners per share (in dollars per share) | $ / shares	$ 25.2127				$ 25.2127	$ 21.7289
Preferred share dividend equivalent							140,220,619
Percentage increase in dividend price		20.00%	20.00%	20.00%
Ordinary shares
Disclosure of classes of share capital [line items]
Ordinary shares excluded | shares				13,700,000
Founder entities | Ordinary shares
Disclosure of classes of share capital [line items]
Share dividend issued (in shares) | shares					3,875,036	6,421,074

Founder Preferred Shares Divi_4

Founder Preferred Shares Dividend Reserve (Details) € in Millions	12 Months Ended
	Dec. 31, 2021EUR (€)	Dec. 31, 2020EUR (€)	Dec. 31, 2019EUR (€)	Dec. 31, 2018USD ($)
Disclosure of classes of share capital [line items]
Equity, beginning balance	€ 2,126.1	€ 2,556.7	€ 2,059.1
Settlement of dividend through share issue | $				$ 16.7538
Equity, ending balance	2,299	2,126.1	2,556.7
Founder preferred shares dividend reserve
Disclosure of classes of share capital [line items]
Equity, beginning balance	245.5	370.1	372.6
Settlement of dividend through share issue	(79.5)	(124.6)	(2.5)
Equity, ending balance	166	245.5	€ 370.1
Founder preferred shares dividend reserve | Founder Preferred shares
Disclosure of classes of share capital [line items]
Equity, beginning balance	245.5
Settlement of dividend through share issue	79.5
Equity, ending balance	€ 166	€ 245.5

Translation reserve Translati_3

Translation reserve Translation reserve table (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of reserves within equity [line items]
Equity	€ 2,299	€ 2,126.1	€ 2,556.7	€ 2,059.1
Equity (restated)		2,126.1		2,090.4
Gains (losses) on exchange differences on translation, before tax	31.7	(23.6)	19.2
Gains (losses) on hedges of net investments in foreign operations, net of tax	(12.9)	13.5	(13.2)
Other comprehensive income/(loss) for the year	53.7	(40.9)	(44.9)
Reserve of exchange differences on translation, hedging relationships for which hedge accounting is no longer applied	50.8	46.4
Increase (decrease) due to changes in accounting policy required by IFRSs
Disclosure of reserves within equity [line items]
Equity				31.3
Hedges of net investment in foreign operations
Disclosure of reserves within equity [line items]
Reserve of exchange differences on translation, continuing hedges		17.3
Reserve of exchange differences on translation, continuing hedges		17.3
Translation reserve
Disclosure of reserves within equity [line items]
Equity attributable to owners of the parent (restated)		84.7
Equity	105.1	84.7	94.8	88.8
Equity (restated)		86.3	94.8	88.8
Other comprehensive income/(loss) for the year	18.8	(10.1)	6
Translation reserve | Increase (decrease) due to changes in accounting policy required by IFRSs
Disclosure of reserves within equity [line items]
Equity		1.6	0	€ 0
GBP net investments [Member]
Disclosure of reserves within equity [line items]
Gains (losses) on exchange differences on translation, net of tax	€ 24.6	€ (25.7)	€ 19

Cash flow hedging reserve (Deta

Cash flow hedging reserve (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Jan. 01, 2021	Dec. 31, 2018
Disclosure of detailed information about hedges [line items]
Reserve of cash flow hedges	€ 10.5	€ (24.5)	€ (13.2)	€ (21.7)	€ 8.5
Increase (decrease) due to changes in accounting policy required by IFRSs		(1.6)
Deferred hedging gains transferred to the carrying value of inventory	27.6
Change in fair value of hedging instrument recognized in OCI in the year	85	(83.7)	31.9
Reclassified to cost of goods sold		0.2	(21.8)
Reclassified from other comprehensive income to finance costs	(62.4)	66.2	(37.4)
Deferred tax income (expense) on cash flow hedge reserve	(13.6)	6	5.6
Swap contract [member]
Disclosure of detailed information about hedges [line items]
Reserve of cash flow hedges	5.1	(4.5)	(6.8)		0.9
Increase (decrease) due to changes in accounting policy required by IFRSs		2.8
Change in fair value of hedging instrument recognized in OCI in the year	73.3	(63.7)	28.1
Reclassified to cost of goods sold		0	0
Reclassified from other comprehensive income to finance costs	(64.1)	66.2	(37.4)
Deferred tax income (expense) on cash flow hedge reserve	(2.4)	(0.2)	1.6
Forward contract [member]
Disclosure of detailed information about hedges [line items]
Reserve of cash flow hedges	5.8	(20)	(6.4)		€ 7.6
Deferred hedging gains transferred to the carrying value of inventory	27.6
Change in fair value of hedging instrument recognized in OCI in the year	9.3	(20)	3.8
Reclassified to cost of goods sold		0.2	(21.8)
Reclassified from other comprehensive income to finance costs	0	0	0
Deferred tax income (expense) on cash flow hedge reserve	(11.1)	6.2	€ 4
Other reserves*
Disclosure of detailed information about hedges [line items]
Reserve of cash flow hedges	10.9
Increase (decrease) due to changes in accounting policy required by IFRSs		2.8
Deferred hedging gains transferred to the carrying value of inventory	27.6
Change in fair value of hedging instrument recognized in OCI in the year	82.6
Reclassified from other comprehensive income to finance costs	(64.1)
Deferred tax income (expense) on cash flow hedge reserve	(13.5)
Cost of Hedging reserve
Disclosure of detailed information about hedges [line items]
Reserve of cash flow hedges	(0.4)
Increase (decrease) due to changes in accounting policy required by IFRSs		€ (4.4)
Change in fair value of hedging instrument recognized in OCI in the year	2.4
Reclassified from other comprehensive income to finance costs	1.7
Deferred tax income (expense) on cash flow hedge reserve	€ (0.1)

Earnings_(loss) per share (Deta

Earnings/(loss) per share (Details) - EUR (€) € / shares in Units, € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Earnings per share [abstract]
Profit (loss), attributable to owners of parent	€ 181	€ 225.2	€ 154
Weighted average Ordinary Shares and Founder Preferred Shares	178,070,770	194,019,070	192,004,803
Basic earnings per share (in euros per share)	€ 1.02	€ 1.16	€ 0.80
Weighted average Ordinary Shares and Founder Preferred Shares	178,070,770	197,894,106	198,425,877
Diluted earnings per share (in euros per share)	€ 1.02	€ 1.14	€ 0.78
Profit (loss)	€ 181	€ 225.1	€ 153.6

Earnings_(loss) per share - Add

Earnings/(loss) per share - Additional Information (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Earnings per share [abstract]
Profit (loss), attributable to owners of parent	€ 181	€ 225.2	€ 154
Weighted average number of ordinary shares (in shares)	176,570,770	192,519,070	190,504,803
Weighted average number of founder preferred shares (in shares)	1,500,000	1,500,000	1,500,000
Adjusted shares for dilutive impact of 2018 non-executive restricted stock awards (in shares)	0

Reconciliation of liabilities_3

Reconciliation of liabilities arising from financing activities (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Total loans and borrowings (Note 21)
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Opening balance	€ 1,758.8	€ 1,875.3
Cash inflow	800	0
Cash outflow	(436)	(32)
Interest accretion	2.2	5.2
Financial liabilities recognised as of acquisition date	19.6	0.4
Exchange movement	64.1	(71.7)
Fair value changes	0	0
Other non-cash adjustments	18.7	(18.4)
Closing balance	2,227.4	1,758.8
Interest accretion	2.2	5.2
Financial payables (Note 22)
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Opening balance	3.3	4.1
Cash inflow	0	0
Cash outflow	(38.1)	(57)
Interest accretion	57.6	58.8
Financial liabilities recognised as of acquisition date	0	0
Exchange movement	(0.2)	0.9
Fair value changes	0	0
Other non-cash adjustments	(2.9)	(3.5)
Closing balance	19.7	3.3
Interest accretion	57.6	58.8
Forward foreign exchange and currency swap contract | Derivatives
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Opening balance	0.2	(0.2)
Cash inflow	0.3	0
Cash outflow	0	(2.2)
Interest accretion	0	0
Financial liabilities recognised as of acquisition date	0	0
Exchange movement	0	0
Fair value changes	(0.1)	2.6
Other non-cash adjustments	0	0
Closing balance	0.4	0.2
Interest accretion	0	0
Cross currency interest rate swap | Derivatives
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Opening balance	72.3	15.3
Cash inflow	1.4	6.8
Cash outflow	(2.3)	(3.9)
Interest accretion	0	0
Financial liabilities recognised as of acquisition date	0	0
Exchange movement	0	0
Fair value changes	(44)	54.1
Other non-cash adjustments	(6.8)	0
Closing balance	20.6	72.3
Interest accretion	€ 0	€ 0

Cash flows from operating act_3

Cash flows from operating activities (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Profit (loss)	€ 181	€ 225.1	€ 153.6
Adjustments for:
Exceptional items	45.3	20.6	54.5
Non-cash fair value purchase price adjustment of inventory	8.4	0	0
Share based payments expense	5.1	9	14.9
Depreciation and amortization	71.6	67.6	68.3
Loss on disposal and impairment of property, plant and equipment	0.7	0.9	0.6
Net finance costs	106	63.7	73.2
Taxation	55.7	70.4	56.7
Operating cash flow before changes in working capital, provisions and exceptional items	473.8	457.3	421.8
(Increase)/decrease in inventories	(23.8)	(12.7)	23.5
Decrease/(increase) in trade and other receivables	24.1	(1.8)	(34.4)
(Decrease)/increase in trade and other payables	(25)	107.2	(40.6)
Increase in employee benefit and other provisions	1.2	2	6.6
Cash generated from operations before tax and exceptional items	450.3	552	376.9
Material reconciling items [member]
Adjustments for:
Exceptional items	€ 45.3	€ 20.6	€ 54.5

Financial risk management - Der

Financial risk management - Derivatives and Hedging (Details) € in Millions, £ in Millions, $ in Millions	May 15, 2024	May 15, 2022	Jul. 29, 2021EUR (€)	Dec. 31, 2021USD ($)	Dec. 31, 2021EUR (€)	Dec. 31, 2020EUR (€)	Dec. 31, 2019EUR (€)	Dec. 31, 2022USD ($)	Dec. 31, 2022EUR (€)	Dec. 31, 2021EUR (€)	Dec. 31, 2021GBP (£)	Dec. 31, 2020USD ($)	Dec. 31, 2020EUR (€)	Dec. 31, 2020GBP (£)
Disclosure of nature and extent of risks arising from financial instruments [line items]
Repayment of current borrowings in future years				$ 9.6	€ 8.7	€ 8.7
Hedges of net investment in foreign operations
Disclosure of nature and extent of risks arising from financial instruments [line items]
Gain (loss) on hedge ineffectiveness recognised in profit or loss					0	0
Gain (loss) on hedge ineffectiveness recognised in profit or loss					0	0
Foreign exchange forward contract | Derivative financial instruments | EUR/USD
Disclosure of nature and extent of risks arising from financial instruments [line items]
Carrying amount of forward currency contracts					17.5	(21.9)
Notional amount										€ 343.6			€ 249
Change in fair value of outstanding hedging instruments					(26.3)	(20.6)
Weighted average hedged rate for the year				120.00%						120.00%	120.00%	113.00%	113.00%	113.00%
Notional amount										€ 343.6			€ 249
Foreign exchange forward contract | Derivative financial instruments | GBP/USD
Disclosure of nature and extent of risks arising from financial instruments [line items]
Carrying amount of forward currency contracts					1.2	(3.7)
Notional amount										€ 58.4			€ 53.5
Change in fair value of outstanding hedging instruments					(0.5)	(2)
Weighted average hedged rate for the year				138.00%						138.00%	138.00%	128.00%	128.00%	128.00%
Notional amount										€ 58.4			€ 53.5
Foreign exchange forward contract | Derivative financial instruments | GBP/EUR
Disclosure of nature and extent of risks arising from financial instruments [line items]
Carrying amount of forward currency contracts					(6.7)	1.4
Notional amount										€ 244.7			€ 159
Change in fair value of outstanding hedging instruments					12	8.5
Weighted average hedged rate for the year				115.00%						115.00%	115.00%	112.00%	112.00%	112.00%
Notional amount										€ 244.7			€ 159
Foreign exchange forward contract | Derivative financial instruments | SEKEUR
Disclosure of nature and extent of risks arising from financial instruments [line items]
Carrying amount of forward currency contracts					0.5	(4)
Notional amount										€ 70.4			€ 77.3
Change in fair value of outstanding hedging instruments					(0.9)	(4.2)
Weighted average hedged rate for the year				10.00%						10.00%	10.00%	9.00%	9.00%	9.00%
Notional amount										€ 70.4			€ 77.3
Foreign exchange forward contract | Derivative financial instruments | SEK/USD
Disclosure of nature and extent of risks arising from financial instruments [line items]
Carrying amount of forward currency contracts					0.1	(2.6)
Notional amount										€ 4.5			€ 14.1
Change in fair value of outstanding hedging instruments					13.5	(2.2)
Weighted average hedged rate for the year				11.00%						11.00%	11.00%	10.00%	10.00%	10.00%
Notional amount										€ 4.5			€ 14.1
Foreign exchange forward contract | Derivative financial instruments | Other currencies
Disclosure of nature and extent of risks arising from financial instruments [line items]
Carrying amount of forward currency contracts					0.3	(0.5)
Notional amount										€ 96.4			€ 16.8
Change in fair value of outstanding hedging instruments					0.6	0.8
Weighted average hedged rate for the year				0.00%						0.00%	0.00%	21.00%	21.00%	21.00%
Notional amount										€ 96.4			€ 16.8
Cross currency interest rate swap | Cash flow hedges | Derivative financial instruments
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount									€ 827.8	€ 827.8
Maturity date of cross currency interest rate swaps (GBP)		May 15, 2022	Jul. 29, 2021
Maturity date of cross currency interest rate swaps	May 15, 2024	May 15, 2022
Change in fair value of outstanding hedging instruments					68.9	(71)
Weighted average hedged rate for the year				111.00%						111.00%	111.00%	111.00%	111.00%	111.00%
Change in value of hedged item					(69.6)	71
Carrying amount of cross currency interest rate swaps										€ (20.6)			€ (89.5)
Change in value of hedged item					(69.6)	71
Notional amount									€ 827.8	827.8
Carrying amount of cross currency interest rate swaps										€ (20.6)			€ (89.5)
Cross currency interest rate swap | Hedges of net investment in foreign operations | Derivative financial instruments
Disclosure of nature and extent of risks arising from financial instruments [line items]
Change in fair value of outstanding hedging instruments					(12.9)	13.5
Weighted average hedged rate for the year				119.00%						119.00%	119.00%	119.00%	119.00%	119.00%
Change in value of hedged item					12.9	(13.5)
Carrying amount of cross currency interest rate swaps										€ 0			€ 14.3
Change in value of hedged item					12.9	(13.5)
Carrying amount of cross currency interest rate swaps										0			€ 14.3
Forward foreign exchange and currency swap contract | Cash flow hedges
Disclosure of nature and extent of risks arising from financial instruments [line items]
Gains (losses) on change in fair value of derivatives					0.6	(2.4)	€ 4.8
Gains (losses) on change in fair value of derivatives					0.6	(2.4)	4.8
Forward foreign exchange and currency swap contract | Foreign exchange swap
Disclosure of nature and extent of risks arising from financial instruments [line items]
Gains (losses) on change in fair value of derivatives					(14.3)	(3.2)	(13.6)
Gains (losses) on change in fair value of derivatives					€ (14.3)	€ (3.2)	€ (13.6)
Senior USD Debt
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount			€ 827.8	$ 916.4				$ 916.4		808.6		$ 926
Notional amount			€ 827.8	$ 916.4				$ 916.4		€ 808.6		$ 926
Senior GBP Debt
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount | £											£ 0			£ 220.2
Notional amount | £											£ 0			£ 220.2

Financial risk management - Mar

Financial risk management - Market Risk (Details) £ in Millions	12 Months Ended
	Dec. 31, 2021EUR (€)	Dec. 31, 2020EUR (€)	Dec. 31, 2019	Dec. 31, 2021GBP (£)	Dec. 31, 2020GBP (£)
Senior GBP Debt
Disclosure of nature and extent of risks arising from financial instruments [line items]
Notional amount | £				£ 0	£ 220.2
Notional amount | £				£ 0	£ 220.2
Interest rate risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, percent	1.00%
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on pre-tax earnings	€ 2,600,000	€ 5,600,000
Liquidity risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Line of credit facility, maximum borrowing capacity	175,000,000
Letters of credit, overdrafts, customer bonds and bank guarantees utilized against the credit facility	€ 2,800,000
Currency risk | Pound Sterling
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, actual change in risk variable, percent	7.30%	(5.20%)	5.30%
Currency risk | Pound Sterling | Foreign exchange forward contract
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on pre-tax earnings	€ 0	€ 700,000
Currency risk | US dollar
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, actual change in risk variable, percent	7.80%	(9.60%)	2.00%
Currency risk | US dollar | Foreign exchange forward contract
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on pre-tax earnings	€ 0	€ 0
Currency risk | US dollar | Foreign exchange forward contract | Derivative financial instruments
Disclosure of nature and extent of risks arising from financial instruments [line items]
Percentage of financial instruments designated as hedging instruments	95.10%	87.90%		95.10%	87.90%
Financial assets	€ 18,800,000
Financial liabilities		€ 28,300,000
Currency risk | Euro | Foreign exchange forward contract | Derivative financial instruments
Disclosure of nature and extent of risks arising from financial instruments [line items]
Percentage of financial instruments designated as hedging instruments	77.20%	84.90%		77.20%	84.90%
Financial liabilities	€ 5,900,000	€ 3,100,000
Currency risk | Swedish Krona
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, actual change in risk variable, percent	(1.80%)	3.80%	(2.20%)
Currency risk | Swedish Krona | Foreign exchange forward contract
Disclosure of nature and extent of risks arising from financial instruments [line items]
Sensitivity analysis for types of market risk, reasonably possible change in risk variable, impact on pre-tax earnings	€ (400,000)	€ (400,000)
Bottom of range | Interest rate risk
Disclosure of nature and extent of risks arising from financial instruments [line items]
Interest rate	0.00%			0.00%

Financial risk management - Mat

Financial risk management - Maturity Analysis (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2021EUR (€)	Dec. 31, 2020EUR (€)
Disclosure of maturity analysis for derivative financial liabilities [line items]
Loan repayment percentage	1.00%	1.00%
Repayment of current borrowings in future years	$ 9.6	€ 8,700,000	€ 8,700,000
Financial liabilities, undiscounted cash flows		3,185,000,000	2,659,400,000
2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		717,700,000	706,400,000
2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		77,100,000	145,100,000
2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		863,800,000	64,900,000
2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		41,300,000	1,709,700,000
2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		39,700,000	5,200,000
More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		1,445,400,000	28,100,000
Borrowings-principal
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		2,161,900,000	1,706,500,000
Borrowings-principal | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		8,500,000	7,800,000
Borrowings-principal | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		8,500,000	7,800,000
Borrowings-principal | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		791,700,000	7,800,000
Borrowings-principal | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	1,683,100,000
Borrowings-principal | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Borrowings-principal | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		1,353,200,000	0
Borrowings-interest
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		306,500,000	161,000,000
Borrowings-interest | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		57,500,000	46,600,000
Borrowings-interest | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		63,500,000	46,800,000
Borrowings-interest | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		50,400,000	47,200,000
Borrowings-interest | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		34,000,000	20,400,000
Borrowings-interest | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		34,100,000	0
Borrowings-interest | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		67,000,000	0
Lease Liabilities
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		90,600,000	80,200,000
Lease Liabilities | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		23,100,000	17,200,000
Lease Liabilities | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		18,200,000	13,600,000
Lease Liabilities | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		11,200,000	9,900,000
Lease Liabilities | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		7,300,000	6,200,000
Lease Liabilities | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		5,600,000	5,200,000
Lease Liabilities | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		25,200,000	28,100,000
Trade and other payables excluding non-financial liabilities
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		647,100,000	601,100,000
Trade and other payables excluding non-financial liabilities | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		647,100,000	601,100,000
Trade and other payables excluding non-financial liabilities | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Trade and other payables excluding non-financial liabilities | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Trade and other payables excluding non-financial liabilities | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Trade and other payables excluding non-financial liabilities | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Trade and other payables excluding non-financial liabilities | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Foreign exchange forward contract
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		805,300,000	677,300,000
Sell | Foreign exchange forward contract | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		805,300,000	677,300,000
Sell | Foreign exchange forward contract | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Foreign exchange forward contract | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Foreign exchange forward contract | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Foreign exchange forward contract | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Foreign exchange forward contract | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Cross currency interest rate swap
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		868,400,000	1,174,400,000
Sell | Cross currency interest rate swap | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		25,000,000	38,500,000
Sell | Cross currency interest rate swap | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		24,900,000	1,135,900,000
Sell | Cross currency interest rate swap | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		818,500,000	0
Sell | Cross currency interest rate swap | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Cross currency interest rate swap | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Sell | Cross currency interest rate swap | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Foreign exchange forward contract
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		(818,000,000)	(647,500,000)
Pay | Foreign exchange forward contract | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		(818,000,000)	(647,500,000)
Pay | Foreign exchange forward contract | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Foreign exchange forward contract | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Foreign exchange forward contract | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Foreign exchange forward contract | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Foreign exchange forward contract | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Cross currency interest rate swap
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		(876,800,000)	(1,093,600,000)
Pay | Cross currency interest rate swap | 2022
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		(30,800,000)	(34,600,000)
Pay | Cross currency interest rate swap | 2023
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		(38,000,000)	(1,059,000,000)
Pay | Cross currency interest rate swap | 2024
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		(808,000,000)	0
Pay | Cross currency interest rate swap | 2025
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Cross currency interest rate swap | 2026
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Pay | Cross currency interest rate swap | More than five years
Disclosure of maturity analysis for derivative financial liabilities [line items]
Financial liabilities, undiscounted cash flows		0	0
Forecast
Disclosure of maturity analysis for derivative financial liabilities [line items]
Repayment based on excess cashflow calculation		€ 0	€ 0

Financial instruments - Categor

Financial instruments - Categories of Financial Instruments (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	€ 0	€ (25)
Derivatives at fair value through profit or loss	0.4	2.7
Financial assets at amortised cost	455.8	534.4
Financial liabilities at amortised cost	(2,883.9)	(2,366.8)
Financial assets (liabilities) at fair value through other comprehensive income	(8.3)	(105)
Total	(2,436)	(1,909.7)
Total non-current loans and borrowings	2,198.3	1,736.3
Borrowings	2,227.4	1,758.8
Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities, at fair value	2,163.5	1,706.4
Financial liabilities	(2,146.5)	(1,688.4)
Trade and other payables excluding non-financial liabilities
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	0	0
Derivatives at fair value through profit or loss	0	0
Financial assets at amortised cost	0	0
Financial liabilities at fair value through other comprehensive income	0	0
Financial liabilities at amortised cost	(647.1)	(601.1)
Financial liabilities	(647.1)	(601.1)
Derivative financial instruments
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	0	0
Derivatives at fair value through profit or loss	0.1	0.2
Financial assets at amortised cost	0	0
Financial liabilities at fair value through other comprehensive income	28	124.8
Financial liabilities at amortised cost	0	0
Financial liabilities	(28.1)	(125)
Loans and borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	0	0
Derivatives at fair value through profit or loss	0	0
Financial assets at amortised cost	0	0
Financial liabilities at fair value through other comprehensive income	0	0
Financial liabilities at amortised cost	(2,236.8)	(1,765.7)
Financial liabilities	(2,236.8)	(1,765.7)
Trade receivables
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	0	0
Derivatives at fair value through profit or loss	0	0
Financial assets at fair value through other comprehensive income	0	0
Financial assets	201.6	141.2
Financial assets at amortised cost	201.6	141.2
Financial liabilities at amortised cost	0
Derivative financial instruments
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	0	0
Derivatives at fair value through profit or loss	0.5	2.9
Financial assets at fair value through other comprehensive income	19.7	19.8
Financial assets	20.2	22.7
Financial assets at amortised cost	0	0
Financial liabilities at amortised cost	0
Cash and cash equivalents
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	0	0
Derivatives at fair value through profit or loss	0	0
Financial assets at fair value through other comprehensive income	0	0
Financial assets	254.2	393.2
Financial assets at amortised cost	254.2	393.2
Financial liabilities at amortised cost	0
Short-term investments not cash and cash equivalents [Domain]
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss		(25)
Financial assets		25
Deferred borrowing costs
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Total non-current loans and borrowings	9.4	6.9
Deferred borrowing costs | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities, at fair value	0	0
Financial liabilities	9.4	6.9
Senior EUR/USD loans | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities	(1,355.8)	(1,295.1)
Other borrowings [Domain] | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities, at fair value	0.1	0.2
Financial liabilities	(0.1)	(0.2)
2024 fixed rate senior secured notes | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities	0	(400)
Twenty Twenty-Eight Fixed Rate Senior Secured Notes | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities	(800)	0
Level 2 | Senior EUR/USD loans | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities, at fair value	1,360.8	1,300.4
Level 1 of fair value hierarchy [member] | 2024 fixed rate senior secured notes | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities, at fair value	0	405.8
Level 1 of fair value hierarchy [member] | Twenty Twenty-Eight Fixed Rate Senior Secured Notes | Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities, at fair value	€ 802.6	€ 0

Financial instruments - Derivat

Financial instruments - Derivative Financial Instruments (Details) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2022
Disclosure of financial assets [line items]
Loans and borrowings	€ 2,198.3	€ 1,736.3
Borrowings	2,227.4	1,758.8
Gross amount of financial instruments as presented upon balance sheet	20.2	22.7
Gross financial liabilities set off against financial assets subject to offsetting, enforceable master netting arrangements or similar agreements	10.8	22.7
Net financial assets subject to offsetting, enforceable master netting arrangements or similar agreements in statement of financial position	9.4	0
Gross financial liabilities subject to offsetting, enforceable master netting arrangements or similar agreements	27.9	125
Related financial instruments that are offset	10.8	22.7
Net financial liabilities subject to offsetting, enforceable master netting arrangements or similar agreements in statement of financial position	17.1	102.3
Derivative financial instruments | Cash flow hedges | Cross currency interest rate swap
Disclosure of financial assets [line items]
Notional amount	827.8		€ 827.8
Change in fair value of outstanding hedging instruments	€ 68.9	€ (71)
Weighted average hedged rate for the year	111.00%	111.00%
EUR/USD | Derivative financial instruments | Foreign exchange forward contract
Disclosure of financial assets [line items]
Carrying amount of forward currency contracts	€ 17.5	€ (21.9)
Notional amount	343.6	249
Change in fair value of outstanding hedging instruments	€ (26.3)	€ (20.6)
Weighted average hedged rate for the year	120.00%	113.00%
GBP/USD | Derivative financial instruments | Foreign exchange forward contract
Disclosure of financial assets [line items]
Carrying amount of forward currency contracts	€ 1.2	€ (3.7)
Notional amount	58.4	53.5
Change in fair value of outstanding hedging instruments	€ (0.5)	€ (2)
Weighted average hedged rate for the year	138.00%	128.00%
GBP/EUR | Derivative financial instruments | Foreign exchange forward contract
Disclosure of financial assets [line items]
Carrying amount of forward currency contracts	€ (6.7)	€ 1.4
Notional amount	244.7	159
Change in fair value of outstanding hedging instruments	€ 12	€ 8.5
Weighted average hedged rate for the year	115.00%	112.00%
SEKEUR | Derivative financial instruments | Foreign exchange forward contract
Disclosure of financial assets [line items]
Carrying amount of forward currency contracts	€ 0.5	€ (4)
Notional amount	70.4	77.3
Change in fair value of outstanding hedging instruments	€ (0.9)	€ (4.2)
Weighted average hedged rate for the year	10.00%	9.00%
Other currencies | Derivative financial instruments | Foreign exchange forward contract
Disclosure of financial assets [line items]
Carrying amount of forward currency contracts	€ 0.3	€ (0.5)
Notional amount	96.4	16.8
Change in fair value of outstanding hedging instruments	€ 0.6	€ 0.8
Weighted average hedged rate for the year	0.00%	21.00%
Deferred Financing Costs [Member]
Disclosure of financial assets [line items]
Loans and borrowings	€ 9.4	€ 6.9

Financial instruments - Deriv_2

Financial instruments - Derivatives (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Disclosure of detailed information about financial instruments [line items]
Loans and borrowings	€ 2,198.3	€ 1,736.3
Derivative financial instruments
Disclosure of detailed information about financial instruments [line items]
Total assets	20.2	22.7
Total liabilities	(27.9)	(125)
Total	(7.7)	(102.3)
Foreign exchange forward contract | Derivative financial instruments
Disclosure of detailed information about financial instruments [line items]
Total assets	20.2	5.5
Total liabilities	(7.3)	(35.5)
Cross currency interest rate swap | Derivative financial instruments
Disclosure of detailed information about financial instruments [line items]
Total assets	0	17.2
Total liabilities	(20.6)	(89.5)
Deferred Financing Costs [Member]
Disclosure of detailed information about financial instruments [line items]
Loans and borrowings	€ 9.4	€ 6.9

Financial instruments - Offsett

Financial instruments - Offsetting of Derivatives (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Derivatives - assets
Gross amount of financial instruments as presented upon balance sheet	€ 20.2	€ 22.7
Related financial instruments that are offset	(10.8)	(22.7)
Net amount	9.4	0
Derivatives - liabilities
Gross amount of financial instruments as presented upon balance sheet	(27.9)	(125)
Related financial instruments that are offset	10.8	22.7
Net amount	€ (17.1)	€ (102.3)

Commitments - Non-cancellable O

Commitments - Non-cancellable Operating Lease Rentals (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disclosure of maturity analysis of commitments [line items]
Minimum lease payments payable under non-cancellable agreements	8.7	7.5
Less than one year
Disclosure of maturity analysis of commitments [line items]
Minimum lease payments payable under non-cancellable agreements	2.2	1.9
Between one and three years
Disclosure of maturity analysis of commitments [line items]
Minimum lease payments payable under non-cancellable agreements	4.1	3.5
Between three and five years
Disclosure of maturity analysis of commitments [line items]
Minimum lease payments payable under non-cancellable agreements	2.2	2.0
More than five years
Disclosure of maturity analysis of commitments [line items]
Minimum lease payments payable under non-cancellable agreements	0.2	0.1

Capital commitments (Details)

Capital commitments (Details) - EUR (€) € in Millions	Dec. 31, 2021	Dec. 31, 2020
Capital Commitment [Line Items]
Total capital commitments	€ 23	€ 17
Property, plant and equipment
Capital Commitment [Line Items]
Total capital commitments	21.3	13.6
Intangible assets
Capital Commitment [Line Items]
Total capital commitments	€ 1.7	€ 3.4

Related parties (Details)

Related parties (Details)	Jan. 01, 2022USD ($)	Jan. 30, 2021EUR (€)	Jan. 30, 2021USD ($)$ / shares	Mar. 13, 2020EUR (€)	Mar. 13, 2020USD ($)	Jun. 15, 2015USD ($)	Aug. 31, 2020EUR (€)	Aug. 31, 2020USD ($)	Dec. 31, 2021EUR (€)shares	Dec. 31, 2021USD ($)$ / sharesshares	Dec. 31, 2020EUR (€)shares	Dec. 31, 2019EUR (€)	Jun. 30, 2021$ / shares	Dec. 31, 2020$ / shares	Aug. 01, 2020$ / shares	Jun. 17, 2020$ / shares	Jun. 14, 2019$ / shares
Disclosure of transactions between related parties [line items]
Payments to acquire or redeem entity's shares									€ 77,600,000		€ 608,600,000	€ 0
Non-Executive Director
Disclosure of transactions between related parties [line items]
Travel expenses reimbursed to related party									400,000		300,000
Travel expenses reimbursed to related party									€ 400,000		€ 300,000
Ordinary shares
Disclosure of transactions between related parties [line items]
Share price (in dollars per share) | $ / shares			$ 25.29							$ 24.50				$ 21.04	$ 25.50
Shares repurchased and canceled | shares									(3,600,000)	(3,600,000)	(29,900,000)
Payments to acquire or redeem entity's shares		€ 10.5	$ 12.8	€ 217,400,000	$ 250,900,000		€ 389,300,000	$ 460,600,000	€ 67,100,000	$ 75,800,000
Restricted Shares | Key management personnel
Disclosure of transactions between related parties [line items]
Number of shares issued (in shares) | shares										2,016,855
Restricted Shares | Non-Executive Director
Disclosure of transactions between related parties [line items]
Share price (in dollars per share) | $ / shares													$ 30.14			$ 21.78	$ 20.74
Mariposa Capital and TOMS Capital | Affiliate Of Founder Entities
Disclosure of transactions between related parties [line items]
Advisory Services Agreement, annual fee | $	$ 4					$ 2,000,000
Advisory Services Agreement, expiration notice term	90 days					90 days
Advisory Services Agreement, termination term	6 months					6 months
Mariposa Capital | Affiliate Of Founder Entities
Disclosure of transactions between related parties [line items]
Travel expenses reimbursed to related party									800,000		€ 1,000,000
Travel expenses reimbursed to related party									800,000		1,000,000
TOMS Capital | Affiliate Of Founder Entities
Disclosure of transactions between related parties [line items]
Travel expenses reimbursed to related party									800,000		900,000
Travel expenses reimbursed to related party									€ 800,000		€ 900,000

Significant events after the _2

Significant events after the Statement of Financial Position date (Details)	Dec. 31, 2021$ / shares	Aug. 05, 2021shares	Jan. 30, 2021EUR (€)shares	Jan. 30, 2021USD ($)shares	Mar. 13, 2020EUR (€)shares	Mar. 13, 2020USD ($)shares	Dec. 31, 2019	Dec. 31, 2018	Aug. 31, 2020EUR (€)shares	Aug. 31, 2020USD ($)shares	Mar. 02, 2022EUR (€)shares	Mar. 02, 2022USD ($)shares	Dec. 31, 2021EUR (€)shares	Dec. 31, 2021USD ($)shares	Dec. 31, 2020EUR (€)shares	Dec. 31, 2020$ / shares	Dec. 31, 2019EUR (€)shares	Dec. 31, 2019$ / shares
Disclosure of non-adjusting events after reporting period [line items]
Percentage increase in dividend price							20.00%	20.00%					20.00%	20.00%
Dividend price per share (in dollars per share) | $ / shares	$ 25.2127															$ 25.2127		$ 21.7289
Repurchase of ordinary shares (in shares) | €													€ 77,600,000		€ 608,600,000
Payments to acquire or redeem entity's shares | €													€ 77,600,000		€ 608,600,000		€ 0
Events after Reporting Period
Disclosure of non-adjusting events after reporting period [line items]
Number of shares repurchased (in shares)		135,621
Ordinary shares
Disclosure of non-adjusting events after reporting period [line items]
Number of shares repurchased (in shares)			507,396	507,396	11,913,682	11,913,682			18,061,952	18,061,952			3,090,082	3,090,082
Payments to acquire or redeem entity's shares			€ 10.5	$ 12.8	€ 217,400,000	$ 250,900,000			€ 389,300,000	$ 460,600,000			€ 67,100,000	$ 75,800,000
Ordinary shares | Events after Reporting Period
Disclosure of non-adjusting events after reporting period [line items]
Number of shares repurchased (in shares)											1,160,547	1,160,547
Payments to acquire or redeem entity's shares											€ 26,900,000	$ 30,500,000
Founder Entities [Member] | Ordinary shares
Disclosure of non-adjusting events after reporting period [line items]
Share dividend issued (in shares)															3,875,036		6,421,074

Uncategorized Items - nomd-2021

Label	Element	Value
Cash flow hedges [member]
Non-cash loss recognized in relation to cross currency interest rate swaps	nomd_NonCashLossRecognizedInRelationToCrossCurrencyInterestRateSwaps	€ 6,800,000
Present value of defined benefit obligation [member]
Disclosure of analysis of present value of defined benefit obligation [Table Text Block]	nomd_DisclosureofanalysisofpresentvalueofdefinedbenefitobligationTableTextBlock	Defined benefit Post-employment Total December 31, 2021 €m €m €m Present value of unfunded employee benefit obligations 77.5 11.1 88.6 Present value of funded employee benefit obligations 264.0 — 264.0 Subtotal present value of employee benefit obligations 341.5 11.1 352.6 Fair value of plan assets (108.4) — (108.4) Recognized liability for net employee benefit obligations 233.1 11.1 244.2 Defined benefit Post-employment Total December 31, 2020 €m €m €m Present value of unfunded employee benefit obligations 79.6 9.0 88.6 Present value of funded employee benefit obligations 285.5 — 285.5 Subtotal present value of employee benefit obligations 365.1 9.0 374.1 Fair value of plan assets (97.9) — (97.9) Recognized liability for net employee benefit obligations 267.2 9.0 276.2
United Kingdom, Pounds | Forward contract [member] | Currency risk [member]
Sensitivity Analysis For FX - annualized basis assuming all other factors remain constant - P&L impact	nomd_SensitivityAnalysisForFXAnnualizedBasisAssumingAllOtherFactorsRemainConstantPLImpact	€ 3,000,000
Sensitivity Analysis For FX - annualized basis assuming all other factors remain constant - P&L impact	nomd_SensitivityAnalysisForFXAnnualizedBasisAssumingAllOtherFactorsRemainConstantPLImpact	3,300,000
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Equity	nomd_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnEquity	1,500,000
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Equity	nomd_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnEquity	2,800,000
United States of America, Dollars | Forward contract [member] | Currency risk [member]
Sensitivity Analysis For FX - annualized basis assuming all other factors remain constant - P&L impact	nomd_SensitivityAnalysisForFXAnnualizedBasisAssumingAllOtherFactorsRemainConstantPLImpact	3,000,000
Sensitivity Analysis For FX - annualized basis assuming all other factors remain constant - P&L impact	nomd_SensitivityAnalysisForFXAnnualizedBasisAssumingAllOtherFactorsRemainConstantPLImpact	3,000,000
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Equity	nomd_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnEquity	(2,000,000)
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Equity	nomd_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnEquity	(1,400,000)
Sweden, Kronor | Forward contract [member] | Currency risk [member]
Sensitivity Analysis For FX - annualized basis assuming all other factors remain constant - P&L impact	nomd_SensitivityAnalysisForFXAnnualizedBasisAssumingAllOtherFactorsRemainConstantPLImpact	1,000,000
Sensitivity Analysis For FX - annualized basis assuming all other factors remain constant - P&L impact	nomd_SensitivityAnalysisForFXAnnualizedBasisAssumingAllOtherFactorsRemainConstantPLImpact	1,100,000
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Equity	nomd_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnEquity	400,000
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Equity	nomd_SensitivityAnalysisForTypesOfMarketRiskReasonablyPossibleChangeInRiskVariableImpactOnEquity	500,000
Reserve of exchange differences on translation [member]
Other comprehensive income, before tax, hedges of net investments in foreign operations	ifrs-full_OtherComprehensiveIncomeBeforeTaxHedgesOfNetInvestmentsInForeignOperations	18,800,000
Reserve of cash flow hedges [member]
Amount removed from reserve of cash flow hedges and included in initial cost or other carrying amount of non-financial asset (liability) or firm commitment for which fair value hedge accounting is applied	ifrs-full_AmountRemovedFromReserveOfCashFlowHedgesAndIncludedInInitialCostOrOtherCarryingAmountOfNonfinancialAssetLiabilityOrFirmCommitmentForWhichFairValueHedgeAccountingIsApplied	€ 2,100,000